Previous Article | Next Article ![]()
Microbiol Mol Biol Rev, March 1998, p. 130-180, Vol. 62, No. 1
Department of Microbiology and
Immunology,
1092-2172/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cell Wall and Secreted Proteins of
Candida albicans: Identification, Function, and
Expression
SUMMARY
INTRODUCTION
CELL WALL COMPOSITION AND ORGANIZATION
Composition
Organization
Layering.
Fimbriae.
CELL WALL PROTEINS
Cell Wall versus Secreted Proteins
Extraction
Composition
Modification
Glycosylation.
Phosphorylation.
Ubiquitination.
Distribution and Expression
Enzymes with Cell Wall Function
Exo-
-(1,3)-glucanase.
-1,3-Glucan transferase.
Chitinases.
-N-Acetylglucosaminidase.
Glutaminyl-peptide-
-glutamylyl-transferase.
Hydrolytic Enzymes and Proteins with Extracellular
Targets
Acid proteinase.
Phospholipase.
Esterase.
Glucoamylase.
Hemolytic factor.
Acid phosphatase.
Miscellaneous.
Morphology-Associated Proteins
Epitope recognized by MAb 4C12.
Epitope recognized by MAb 3D9.
Hwp1p.
Hyr1p.
Immunomodulatory 65-kDa Mannoprotein (MP65)
Heat Shock Proteins
hsp90.
hsp70.
Heat shock or stress mannoproteins.
Glycolytic Enzymes
Enolase.
Phosphoglycerate kinase.
Glyceraldehyde-3-phosphate dehydrogenase.
Alcohol dehydrogenase.
Binding Proteins (Receptors) for Host Ligands
Serum proteins.
(i) Serum albumin and transferrin.
(ii) Fibrinogen.
(iii) Complement fragment C3d.
(iv) Complement fragment iC3b.
Extracellular matrix proteins.
(i) Laminin.
(ii) Fibronectin.
(iii) Entactin.
(iv) Vitronectin.
(v) Collagens.
Mannan adhesins and other binding proteins.
(i) Mannan adhesins.
(ii) Hydrophobic proteins.
(iii) Fimbriae.
(iv) Plastic binding proteins.
(v) Epithelial binding lectin-like protein.
(vi) Agglutinin-like proteins.
(vii) Adherence to Streptococcus spp. and other
bacteria.
(viii) Adherence to salivary proteins.
(ix) Miscellaneous.
WHERE ARE WE GOING? THE MYSTERIES AND CHALLENGES
FINAL COMMENT AND OUTLOOK
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
The cell wall is essential to nearly every aspect of the biology and pathogenicity of Candida albicans. Although it was intially considered an almost inert cellular structure that protected the protoplast against osmotic offense, more recent studies have demonstrated that it is a dynamic organelle. The major components of the cell wall are glucan and chitin, which are associated with structural rigidity, and mannoproteins. The protein component, including both mannoprotein and nonmannoproteins, comprises some 40 or more moieties. Wall proteins may differ in their expression, secretion, or topological location within the wall structure. Proteins may be modified by glycosylation (primarily addition of mannose residues), phosphorylation, and ubiquitination. Among the secreted enzymes are those that are postulated to have substrates within the cell wall and those that find substrates in the extracellular environment. Cell wall proteins have been implicated in adhesion to host tissues and ligands. Fibrinogen, complement fragments, and several extracellular matrix components are among the host proteins bound by cell wall proteins. Proteins related to the hsp70 and hsp90 families of conserved stress proteins and some glycolytic enzyme proteins are also found in the cell wall, apparently as bona fide components. In addition, the expression of some proteins is associated with the morphological growth form of the fungus and may play a role in morphogenesis. Finally, surface mannoproteins are strong immunogens that trigger and modulate the host immune response during candidiasis.
INTRODUCTION
|
|
|---|
Candida albicans is a serious agent of infection, particularly in immunocompromised patients. The delicate balance between the host and this otherwise normal commensal fungus may turn into a parasitic relationship, resulting in the development of infection, called candidiasis. The nature and extent of the impairment of normal host defense influence the manifestation and severity of infection. In general, superficial mucocutaneous candidiasis is frequent in patients with T-cell deficiencies, such as AIDS patients. The more serious, life-threatening, deep-seated or disseminated candidiasis is normally found in a spectrum of severely immunocompromised patients (29, 390). The fungus is not a mere passive participant in the infectious process, and a hypothetical set of virulence factors for C. albicans has been proposed and supported by various studies. These fungal attributes include the production of secreted hydrolytic enzymes, dimorphic transition (morphogenetic conversion from budding yeast to the filamentous growth form or hypha), antigenic variability, the ability to switch between different cell phenotypes, adhesion to inert and biological substrates, and immunomodulation of host defense mechanisms (for a review of these topics, see reference 96).
Initially, the cell wall was considered an almost inert structure that supplies rigidity and protection to the protoplast. Today, the cell wall is well established as being essential to almost every aspect of the biology and pathogenicity of C. albicans (64). The cell wall acts as a permeability barrier and is the structure that maintains the characteristic shape of the fungus. Also, as the most external part of the cell, the wall mediates the initial physical interaction between the microorganism and the environment, including the host. For these reasons, the cell wall of C. albicans is the focus of study by numerous research groups. Their objectives are the elucidation of both basic biological processes and functional mechanisms regulating the synthesis, organization, and environmental interactions of this complex macromolecular structure. Proteins have been implicated in most of the cell wall functions. Extensive reviews exist on different aspects of the cell wall of C. albicans (64, 478-482, 491, 493); however, recent reviews that focus on proteins have been limited primarily to the function of proteins as adhesins (49, 50, 110, 111, 151, 209, 406). This review focuses on both general characteristics of the cell wall and secreted proteins and specific aspects of individual proteins.
Although hydrolytic enzymes such as acid phosphatase were examined previously, studies on the identity and function of protein components began in the early to mid 1980s with studies in 1983 by Chaffin and Stocco (71), in 1985 by Elorza et al. (125) and Sundstrom and Kenny (524), and in 1986 by Pontón and Jones (414). In the first part of this decade, there has been an explosive growth in the number of studies of the cell wall proteins. These studies have been driven by presumed virulence functions of specific proteins and fueled by the realization that this is a complex, dynamic "organelle." Out of such impetus has come the identification of specific proteins not yet associated with specific pathogenic function and observations with more general import for the cell and cell wall proteins. This increasing knowledge of the protein component of the cell wall may result in a better understanding of the pathogenic mechanisms of the fungus and also may contribute to the design of innovative therapeutic regimens and diagnostic procedures (175, 333). At times, these studies have revealed several surprises and unexpected findings, which only add more attraction to the study of this fascinating microorganism. In writing this review, we have focused on the protein component with three objectives: (i) to summarize general aspects of proteins; (ii) to summarize studies on specific proteins or protein families; and (iii) to consider the implications, unanswered questions, and future research directions suggested by these studies.
Cell Wall and Morphology
Although the terms "dimorphism" and "dimorphic fungus", i.e., existing in two morphological forms, are well established and commonly accepted when referring to C. albicans, strictly speaking this fungus has the ability to adopt a spectrum of morphologies, and thus C. albicans could be considered a "polymorphic" or "pleomorphic" organism (244, 390). Since changes in the cell wall determine the shape of the whole fungal cell, the cell wall is the structure ultimately responsible for a given morphology. C. albicans can reproduce by budding, giving rise to the formation of yeast cells (also designated blastospores or blastoconidia). The production of germ tubes results in the conversion to a filamentous growth phase or hypha, also called the mycelial form. The formation of pseudohyphae occurs by polarized cell division when yeast cells growing by budding have elongated without detaching from adjacent cells. Under certain nonoptimal growing conditions, C. albicans can undergo the formation of chlamydospores, which are round, refractile spores with a thick cell wall. These morphological transitions often represent a response of the fungus to changing environmental conditions and may permit the fungus to adapt to different biological niches. The transition from a commensal to a pathogenic lifestyle may also involve changes in environmental conditions and dispersion within the human host. The ultrastructure, composition, and biological properties of the cell wall are affected by these morphological changes (64). Although progress has been achieved in the recent years, the molecular mechanisms governing these morphogenetic conversions are still not fully understood, partly due to the difficulty of genetic manipulations in this fungus (274, 275, 474). Recent reports that may herald rapid advances in this area have identified transcriptional regulatory genes, a general transcriptional repressor TUP1 (38), a putative transcriptional factor RBF1 (220), and a myc-like transcriptional factor EFG1 (516) that affect cellular morphology when their expression is altered. Most of the observations from these studies have been incorporated by Magee (310) into a model for the regulation of pseudohyphal growth.
Cell Wall and Interactions with the Host
Two major aspects of the host-parasite interactions are the adhesion of C. albicans cells to host cells and tissues and the immunomodulation of the host immune response.
Adhesion is a prerequisite for colonization and an essential step in the establishment of infection. C. albicans adheres to epithelial cells, endothelial cells, soluble factors, extracellular matrix, and inert materials implanted in the body of the host. Multiple adherence mechanisms appear to be used by C. albicans cells (49, 50, 110, 111, 151, 209, 252, 406). Physical interactions of this fungus with the host are mediated at the cell surface, and cell wall constituents implicated in binding have been designated adhesins (49). The large repertoire of adhesins displayed by this fungus may reflect the variety of host sites that it can invade (49, 50, 110, 111, 209). Specific characteristics of individual cell wall moieties participating in adhesion events are discussed later in this review.
Another important aspect of interactions with the host, with direct implications for pathogenesis, is the potential of this fungus to modulate the immune response mounted by the host (64, 96, 107). The capacity of cell wall constituents, including glucan, chitin, and mannoproteins, to modulate (activate or depress) the immune response is well documented (11, 64). Mannans and mannoproteins display the most potent immunomodulatory activity, being able to regulate the action of virtually all arms of the immune system (natural killer cells, phagocytic cells, cell-mediated immunity, and humoral mechanisms) (64, 107, 402, 412). Although individual cell wall moieties with immunomodulatory properties are described below, readers are referred to excellent reviews on this topic (11, 64, 107).
CELL WALL COMPOSITION AND ORGANIZATION
|
|
|---|
Composition
Approximately 80 to 90% of the cell wall of C. albicans is carbohydrate. Three basic constituents represent the
major polysaccharides of the cell wall: (i) branched polymers of
glucose containing
-1,3 and
-1,6 linkages (
-glucans); (ii)
unbranched polymers of N-acetyl-D-glucosamine
(GlcNAc) containing
-1,4 bonds (chitin); and (iii) polymers of
mannose (mannan) covalently associated with proteins
(glyco[manno]proteins). In addition, cell walls contain proteins
(6 to 25%) and minor amounts of lipid (1 to 7%) (50, 64, 490,
493).
The microfibrillar polymers (
-glucans and chitin) represent the
structural components of the wall. They form a rigid skeleton that
provides strong physical properties to the cell. From a quantitative point of view,
-glucans are the main constituent, accounting for 47 to 60% by weight of the cell wall. Chitin is a minor (0.6 to 9%) but
important component of the C. albicans wall, particularly of
the septa between independent cell compartments, budding scars, and the
ring around the constriction between mother cell and bud (126,
360).
On the other hand, mannose polymers (mannan), which do not exist as
such but are found in covalent association with proteins (mannoproteins), represent about 40% of the total cell wall
polysaccharide and are the main material of the cell wall matrix
(50, 64, 480, 490, 493). The term "mannan" has been used
also to refer to the main soluble immunodominant component present in
the outer cell wall layer of C. albicans, called
phosphomannoprotein or phosphopeptidomannan complex. This cell wall
fraction contains homopolymers of D-mannose (as the main
component), 3 to 5% protein, and 1 to 2% phosphate (436).
The general features of cell wall mannoproteins in C. albicans are basically identical to those found for
Saccharomyces cerevisiae, one of the most thoroughly investigated yeasts in this regard. Several studies have resulted in a
detailed knowledge of the structure of this cell wall constituent in
C. albicans (12, 262-265, 494-498). Thus,
mannose polymers are linked to the protein moiety through asparagine
(by N-glycosidic bonds through two GlcNAc
[di-N-acetylchitobiose] residues) and threonine or serine
(by O-glycosidic, alkali-labile linkages) residues. The
N-glycosidically linked carbohydrate is composed of backbone chains of
-1,6-linked mannopyranosyl residues to which oligosaccharide side
chains are attached. The side chain mannopyranosyl residues contain
-1,2,
-1,3,
-1,2,
-1,6, and phosphodiester linkages as well
as branches (
-1,6) that are oversynthesized under acidic growth
conditions (150, 152, 261-267, 494-498). The
O-glycosidically-linked sugar component consists of single mannose
residues and short, unbranched mannose oligosaccharides
(412). Several studies raise the question of additional
sugars present in cell wall constituents. These observations include
the following: (i) not all proteinaceous moieties present in cell wall
extracts from this fungus react with concanavalin A, a lectin
recognizing
-mannosylpyranose, or with polyclonal and monoclonal
antibodies that recognize other mannan epitopes, such as factor 6, a
mannooligosaccharide that confers serotype A specificity
(57); (ii) differences in glycosylation and in sensitivity
to neuraminidase have been detected in candidal receptors for
complement (4, 563); and (iii) treatment with neuraminidase
affects the electrostatic surface properties of C. albicans
as detected with a fluorescent probe (227). As suggested in
these studies, the observations raise the possibility that additional
sugars are cell wall constituents. However, the observations could
reflect the existence of contaminating proteases in the glycosidase
preparation. Sugar residues other than mannose may define either
additional functional or antigenic motifs or both in cell wall
glycoproteins.
The percent composition of walls from yeast cells and filamentous forms
are similar, although the relative amounts of
-glucans, chitin, and
mannan vary according to the C. albicans growth form considered (50, 480, 491). Hyphal cells contain at least
three times as much chitin as yeast cells do (77, 127, 518).
Chitin is the first polymer to appear in regenerating protoplasts
(124, 375). Although the ratio of
-1,3- to
-1,6-glucan
in the insoluble fraction is similar in yeast and hyphal cells, the
insoluble glucan in the initial period of germ tube formation contains
considerably more
-1,3 linkages than that found in yeast and mature
hyphal cells (518). The literature contains several reports
on the identification of morphology-specific proteins and mannoproteins
that are discussed later in this review.
Organization
The different cell wall components interact with each other to
give rise to the overall architecture of the cell wall. Besides hydrogen and hydrophobic bonds, there is also experimental evidence for
the presence of covalent linkages between different components (453, 482). Surarit et al. (527) reported the
presence of glycosidic linkages between glucan and chitin in the
nascent wall of C. albicans. Recent evidence indicates that
mannoproteins may also establish covalent associations with
-glucans
(237, 238, 462, 463). It is suggested that
-1,3- and
-1,6-glucans are linked to proteins by phosphodiester linkages, a
process that may involve the participation of a GPI (glycosyl
phosphatidylinositol) anchor (238) (see below). Protein and
mannoprotein species that are released only after digestion of the
glucan cell wall network with
-glucanases may play a key role in
configuring the final cell wall structure characteristic of each growth
form (yeast and mycelium) of C. albicans (453, 479-482). Interactions between glyco(manno)proteins and
chitin also appear to exist in the wall of C. albicans cells
as deduced from two lines of evidence: (i) chitinase treatment of
isolated cell walls solubilizes protein moieties, and (ii) the kinetics
of incorporation of protein and mannoprotein constituents into the
walls of regenerating protoplasts is altered in the presence of
nikkomycin, an antibiotic that blocks chitin synthesis (124,
319).
Cell wall architecture has been studied most extensively in S. cerevisiae and is likely to be a model for C. albicans
since there are some similar observations, in particular sensitivity to
enzymatic digestion, glucan-mannoprotein linkages, and candidate proteins, that fit the same model (237, 238, 246, 247, 268, 462,
463). In a very recent study, Kollár et al.
(268) detected the presence of material containing all four
major cell wall components,
-1,3-glucan,
-1,6-glucan, chitin, and
mannoprotein. Their analysis indicated that
-1,6-glucan has some
-1,3-glucan branches that may be linked to the reducing end of
chitin. The
-1,6-glucan and mannoprotein are attached through a
remnant of the mannoprotein GPI anchor. Reducing ends of
-1,6-glucan
may also be attached to the nonreducing end of
-1,3-glucan. The
proportion of cell wall polysaccharide involved in this type of
structure is not clear. The following cell wall building block, where
the linkages are indicated by the long dashes, is proposed (247,
268): Mannoprotein
GPI remnant
-1,6-glucan
-1,3-glucan
chitin. The authors point out that these linkages are likely to be formed in the periplasmic space as
a common end of the individual biosynthetic pathways. Chitin and
-1,3-glucan are synthesized at the plasma membrane and extruded into
the periplasm, mannoprotein is synthesized in the cytoplasm and
transported through the secretory pathway, and
-1,6-glucan synthesis
may occur partially in the endoplasmic reticulum or Golgi complex
(268). Not all components are necessarily present in a
complex; therefore, the authors suggest that more chitin may be present
in inner cell wall layers and more mannoprotein may be present in the
outer layers.
Layering.
Since polysaccharides are poorly reactive to
the ordinary fixatives and stains used for transmission electron
microscopy, only a few well-defined ultrastructural details are
obtained by conventional protocols (Fig.
1A and B). However, transmission electron
microscopy studies performed with more special
techniques or with cytochemical stains and contrasting agents show
several layers in the cell wall of C. albicans (Fig. 1C to
F). The appearance of these layers is variable and seems to be related
to the strain examined, growth conditions, morphology, and preparation
of the specimens (50, 64, 422). Thus, there is no consensus
about the number of layers present in the cell wall. Different authors have reported the presence of three to eight different layers (28,
64, 186, 421, 438). The outer cell wall layer appears as a dense
network with a fibrillar or flocculent aspect (64, 480),
whereas the inner wall layer appears contiguous with the plasmalemma
with extensive membrane invaginations involved in anchoring of the cell
wall to the membrane (192, 276). The microfibrillar polysaccharides glucan and chitin, the components that supply rigidity
to the overall wall structure, appear to be more concentrated in the
inner cell wall layer, adjacent to the plasma membrane. In contrast,
proteins and mannoproteins appear to be dominant in the outermost cell
wall layer (Fig. 1B), although they are also present through the entire
wall and at the inner regions of the cell wall. Some of the latter
proteins may be covalently associated with glucans. Evidence from
several cytochemical and cytological studies indicate that the cell
wall layering may be due to the distribution of mannoproteins at
various levels within the wall structure (64). In any case,
it seems clear that layering may be the result of quantitative
differences in the proportions of the individual wall components
(
-glucans, chitin, and mannoproteins) in each layer rather than of
qualitative differences (389).
|
Fimbriae. The outer cell wall layer that is composed mainly of mannoproteins appears as a dense network of radially projecting fibrils (28, 64), designated fimbriae (154, 583). These fibrils extend for 100 to 300 nm (190, 276) and are approximately 5 nm in diameter (28). Both filamentous forms and blastospores exhibit this characteristic feature (28). C. albicans fimbriae consist of many subunits assembled through noncovalent hydrophobic interactions (583). The major structural subunit of fimbriae is a glycoprotein with an apparent molecular mass of 66 kDa, while the unglycosylated protein has an approximate molecular mass of 8.64 kDa (583). In crude extracts, in addition to the 66-kDa moiety, components migrating with an electrophoretic mobility equivalent to proteins of 54, 47, and 39 kDa reacted with monoclonal antibodies (MAbs) raised against purified fimbriae, suggesting the presence of species with differing degrees of glycosylation (585). The hydrophobic status of the cells profoundly affects fimbrial structure. Hydrophilic cells have long, compact, evenly distributed fibrils, while hydrophobic cells have short, blunt fibrils (190) (Fig. 1E and F). The overall hydrophilic status may be due to masking of hydrophobic components by hydrophilic surface fibrils (190). Fimbrial components mediate the adherence of C. albicans to glycosphingolipid receptors on human epithelial cells (279, 583, 584, 586) as discussed later.
Celerin et al. (67, 68) reported that in the fungus Mycrobotryum violaceum, fimbriae are composed of a protein with strong similarity to collagen. The fimbrial protein from C. albicans discussed above does not appear to be related to this collagenous fimbrial protein (68). However, this type of collagenous fimbria appears to be conserved among fungal species since antiserum to the protein domain reacts with surface proteins of many fungi (67). The antiserum also reacts with 81- and 84-kDa surface moieties that may represent a second putative candidal fimbria (67). Although some fungi contain more than one type of fimbria (577), there is no additional evidence for multiple types of fimbriae in C. albicans. If such collagenous fimbriae are found in C. albicans, additional fimbria-mediated interactions of the microorganism with the host cells and tissues may be possible (see below).CELL WALL PROTEINS
|
|
|---|
Cell Wall versus Secreted Proteins
Should location or function determine the classification of a cell wall protein or secreted protein? Are proteins either one or the other? Proteins that are found in the in vitro growth medium are often called secreted or extracellular proteins. To reach this location, these proteins travel through the cell wall, where they coexist with cell wall-bound moieties and by location are proteins that contribute the total cell wall proteinaceous component. However, it seems reasonable to consider transiently associated proteins with an environmental destination as being secreted. On the other hand, how do we classify a protein when the association does not appear to be transient or when the postulated function of the protein is within the cell wall? There are proteins that are cell associated under one growth condition and secreted under another (519). Cytochemical detection of phospholipase activity shows a localized cell wall location in cells grown on yeast extract medium and a development of a more generalized cell wall, cell surface, and secreted localization in cells in contact with the chorioallantoic membrane (425, 427). There are enzymes recovered from culture supernatants whose functions are thought to be cell wall biosynthesis and remodeling (75). For most proteins, extracellular locations have not all been examined, so that some proteins that are reported as cell wall associated might also be found in culture fluids if examined. Several cell wall components that are not thought to be secreted have been detected in supernatants of C. albicans cell cultures (2, 178, 299, 536, 543). The relationship of some of these moieties with the cell wall structure is unclear. They may come from the outer wall layers. Alternatively, they may be released by lysed cells or as a consequence of the controlled degradation of the cell wall structure, required for wall expansion during growth. One of the criteria that has been used to demonstrate a cell surface location is binding of a ligand or antibody. When similar observations are made with extracellular proteins such as secreted acid proteinase (397) or phospholipase (425, 427), should this finding be differently interpreted, particularly when there may be a function for the cell associated protein (147, 433)? This discussion makes clear that for some proteins, classification as cell wall or secreted may be dependent upon the growth conditions of the organism, the conditions under which localization has been examined, and our view of the function of the protein. As the mechanisms of targeting proteins to subcellular locations are elucidated and protein functions more completely examined, these issues should be resolved. In this review, we have included both proteins whose function is thought to be in the cell wall and those whose role is thought be primarily extracellular.
In the next four sections, we consider general questions of cell wall protein extraction, protein composition of the extracts, protein modification, and distribution of proteins within the cell wall. In these studies, the emphasis has been on definition of cell wall protein by location, since the principal concern has been the removal of a cytoplasmic contribution to the extract. In the following sections, we review specific proteins that have been grouped by various functional and identity relationships.
Extraction
Different techniques have been used to extract cell wall components of C. albicans. These include physical, chemical, and enzymatic methods and a combination of them. The choice of extracting reagents and techniques, the sequence of extraction methods, and the use of either intact cells or purified cell walls as the starting material may affect both qualitative and quantitative solubilization of cell wall components. In general, and due to the insolubility of both chitin and glucans, sequential alkali and acid treatments are required to effect their extraction (140, 141). In early studies, mannans were extracted from whole cells or isolated cell walls by alkali treatment and further precipitated with Fehling's solution as a copper complex (408). A milder procedure involved mannan extraction from cells resuspended in citrate buffer (pH 7) by autoclaving and further purification by precipitation with Fehling's solution (405) or with Cetavlon (66, 376, 392). This topic is covered more extensively in other reviews (141).
Proteinaceous components have been extracted or solubilized from the
cell wall of C. albicans by a variety of techniques. Most of
the studies have involved either detergents (such as sodium dodecyl
sulfate or n-octylglucoside), reducing agents (such as dithiothreitol [DTT] and
-mercaptoethanol [
ME]), or
hydrolases (such as proteases, Zymolyase, or other
-glucanases, and
chitinases) to release proteins from both isolated cell walls and
intact cells (57, 59, 61, 71, 78, 122, 125, 319, 365, 414, 508, 524, 525). These reagents have been used alone or in combination. Although sulfhydryl compounds such as
ME appear to be less efficient that hydrolases such as Zymolyase in releasing cell wall-bound proteins
and glycoproteins (295), these chemical agents solubilize a
complex array of proteinaceous components from the walls of intact
C. albicans cells (57, 58). On the other hand,
some
-glucanases used to solubilize cell wall moieties actually are enzymatic complexes that may contain other unidentified or uncontrolled hydrolytic activities, which may alter the native characteristics of
the released molecules.
Other extraction procedures have been less frequently reported and
include chemical, enzymatic, and physical methods alone or in
combination.
-Elimination with NaOH has been used to release putative structural proteins (369).
Ethylenediamine has also been used in structural studies to
extract proteins (455). Salt (NaCl) was used to extract the
surface determinant of a MAb (40) and a surface adhesin
(225). Homogenization has been used to shear fimbriae
(583), and
-mannosidase treatment followed by sonication
has been used to release wall antigens (195).
There has been little comparison of the various methods used to extract
the wall proteins. Casanova and Chaffin (57) compared five
extracts for yeast cells and germ tubes: (i)
ME extract of intact
cells at alkaline pH; (ii) the Zymolyase extract of the treated cells;
(iii)
ME extract of isolated cell walls at alkaline pH; (iv) the
Zymolyase extract of the treated cell walls; and (v) a sodium dodecyl
sulfate (SDS)-
ME extract of isolated cell walls. The extracts were
examined by blotting with concanavalin A, two MAbs (MAb 4C12 to a
high-molecular-weight component of germ tubes [59] and
MAb 24.17 to a mannan epitope of a high-molecular-weight component
[72]) and antiserum for factor 6. The authors
concluded that the two sequential extracts obtained from intact cells
were most satisfactory. In addition, although extraction with reducing agents is frequently thought to release medium to small components from
the cell wall, this study showed that
ME also released the high-molecular-weight components. These appeared to be larger than the
same component present in Zymolyase extracts.
ME and other reducing
reagents are believed to solubilize mainly components associated with
the outermost layers of the cell wall (50, 61, 295). These
reagents also increase cell wall porosity and facilitate subsequent
action of cell wall degrading enzymes (103, 589). The
hydrolysis of glucan by Zymolyase or glucanases may release proteins
enmeshed or covalently attached to the glucan. Proteins covalently
attached to glucan are postulated to represent species contributing to
cell wall structure (59, 122, 123, 125, 482). Covalent
attachment of mannoprotein to glucan, perhaps through phosphodiester
linkages, has been suggested, as noted below (237, 238, 462,
463).
A valid question is whether the proteins found in these extracts are
genuine cell wall components. It has been suggested that treatment of
intact C. albicans cells with reducing agents (DTT or
ME)
may release some intracellular macromolecular components (50). This question has been examined most thoroughly for
extracts obtained with
ME. As discussed later in this review,
receptors or binding proteins for ligands that bind to the intact cell
are found in such extracts. On the other hand, several proteins
previously associated with a cytoplasmic function have also been found
in the wall extracts (6, 8, 161, 303, 520). These
observations led to additional experiments using different approaches
to demonstrate that the proteins found in the extract were genuine wall
components. Transmission electron microscopy demonstrated that each of
the moieties was indeed present in the cell wall, including the cell wall interior (6, 8, 303). Chaffin and colleagues (6, 303) also used a more general method to identify genuine cell wall proteins. Intact cells were treated with a derivative of biotin
that does not permeate the membrane and therefore does not label
cytoplasmic proteins. The extracted biotinylated proteins included
those previously thought to be confined to the cytoplasm. This
demonstrated that the proteins were present in the cell wall prior to
extraction and that their presence in the extract was not due to
cytoplasmic contamination. Support for the validity of the extraction
procedure was also obtained with parental and mutant strains of
S. cerevisiae (294). Two members of the Ssa family of proteins (Ssa1p and Ssa2p) were detected in the cell wall and
cytoplasm of the parental strain, whereas in the mutant strain missing
these two proteins the remaining members of the family were detected in
the cytoplasm but not in the cell wall. The failure to find Ssa
proteins in the cell wall of the mutant strain demonstrated that the
cell wall extract was not contaminated with the Ssa proteins of the
cytoplasm. Hence, current evidence indicates that treatment with
sulfhydryl compounds is a suitable method to release autochthonous cell
wall protein and glycoprotein components without substantially altering
their biological characteristics (6, 60, 61, 293, 295, 296, 300,
302, 377).
Composition
Analysis of the protein and glycoprotein constituents solubilized
from isolated cell wall preparations and from intact cells of both
candidal growth forms by different treatments has revealed both a
complex array of protein-containing components and quantitative and
qualitative differences in the protein composition of yeast and
mycelial cell walls (57-59, 71, 125, 295, 319, 320, 324, 363,
414-416, 524) (Fig. 2). Some
components have been characterized as high-molecular-weight
mannoproteins (HMWM). The identity of these proteins may vary with the
morphology of the organism. Several HMWM are released by treatment with
-glucanases and may be covalently attached to structural
polysaccharides. These HMWM may play an important role in modulating
the organization of the different cell wall constituents to obtain the
final supramolecular structure of the wall specific for each C. albicans morphology. In addition, HMWM contain large amounts of
carbohydrate and consequently could be major elicitors of anticandidal
host immunity (59, 62, 123, 159, 160, 297, 301, 326, 327, 415,
479, 523). In the medium- to low-molecular-weight range, from 20 to more than 40 polypeptide species (depending on the study considered)
have been identified (61, 71, 125) (Fig. 2). As discussed
above, the evidence suggests that these proteins are bona fide cell
wall constituents.
|
There is a growing body of experimental evidence indicating that the
properties
expression, distribution, and chemical characteristics
of cell wall proteins and glycoproteins observed in vitro and in vivo are
dependent on multiple factors. These include growth conditions, organism-related factors (such as growth state, morphology of the
cells, strain and serotype, phenotypic switching, cell surface hydrophobic or hydrophilic status), and the nature of the biological specimens (intact cells or isolated wall preparations) that are subjected to analysis (5, 7, 24, 44, 57, 63, 106, 159, 190, 191,
195, 210, 284, 297, 301, 326, 416, 422, 477, 513, 529). Iron
availability, which has been shown to be important for pathogens in
establishing infection (46, 400, 566), affects the cell
surface (529). There are quantitative but not qualitative
changes in the profile of surface proteins associated with growth at
different iron concentrations. Yeast cells of most strains grown in
limiting or excess iron do not adhere as well to human buccal
epithelial cells as do organisms grown at intermediate concentrations
that support optimum growth. The effects of growth conditions on the
expression of specific proteins are discussed for each protein in later
sections. The cell wall may be thus envisaged as a highly dynamic
"organelle." The fungus is capable of expressing differentially
variable wall constituents that may be useful for switching between
commensal and pathogenic lifestyles and for modulating and/or evading
the immune host defense.
Modification
Posttranslational modifications of proteins include glycosylation, acetylation, prenylation, phosphorylation, ubiquitination and addition of a GPI moiety. Organisms use these modifications to confer structural options for proteins, to provide regulatory control of their functions and to target proteins to specific cellular locations. While not all of these modifications have been described in C. albicans, it is likely that the organism possesses the ability to modify its proteins by most, if not all, of the posttranslational modifications.
Glycosylation. Without any doubt, glycosylation is the most important modification of the proteins in the fungal cell wall. Attachment of sugar moieties to proteins results in the formation of the glycoproteins, which in the case of C. albicans are mainly mannoproteins. The general features of mannoproteins have been discussed above. However, the presence of nonglycosylated proteins has also been found in the cell wall of C. albicans (6, 8, 58, 61, 161). Mannosylated proteins can be broadly divided into two classes. The HMWM, most of which are larger than 200 kDa, are postulated to have structural functions within the cell wall. Some medium- to low-molecular-weight proteins also react with concanavalin A, indicating their mannan content. Within this broad division, the amount of carbohydrate attached to the same polypeptide may vary (59, 122, 364). Within the high-molecular-weight class, there is a difference in the size of the side chains associated with morphology. Oligosaccharides obtained from mannoproteins from yeast cells average 600 residues, and those from germ tubes average 300 residues (122). Cell wall proteins may also be O glycosylated with unbranched mannose chains containing one to a few residues (412). Elorza et al. (123) have suggested that some proteins are initially secreted as O-glycosylated proteins and become cross-linked with glucan and/or other N-glycosylated proteins only after incorporation into the cell wall structure.
Phosphorylation.
Phosphorus is a minor component of
the cell wall of C. albicans (77). It has been
assumed that it is present in cell wall mannoproteins in phosphodiester
linkages between mannose residues (17, 454). Bulk mannan
from C. albicans can be fractionated into five fractions
that differ in the amount of phosphate (393). Phosphomannoprotein complexes from cells of both C. albicans
A and B serotypes have been characterized (261-263,
494-498). This material contained 0.9 to 1.6% phosphate
depending on the morphology and strain considered, and the authors
concluded that
-(1,2) oligomannosaccharides were attached by
phosphodiester linkage to other branching moieties.
-(1,2)
oligomannosidic epitopes were further observed on a C. albicans 14- to 18-kDa phospholipomannan moiety (545),
a glycolipid with important immunologic properties (133-135, 228,
229, 424), whose mannose residues may be added differently from
mannan (546). Not all the glycoproteins in the cell wall of
C. albicans contain phosphate, and some proteins may contain
phosphate but not carbohydrate (58).
-1,6- and
-1,3-glucan
moieties present in C. albicans cell wall mannoproteins may
be connected to a GPI anchor, which is known to be phosphodiester linked to the C-terminal amino acid of the mature protein (237, 238, 247, 268). This is in agreement with the hypothesis that proteins destined to be incorporated into the cell wall are linked to
-glucan through the glycan part of their GPI anchors
(104), as has been demonstrated for the S. cerevisiae
-agglutinin (306, 573). The GPI anchor
targets
-agglutinin to the cell wall (573). Pulse-chase
experiments indicate that a plasma membrane-bound form is released to
periplasmic space as an intermediate form that is then incorporated
into the cell wall (305, 306). Recent studies of the linkage
between mannoprotein and glucan suggest that the GPI remnant consists
of ethanolamine-phosphate-mannose5, with the terminal
mannose attached to the nonreducing end of
-1,6-glucan (268). A transglycosylation reaction is proposed to effect
the linkage.
Ubiquitination.
Ubiquitin is a small (approximately
8,500-Da) polypeptide first isolated from bovine thymus
(167). Sequence analysis of various ubiquitin genes has
revealed striking evolutionary conservation among species
(138). Ubiquitin plays important roles in protein modification, protein degradation, gene transcription, organization of
chromatin structure, and stress resistance in higher eukaryotes (138, 139, 197). It is also associated with some cell
surface protein and signaling functions (69, 368, 404, 504,
553). In yeast, a role for ubiquitination in endocytosis and/or
turnover of plasma membrane protein receptors including
-receptor
has been demonstrated (198, 269, 442). The C terminus of
ubiquitin is covalently attached to
-amino groups of lysine in
protein substrates by an enzymatic conjugation system. A large number of enzymes responsible for the formation and processing of
ubiquitin-protein conjugates have been described (138),
including in C. albicans (98). We have cloned a
polyubiquitin gene (UBI1) of C. albicans that
contains three tandem copies, head-to-tail spacerless repeats, of the
sequence coding for the 76 amino acids of the ubiquitin protein
(485). The gene has also been cloned from a different strain
(15). Northern blot analysis revealed a single mRNA
population of about 1 kb present in similar amounts in both yeast and
mycelial cells (485). Indirect immunofluorescence
demonstrated that ubiquitin determinants were located on the cell
surface, and Western blot analysis of a
ME extract demonstrated that
several cell wall proteins contained ubiquitin-like epitopes. The cell
wall species that are ubiquitinated are discussed below with the
individual proteins. The role of ubiquitin in the cell wall whether in
protein degradation, stress protection, or perhaps even modulation of activity of receptor-like molecules remains to be assessed.
Distribution and Expression
As described above, transmission electron microscopy
studies of the C. albicans cell wall show the existence of
several layers. The structural appearance of these layers is variable
and seems to be related to the strain examined, the growth conditions,
the morphology (yeast cells or germ tubes) exhibited by the
microorganism, and the sample preparation protocol (50, 64,
422) (Fig. 1). After total removal of proteins and mannoproteins
by treatment with strong alkali or heating, the cell wall appeared to
be significantly thinner with loss of any appreciable layering. These
structural changes were paralleled by the absence of electron-dense
components detectable with ordinary electron microscopy dyes,
concanavalin A binding sites, and positive staining with reagents
specific for mannoproteins (periodate-silver). Thus, the cell wall
layering appears attributable to the distribution of mannoproteins at
various levels within the wall structure (64). Treatment of
cells with sulfhydryl agents and hydrolytic enzymes, coupled with
specific cytochemical staining, has consistently shown that
mannoprotein constituents are preferentially located at the outermost
layer of the wall of C. albicans cells. The surface has a
fibrillar or flocculent aspect with thin, delicate filaments or
fimbriae (Fig. 1; see below). This material is present mostly in
virulent strains, and it is also more abundant in isolates exhibiting
increased adherence to host tissues (64). Proteins whose
biological function is at the cell surface or the extracellular
environment may nevertheless be found at the innermost layer of the
wall and through the wall as they travel from the plasma membrane and
periplasmic space to their destination (478). Thus, some
proteins destined for the extracellular environment may also be
obtained in cell wall extracts. Evidence for this mannoprotein traffic
in C. albicans has been reported (423).
Immunoelectron microscopy shows that proteins on the cell surface
visualized by indirect immunofluorescence are also detected at the cell
surface as well as near the plasma membrane with some protein
distributed through the wall (6, 303). On the other hand, a
protein that is not detected at the cell surface by indirect
immunofluorescence but is present in cell wall extracts is located only
in the interior of the wall (8). Using a panel of MAbs to
localize proteins, Pontón et al. (416) demonstrated
various distribution classes of cell wall proteins: (i) expressed only
on the germ tube surface, (ii) expressed on the germ tube surface and
within the yeast cell wall, (iii) expressed on both yeast cell and germ
tube surfaces, and (iv) expressed within the wall of both germ tubes
and yeast cells. A fifth category, expressed only on yeast surfaces, is
also reported (296). Proteins that are associated with
-glucans should be concentrated near the plasma membrane with the
structural polysaccharide. In any case, since asymmetry in mannoprotein
distribution is evident in C. albicans walls
(64), layering is more likely to be the result of
quantitative differences in the proportions of the individual wall
components (
-glucans, chitin, and mannoproteins) in each layer
rather than qualitative differences (389).
Differences in the distribution of proteins and glycoproteins at the cell surface are also noted. This asymmetry may be related to the physiologic role played by each particular moiety. High-molecular-weight mannoproteins that may play an important and active morphogenetic role in modulating the organization of the cell wall (59, 62, 123, 160, 326, 327, 480) are homogeneously distributed on the cell surface (59, 62, 159). Some proteins and mannoprotein moieties that are receptors for different host ligands exhibit clustering or asymmetric cell surface distribution (60, 296, 328). The distribution of common or morphology-associated, homogeneously or heterogeneously distributed cell surface antigens of C. albicans as revealed by immunofluorescence microscopy is shown in Fig. 3.
|
At least three cell moieties appear to have posttranslational
regulation of their localization in the cell wall. A MAb that recognized a hyphal surface protein detected a smaller protein in the
plasma membrane of yeast cells (394). The C3d binding protein was detected as a 60-kDa moiety in germ tube cell walls, while
a 50-kDa component was found in yeast cell membranes (563). The third example is a 30-kDa protein found in the cell wall of germ
tubes but not yeast cells (5). However, the gene is
expressed in yeast cells and presumably translated, although the
cellular location of the protein is not known. Another group of
proteins to be discussed below, i.e., enolase, hsp70,
3-phosphoglycerate kinase, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), well-known cytoplasmic proteins, have recently been described as also present in the cell wall. They may represent proteins with
regulation of partition between two cellular compartments
cytoplasm and cell wall.
Other proteins, such as hydrolytic enzymes [discussed below], are altered in their expression by environmental substrates. Another example of an apparently environmentally regulated protein is the 58-kDa fibrinogen binding protein that is expressed by cells growing on Lee medium but not by cells growing on yeast extract-peptone-glucose medium (5). The foregoing discussion makes clear that the expression and localization of proteins in the cell wall are complex and dynamic processes. The presence and location of proteins and glycoproteins in the cell wall are likely to be affected by several mechanisms including gene expression, posttranslational regulation, subcellular partitioning, and targeting of destination within the cell wall.
Enzymes with Cell Wall Function
As discussed above, a number of hydrolytic enzymes have been recovered from both cell-associated locations (cell wall and periplasm) and culture medium whose function is postulated to be within the cell wall (Table 1). These enzymes are thought to be involved in cell wall biosynthesis or the remodeling that accompanies growth and division of cells.
|
Exo-
-(1,3)-glucanase.
Secretory exo-
-glucan
hydrolases (
-glucanases or
-glucosidases) are widely occurring
enzymes in many yeast and fungal species. Although the exact
physiological roles of these enzymes are unknown (141, 386),
they participate in the metabolism of
-glucan, which is the main
structural microfibrillar polymer of the cell wall in C. albicans (64). The most widely accepted biological role
of glucanases is limited hydrolysis of cell wall glucan during morphogenetic events (141, 386).
-Glucanases have been
described to be associated with the C. albicans cell wall
(387, 428).
-(1,3)-glucanases has been reported mainly for S. cerevisiae, where at least two isoenzymes, arising by differential
glycosylation of a primary gene product, are secreted into the medium
(430). In C. albicans, exo-
-(1,3)-glucanase
activity was found to be secreted and exported mainly during germ tube
formation. Negligible enzyme was released into the medium when yeast
cells were grown (429). As with
-N-acetylglucosaminidase, this may be related to the more
porous nature of the germ tube cell wall (519). In contrast
to S. cerevisiae, only one exoglucanase has been detected in
C. albicans, and it accounts for most of the total glucanase activity present in the growth medium and cell extracts (307, 361,
428). However, there are some discrepancies between results reported from different groups. The enzyme purified from cell extracts
of C. albicans 1001 was reported to be a heterodimer of
subunits with molecular masses of 63 and 44 kDa (362).
Subsequently, the major exoglucanases secreted into the medium by
strains 1001 and 3153A were found to be identical, single
nonglycosylated polypeptides, with a molecular mass of about 38 kDa
(307). The peptides had significant chemical and
immunological similarity to the major exoglucanase secreted by S. cerevisiae. Cloning and sequencing of the gene EXG
(previously XOG1) coding for the exo-
-(1,3)-glucanase of
C. albicans (75, 308) revealed high identity to
the
-(1,3)-exoglucanase EXG1 gene cloned from S. cerevisiae (561). A single transcript was detected in
both yeast and hyphal forms, and the levels of expression appeared
proportional to the growth rate (74). Sequence analysis
indicated a signal peptide for secretion and a recognition by a
KEX2-like protease (75). A mature enzyme of 400 amino acid residues with no sites for N-linked glycosylation was
predicted. These results are consistent with the characteristics
(carbohydrate content and molecular mass) of the secreted enzyme
previously reported (307). Recombinant
exo-
-(1,3)-glucanase of C. albicans purified from
S. cerevisiae has been found to contain a number of short
blocks of sequence homology to several genes for cellulases of the
family A glucanases, including the conserved sequence site NEP, which
has previously been shown to be important in the catalytic function of
several cellulases (76). Glu-330 has been identified as the
catalytic nucleophile in the enzyme (308).
-1,3-Glucan transferase.
Many yeasts, including
C. albicans and S. cerevisiae, contain a highly
conserved protein with a size ranging from 31.5 to 34 kDa depending on
the species (196). It is a major cell wall mannoprotein in
S. cerevisiae (466). In C. albicans, a
protein of 34 kDa is secreted by protoplasts and observed as an
aggregate in gel filtration (122). When released by
Zymolyase, it eluted as a low-molecular-weight species. The protein
appeared to have a single N-linked oligosaccharide of 2.5 kDa and a
residual protein moiety of 31.5 kDa. A cell wall protein with an
approximate molecular mass of 34 kDa was isolated as a by-product
during purification of an endo-(1,3)-
-glucanase from the material
secreted to the medium by C. albicans (178). The
enzyme displayed a unique glucanosyl transferase activity and did not
contain any exo- or endo-
-glucanase activity. The authors suggested
that this 34-kDa protein is a glucan-branching enzyme responsible for
the transformation of the initial linear
-(1,3)-glucan into the
branched
-(1,3)-
-(1,6)-glucan that is found in the cell wall of
the fungus. The C. albicans BGL2 gene encoding the
-1,3
glucan transferase has been cloned (471) and is similar to
the S. cerevisiae BGL2 gene (245). The S. cerevisiae enzyme has been described as an exoglucanase
(245) and as an endoglucanase (373). However,
more recently, the S. cerevisiae enzyme has been shown to be
homologous to the sequence of the C. albicans enzyme and
corresponds to Bgl2p (165). More sensitive assays revealed
that at low concentrations of glucose oligosaccharides, glucanase
activity was observed, while at higher concentrations,
glucosyltransferase activity predominated. The enzyme transfers
-1,3
glucan oligosaccharides from a donor
-1,3 glucan to an acceptor
-1,3 glucan, forming a linear polymer joined by a
-1,6 linkage
(587). This activity would permit the enzyme to participate
in cross-linking or repair of glucan within the cell wall.
Chitinases. Chitinases are produced by many organisms including chitin-containing organisms that produce both chitin synthases and chitinases. In C. albicans, the most likely role for these enzymes, like glucanases, is limited hydrolysis of cell wall chitin during morphogenetic events (141). C. albicans contains three chitinase genes, CHT1, CHT2, and CHT3 (346). More than half the chitinase activity detectable in whole-cell extracts is associated with secreted enzyme (periplasmic and cell wall) (170). Reactivity is detected in supernatants of washed cells and with intact cells by using a substrate that does not enter the cell (346). Chitinase production increases during exponential growth and is greater in cells grown on yeast extract-peptone-dextrose (YEPD) medium than on a minimal medium. One of the roles of chitinase in S. cerevisiae, where chitin is confined primarily to the septum, is mother-daughter separation. Disruption of S. cerevisiae CTS1 results in clumps of cells due to failure of the cells to separate (273). Treatment of C. albicans yeast cells with a chitinase inhibitor also leads to inhibition of cell separation and clumps of cells (170).
The C. albicans chitinase gene(s) was identified by use of degenerate PCR primers based on conserved fungal chitinase sequences (346). The deduced amino acid sequence encoded by the CHT2 open reading frame (ORF) predicted a polypeptide of 583 amino acids, and that encoded by CHT3 predicted a polypeptide of 567 amino acids. The deduced sequence from CHT1 consisted of 416 amino acids (347). The C. albicans chitinases were similar (36 to 38%) to that of S. cerevisiae (346). However, the similarity was 55 to 65% in the N-terminal region containing the putative catalytic domain. There are potential N-glycosylation sites in the sequences. Near the 3' end of the sequences of CHT2 and CHT3 is a sequence encoding a region that is rich in serine and threonine, which may be potential sites for O glycosylation. This region is not present in CHT1, which encodes a smaller putative protein (347). Expression of CHT2 and CHT3 was detected in both yeast cells and hyphae, although greater expression was associated with yeast growth (346). Expression of CHT1 was not detected under the various growth conditions examined. Preliminary results using a disruption of CHT2 suggested that the chitinase participated in cell separation as cells tended to form clumps or clusters.
-N-Acetylglucosaminidase.
Production of
-N-acetylglucosaminidase by C. albicans cells
is induced by the presence of GlcNAc in the medium (519).
GlcNAc, the
-N-acetylglucosaminidase reaction product,
also induces the synthesis of other enzymes required for the metabolism
of this amino sugar (171, 492, 519). The enzyme may function
as a chitobiase that, in conjunction with chitinase, completes the
hydrolysis of chitin to provide both nitrogen and carbon sources from
chitin. The enzyme, for which two molecular forms with different
glycosylation levels appear to exist (364), is secreted and
deposited into different regions of the cell envelope of both the yeast
and mycelial forms (365, 426, 519). The enzyme is also
released to the culture medium of both growth forms but to a greater
extent (at least fourfold greater) during hyphal formation
(519). It is suggested that the germ tube wall is more
porous than that of yeast cells and, consequently, that release of
extracellular enzymes to the medium is facilitated by the hyphal
formation process.
-N-Acetylglucosaminidase acts on a
number of natural and synthetic substrates including diacetylchitobiose
and triacetylchitotriose. In its native form, the enzyme appears to be
a monomer with a molecular mass of 66 kDa (519).
-N-Acetylglucosaminidase from C. albicans is
specifically a chitobiase (519). It may act coordinately with chitinase, which is also present in this fungus (22),
in the hydrolysis of chitin to form GlcNAc. However, the role of these
enzymes in cell metabolism is not clear (223), but there is
no direct role in morphogenesis (383). In vivo, cleaving of GlcNAc from complex carbohydrates by C. albicans
-N-acetylglucosaminidase may provide a suitable carbon
source for the fungus. Alternatively, removal of GlcNAc residues from
glycoproteins of the fungal cell surface may cause conformational
changes that modify adhesion of C. albicans cells to host
tissues (55). Jenkinson and Shepherd (223)
reported that a C. albicans mutant defective in the
production of
-N-acetylglucosaminidase was less virulent
in an experimentally induced candidiasis mouse model than was the
wild-type strain, thus suggesting a possible role for this enzyme as a
candidal virulence factor. On the other hand, the phenotypic properties of the mutant suggest that the enzyme is not essential for the growth
of C. albicans cells (223). Hence, further work
is required to determine the role of this enzyme in pathogenicity. The
entire
-N-acetylglucosaminidase gene (HEX1)
from C. albicans has been cloned (55). The
organism appeared to use alternative transcription termination sites
depending upon growth conditions, since the HEX1 mRNA from
cells grown on GlcNAc was 200 nucleotides longer than the transcript
from cells grown on glucose. Plasmid-borne HEX1 also
responded to GlcNAc induction.
Glutaminyl-peptide-
-glutamylyl-transferase.
The
activity of the enzyme glutaminyl-peptide-
-glutamylyl-transferase
(transglutaminase) has been detected in cell extracts obtained from
both growth phases of C. albicans. The activity was
associated mostly with the cell wall fraction, whereas the cytosol
contained almost negligible amounts of enzyme activity (456). This distribution suggested an extracellular (cell
wall-bound) location for transglutaminase in intact cells. Although the
wall component displaying this enzymatic activity has not been
characterized, the postulated transglutaminase activity could be
involved in the formation of covalent bonds between different wall
proteinaceous moieties (456). In this context, it has been
suggested that formation of such covalent linkages could play a role in
maintaining the spatial organization of the cell wall during the
biogenesis and assembly of this structure.
Hydrolytic Enzymes and Proteins with Extracellular Targets
The enzymes in the previous section are postulated to find substrates and to have their primary function within the cell wall. This section considers enzymes whose substrates are not associated with the cell wall but are found in the environment (Table 1). The action of these enzymes may provide access to nutrients for the organism. When hydrolysis of these substrates or action of extracellular proteins affects the function and viability of the host, the enzymes may be considered virulence factors that contribute to the establishment of infection. These proteins are at least transiently associated with the cell wall during their translocation across the cell wall to the external environment. However, in some cases, the association is less transient. The distribution of some of these enzymes is variable and, under some growth conditions, may be primarily cell associated in the periplasm and cell wall. Some of these proteins have also been localized to the cell surface by the same criteria that have established a cell surface location for adhesins whose function is at the cell surface. One of these extracellular proteins, Sap, also found at the cell surface, may contribute to adherence (209, 406). We have also included in this section a discussion of a secreted protein with immunomodulation properties whose relationship with other secreted moieties has not been established. Additional studies of the function, localization, and molecular mechanisms of targeting proteins to specific locations will help resolve questions about the cell-associated and extracellular distribution of these proteins.
Acid proteinase. The extracellular proteolytic activity is one of the several hydrolytic enzyme activities described for C. albicans (390) and is due to aspartyl proteinase enzymes. The candidal secreted aspartyl proteinase was first identified by Staib (514, 515), and over the last 25 years its biological characteristics, including its role as a potential virulence factor of C. albicans, have been studied by a number of laboratories. The proteolytic activity is associated with a 42- to 45-kDa acid carboxyl proteinase. The enzyme has broad substrate specificity and is active in the range of pH 2.0 to 7.0, with the pH optimum varying from 2.5 to 4.5 depending on the substrate (109, 451). As discussed below, there is a family of aspartyl proteinases whose expression appears to be regulated by the strain, cell type, and environment. As a protease, the enzyme may have a variety of substrates, and these substrates may vary depending upon the host organ, e.g., skin or blood, that is colonized or infected. This potential spectrum of substrates and expression of isoenzymes may account for the different roles that have been postulated for the enzyme as a virulence factor. Purification of Sap1, Sap2, and Sap3 showed isoenzyme differences in antigenic similarity, thermal stability, and activity at low pH (509). The crystal structure of the enzyme showed details of the binding site, suggesting the possibility of structural differences among isoenzymes that might affect substrate specificities (1, 94). The techniques and strains that are being developed and constructed and understanding isoenzyme differences should contribute to elucidation of the role of the enzyme in colonization and infection.
Aspartyl proteinases are secreted by pathogenic species of Candida in vivo during infection (99, 100, 349, 450). The enzymes are secreted in vitro when the organism is cultured in the presence of exogenous protein (usually bovine serum albumin) as the nitrogen source (18, 109, 206, 434, 441, 447, 448, 451). However, exogenous protein in the culture medium was found not to be essential for induction of enzyme synthesis (205). Instead, the pH of the medium seems to act directly upon secretory aspartyl proteinase synthesis and not as a secondary effect of the nitrogen supply from the proteinase-mediated protein digestion, as initially thought. In any case, induction of C. albicans extracellular aspartyl proteinase appears to involve stimulation of a signal transduction event at the plasma membrane level (281). This stimulation appears to be induced by large proteins and/or polypeptides (containing eight or more amino acid residues), since internalization of small peptides with less than seven residues by peptide transport was not the inducing signal for proteinase production. Initially designated Cap (Candida aspartyl proteinase), this enzymatic activity has been given a variety of labels. Thus, the first cloned gene in C. albicans was referred to as PEP1, because of its similarity to the pepsinogen gene (372). However, the Candida proteinase is similar to many different aspartyl proteinase genes and is not homologous to pepsinogen. The study reporting the cloning of the second gene referred to both secreted aspartyl proteinase genes as PRA genes (574), because of their similarity to the Pra gene product of S. cerevisiae. However, Pra proteinase is a vacuolar enzyme that is not secreted. A related Candida aspartyl proteinase that also is not secreted is more closely homologous to the Pra proteinase (304), while a Saccharomyces homolog of the Candida secreted aspartyl proteinase is not Pra (571). For these reasons, it was proposed that the Candida secreted aspartyl proteinase be referred to as Sap (SAP gene; Sap protein) (311, 571). The biochemical properties of Sap (i.e., molecular weight, pI, sensitivity to inhibitors, substrate specificity, N-terminal amino acid sequence of the protein) vary depending on the strain and laboratory (109, 451). The recent cloning and sequencing of seven distinct SAP genes (from SAP1 to SAP7) (214, 215, 359, 366, 571, 574) may contribute to an explanation of such discrepancies. The seven cloned genes each encode a mature protein that is highly conserved and a precursor peptide that contains the most evolutionarily divergent region of the SAP genes (570). Comparison of the N-terminal protein sequences suggested the existence of at least one more SAP gene (SAP8) (371). SAP8 was subsequently cloned by Hube and colleagues (511). Also, a ninth gene (SAP9) has been cloned (461). Hence, a family consisting of at least nine SAP genes can be drawn upon to produce Sap enzymatic activity in C. albicans. Recently, the levels of the Sap1, Sap2, and Sap3 isoenzymes were monitored under a variety of growth conditions for several C. albicans strains (570), including strain WO-1, which alternates between two switch phenotypes, white (W) and opaque (O) (510). These studies revealed that the specific Sap isoenzyme produced is determined by the cell type (strain) whereas the level of Sap production is affected by environmental factors, and they showed that both the yeast-to-mycelium transition and phenotypic switching can determine which of the Sap isoenzymes is produced (570). A study of the expression of seven members of the SAP gene family in different strains and phenotypes and under different conditions was performed by another group (214). SAP1 and SAP3 levels were regulated during the phenotypic transition between W and O forms. SAP2 was the dominant transcript in the yeast form, and its expression was autoinduced by peptide products of its own enzymatic activity and repressed by amino acids. SAP4 and SAP6 expression was observed only at neutral pH during morphogenetic conversion from yeast to hypha induced by serum. Expression of SAP7 was not detected under any of the experimental conditions used throughout the study. The authors concluded that the different members of the SAP gene family may play distinct roles in colonization and invasion of the host (214). SAP8 is the third gene of the family to be expressed in the opaque phenotype (511). Regardless of the question of how many C. albicans secreted proteinases exist and what role each may play, evidence suggests that aspartyl proteinase either is not glycosylated or is glycosylated at a very low level. One of the reported enzymes does not appear to contain any putative N-glycosylation sites in the deduced amino acid sequence (215). The addition of tunicamycin (an inhibitor of N glycosylation [112]) had no effect on the secretion, molecular weight, and activity of aspartyl proteinase (370). In addition, the purified enzyme does not react with concanavalin A (453) or stain with periodic acid-silver reagent (370). Therefore, if the functional protein does contain any oligosaccharide residues, they are believed to be O linked with the peptide chain. The Asn-Ala-Thr consensus glycosylation sequence has been found in the prepropeptide region, but there is no convincing evidence that this site is actually glycosylated (215). An immunocytochemistry analysis with affinity-purified antibodies to the enzyme detected reactivity in granules, and this reactivity was inhibited by glycogen, suggesting that the antibodies cross-reacted with glycogen-like polysaccharides (3). A 45-kDa intracellular form of the secretory aspartyl proteinase that seems to be the precursor of the 43-kDa mature enzyme has been reported (205, 206). It has been suggested that although the mature form is not glycosylated, that glycosylation may occur to some extent in the 45-kDa precursor (353), which may partly explain the results reported by Akashi et al. (3). Proteinase production is believed to enhance the ability of the organism to colonize and penetrate host tissues and to evade the host immune system (31, 96, 109, 209, 232, 433, 435, 451, 552). A correlation between virulence and levels of proteinase production in both C. albicans clinical isolates (99, 157) and laboratory strains with altered proteinase levels (277, 350, 441) supports a potential role in virulence. More virulent strains of C. albicans can be isolated from patients with AIDS than from normal subjects, and this characteristic may be associated with an elevated production of aspartyl proteinase (101, 397). In this context, the enzyme has been reported to be rare or absent in nonpathogenic strains or species of Candida (348). Mutant strains of C. albicans that do not secrete this enzyme show significant reductions in lethality for mice (277, 350). It has also been suggested that the protease could promote the release of cell wall mannan by cleaving the peptide moiety of candidal cell wall mannoproteins (381). The released mannan may cause stimulation or suppression of cell-mediated (oligosaccharide fragments of mannan appear to be potent inhibitors of cell-mediated immunity) and humoral immune functions (381). The enzyme is able to degrade a number of important defensive host proteins such as immunoglobulins and complement (232, 446, 451). Infection with high-proteinase-generating C. albicans strains (378) and injection of purified candidal proteinase alone (445) can cause a decrease in the levels of host defense molecules. The decrease presumably renders the host more susceptible to candidiasis. In this context, it has also been reported that C. albicans proteinase can trigger the kininogen-kinin proteolytic cascade in the bloodstream (233). Activation of this and of other interrelated cascades that are triggered by this system (complement, fibrinolysis, and arachidonic cascades) can have a variety of negative immunologic consequences for the host. Proteolytic activity may also play a key role in providing a suitable environment that strongly affects the final outcome of Candida infections in burn patients (379), who are more susceptible to fatal candidiasis than are normal individuals. In vitro, at least Sap2p hydrolyzes mucin, and it may contribute in vivo to penetration of the gastrointestinal mucin barrier and provide access to underlying cells (84). The protease may also mediate adhesion to endothelial and epithelial cells, since enzyme inhibitors inhibit binding to endothelial cells and reduce cavitation of yeast cells binding to murine corneocytes (147, 433). More direct evidence of the implication of Sap proteins in virulence has come from recent studies by Hube, Sanglard and colleagues (214a, 460a). The authors constructed strains harboring disruptions in a number of SAP genes, including SAP1, SAP2, and SAP3 (214a) and a triple-knockout of SAP4, SAP5, and SAP6 (460a). In all cases, mutants showed decreased virulence in an animal model of disseminated candidiasis.Phospholipase. Extracellular (secreted) phospholipase activities that have been reported for C. albicans include phospholipases A, B, and C (19, 23, 174, 217, 425, 427, 533). C. albicans also secretes lysophospholipase and lysophospholipase-transacylase (19, 23, 174, 217, 355, 425, 427, 533, 534); however, these activities appear to be associated with the same enzyme (355, 533, 534). Phospholipase A and lysophospholipase activities have been found in the cell wall of yeast cells and hyphae by cytochemical techniques (425, 427). Enzyme activity was associated more closely with the walls of older yeast cells than of younger cells and was more prominent at the tip of growing hyphae than in the lateral walls (425, 427). When yeast cells and germ tubes were grown in the same medium but at a different pH, the specific activity of extracellular phospholipase A was similar for yeast cells and germ tubes while that of lysophospholipase was higher for the yeast form (174).
Two forms of lysophospholipase-transacetylase have been purified from culture supernatants of yeast cells of one strain (533, 534). The enzymes appeared to be monomers of approximately 81 and 41 kDa. Both enzymes had hydrolase and transacetylase activities, with the hydrolase activity being more prominent at low substrate concentrations and the transacetylase activity being more prominent at higher concentrations. The larger species contained proline and higher specific activities for the two reactions than the smaller species. In addition, rabbit polyclonal antiserum against the smaller species did not react with the larger species in Western blot assays. A single enzyme was purified from another strain (355). This enzyme was a 84-kDa glycoprotein that had both hydrolase and transacetylase activities. The enzyme was biochemically distinct from the two enzymes purified in the first studies and did not react with the antibody prepared to the smaller species in the previous study. Since these enzymes are associated with membrane damage of the host cells, adherence, and penetration, they are putative virulence factors of C. albicans. A correlation between phospholipase activity and adhesion to buccal epithelial cells and virulence in a mouse model has been reported (23). C. albicans strains that adhered and were virulent were also higher producers of extracellular phospholipase activity than were other C. albicans, C. parapsilosis, and S. cerevisiae strains that did not adhere. More recently, the role of phospholipases in the pathogenesis of C. albicans was explored by Ibrahim et al. (217). These authors used three different approaches to demonstrate the contribution and role of these enzymes as virulence factors. First, blood isolates of C. albicans produced higher extracellular phospholipase activities than did commensal isolates. Second, an isolate with high extracellular phospholipase activity was invasive in an infant mouse model of candidiasis whereas an isolate with low extracellular phospholipase activity was not. Third, among several selected putative virulence factors examined in an animal model of invasive candidiasis with different isolates, only the levels of phospholipase activity were found to be predictive of mortality. Characterization of phospholipases produced by three isolates showed the secretion mainly of phospholipase B and lysophospholipase-transacylase. These results implicated extracellular phospholipases in the pathogenesis of hematogenous infections caused by C. albicans. A partial PLB1 sequence is available (473).Esterase. Esterase activity has been found in a variety of pathogenic Candida species (56, 419, 452). Recently, induction of an extracellular esterase from C. albicans in culture media containing different Tweens (polyoxyethylenesorbitan compounds) as the sole carbon source was reported (551). Levels of enzyme activity correlated with fungal growth and substrate concentration. Activity was stimulated by activators of lipase activity. The induced esterase was heat labile and had maximum activity at pH 5.5. Thin-layer chromatography of the reaction products suggested that the enzyme is a monoester hydrolase and thus not a lipase in strict sense. Esterase activity was present in a variety of Candida clinical isolates, with no apparent correlation between enzymatic activity and relative pathogenicity. Its biological significance remains to be established.
Glucoamylase.
The C. albicans gene encoding
secreted glucoamylase [
-(1,4)-D-glucan glucohydrolase]
has been cloned by conferring on S. cerevisiae cells the
ability to grow on media containing starch as the sole carbon source.
The enzyme is efficiently secreted in the heterologous host
(82). Coding and promoter regions in the sequence were
identified. The gene, which contains no introns, codes for a protein of
946 amino acids with a deduced molecular mass of 105 kDa. However,
there are 17 potential sites for N glycosylation, which may explain the
fact that the partially purified enzyme has an apparent molecular mass
of 200 kDa. Importantly, the first 20 amino acid residues are
characteristic of a typical signal sequence found in secreted proteins.
Because of the highly efficient translation and secretion of the gene
product, this gene promoter and its signal sequence have been used for
the expression of heterologous proteins in S. cerevisiae
(292). The sequence was also used in vaccine development for
the expression of glycoprotein antigens (83).
Hemolytic factor. The ability of pathogenic organisms to acquire iron in the mammalian host has been shown to be critical in establishing infection (46, 400, 566). Iron availability is a limiting growth factor for C. albicans in human serum, where iron may be sequestered by transferrin (118, 367). In this context, it has been recently reported that C. albicans exhibits hemolytic activity when grown on glucose-enriched blood agar (317). The activity is present on intact organisms, and hyphae display greater activity than yeast cells. The factor is also secreted into the culture medium. However, the identity of the cell surface moiety responsible for this activity remains to be characterized. In any case, this hemolytic activity may be a putative virulence factor for C. albicans, allowing iron acquisition from hemoglobin released from lysed host erythrocytes and restoring the ability to grow in human serum.
Acid phosphatase. Among the catalytic mannoproteins detected outside the plasma membrane barrier in C. albicans, acid phosphatase was one of the first to be characterized. It is a candidal hydrolase, for which some role in the pathogenesis of candidiasis has been suggested but not confirmed (390, 493). C. albicans acid phosphatase is an inducible enzyme that has been purified to homogeneity; the purified enzyme is a 125- to 130-kDa mannoprotein with a pH optimum of 3.6 to 4.5 (78, 391). The location (or distribution) within the cell wall structure of acid phosphatase in C. albicans (78, 105, 547) is similar to that of acid phosphatase in S. cerevisiae, where the enzyme was found to be located in the outermost and innermost cell wall layers (137, 290).
Miscellaneous. Lipase activity is secreted by C. albicans cells growing in medium containing Tweens 80, 60, 40, and 20 as the carbon source (148). A candidal gene, LIP1, conferring lipase activity on S. cerevisiae has been isolated. The deduced sequence contained 351 amino acids with a predicted molecular mass of 38 kDa and five potential N-glycosylation sites. Southern blot analysis at low stringency suggested the presence of a lipase family.
Hyaluronidase and chondroitin sulfatase are produced by most isolates of C. albicans and secreted to the surrounding environment (499). The enzymes are produced by C. tropicalis, C. guilliermondii, C. parapsilosis, and C. krusei but by a smaller proportion of isolates. There was no apparent difference in the frequency of enzyme production by isolates from individuals with or without oral infection. These enzymes are considered to be important virulence factors for oral bacterial pathogens and may also contribute to oral candidal infection. A recent report by Shimizu et al. (500) supported the importance of the combined action of these two enzymes along with acid proteinase and phospholipase in the virulence of C. albicans. Recently, El Moudni et al. showed that C. albicans cells contain high levels of metallopeptidase (121). The enzyme displays an electrophoretic mobility equivalent to about 52 kDa. By using a metallopeptidase-specific antiserum in indirect immunofluorescence and immunoelectron microscopy studies, the enzyme was localized in the cell wall and along the plasmalemma (120). Identification of such type of enzymatic activity could have important implications for the ability of C. albicans to invade host tissues if the enzyme is indeed proved to be a matrix proteinase and to degrade extracellular matrix. Finally, a mannoprotein exhibiting trehalase activity is secreted into the cell envelope of C. albicans, from which it can be extracted by DTT treatment of intact cells (365, 429). About half the activity was associated with the cell envelope (429). Trehalase activity increased throughout yeast cell growth and remained elevated during the first hour after induction of germ tubes. In starved cells, all of the activity was extracellular. An immunosuppressive, B-cell mitogenic (ISM) protein with an apparent molecular mass of 43 kDa (p43) has been purified from the culture filtrates of C. albicans (536). The immunosuppressive and B-cell mitogenic properties of this protein were associated with the host susceptibility to C. albicans infection. Treatment of BALB/c and C57BL/6 mice with p43 facilitated fungal growth, and loss of the capacity to produce p43 correlated with the loss of fungal virulence. Immunization of BALB/c mice with p43 fully protected the mice against the fungal infection (537). In addition, passive administration of specific anti-p43 antibodies significantly protected the animals against challenge with living microorganisms. In any case, immunomodulation may be not the primary biological function of this candidal moiety. The N-terminal sequence of the purified peptide did not correspond to known sequences.Morphology-Associated Proteins
C. albicans is generally considered a dimorphic organism, capable of reproducing by budding, leading to the formation of yeast cells, or by production of germ tubes, resulting in filamentous growth (mycelium). Since the cell wall is the structure ultimately responsible for shape, and since the final steps of cell wall assemblage occur externally to the plasma membrane, the research efforts of a number of investigators in different laboratories have concentrated in the study of this morphogenetic event, as well as on the characterization of cell wall components (especially proteins and mannoproteins) that are growth phase specific. These studies have been fueled by four important considerations: (i) the interest in morphogenesis itself as an important biological phenomenon, (ii) the commonly postulated relationship between growth in the mycelial form and pathogenicity, (iii) the coordination between expression of adhesion factors and germ tube formation, and (iv) the idea that characterization of mycelium-specific antigens would provide the basis for the development of improved serodiagnostic test for the detection of invasive candidiasis (50, 64, 79, 96, 209, 352, 416, 418, 453, 480).
However, characterization of morphology-specific cell wall components is complicated by the fact that expression of cell wall components is a dynamic process. This process is influenced by environmental and nutritional factors and varies among strains (5, 42-44, 422, 550). Thus, for most phase-specific antigens, it is not clear whether they represent de novo synthesis of proteins associated with morphogenesis or, rather, constitute spatial and/or temporal rearrangements of preexisting components that were in a cryptic state before the morphogenetic event. There is evidence indicating the presence of specific antigens associated with yeast or mycelial cells, as reported by several groups who investigated the antigenic determinants of C. albicans during cellular proliferation (41-43, 50, 59, 62, 63, 72, 159, 207, 283, 394, 414-416, 422, 508, 525, 526, 534). On the other hand, several apparently morphology-specific proteins are also present in the other form in a cryptic state. These include the molecule recognized by a MAb, which is a surface protein in hyphae but a plasma membrane protein in yeast cells (394); a 30-kDa cell wall protein of germ tubes but not yeast cells, although mRNA was detected in both yeast cells and germ tubes (5); and differences in size and location reported for the receptor of the complement fragment C3d (563). In a final example, Gozalbo et al. (175) reported isolation of a gene that directed the synthesis of a 1.5 kb transcript in both yeast cells and germ tubes. Affinity-purified antibody to the gene product was used to determine cellular location and size. Two proteins of 25 and 48 kDa were detected in the membrane fraction of both yeast cells and germ tubes and the material secreted by protoplasts. In cell wall extracts, reactivity with two proteins of approximately 40 and 60 kDa was detected only in extracts from yeast cells obtained with Zymolyase. All of the observations indicate that the same gene products may be expressed in yeast and mycelial cells but located differentially within the cell. Thus, dimorphism may involve, in addition to differential gene expression and cell wall organization, a distinct pattern of both posttranscriptional and posttranslational processing of some gene products leading to differential location of the processed proteins.
Cell wall proteins associated with morphology are summarized in Table 2 and the following sections.
|
Epitope recognized by MAb 4C12. We have identified two major HMWM components solubilized from isolated mycelial-phase walls after degradation of the glucan network with Zymolyase (59). The proteins have an electrophoretic mobility corresponding to apparent molecular masses of 260 and 180 kDa (HMWM-260 and HMWM-180). These moieties were not detected in the wall of blastoconidia. These components behaved as a highly disperse population of mannoproteins with molecular masses ranging from about 150 kDa to more than 600 kDa on gel chromatography (122).
As shown by indirect immunofluorescence with MAb 4C12, which recognizes the peptide moiety of HMWM-260, expression of this species was dependent on the morphology of the cells of strain ATCC 26555 (59). No fluorescence was observed on blastoconidia or on short germ-tube-like structures. The HMWM-260 species appeared to be homogeneously distributed on the surface of long mycelial filaments. Western blot analysis of the Zymolyase extract of hyphal cells showed that MAb 4C12 reacted with its homologous antigen and with another high-molecular-weight species, HMWM-180. The reactive bands were polydisperse. In another strain (3153A), the reactive component could also be released, by treatment with
ME, in a form that was larger
than that released by Zymolyase (57). The reactive material
released by Zymolyase was more polydisperse in this strain than in ATCC
26555 and had two major components of 260 and 220 kDa. Three
observations suggested that the reactive species may represent
different degrees of glycosylation of the same protein: (i) MAb 4C12
recognized only a single 180-kDa band in the material secreted by
protoplasts in the presence of tunicamycin, and it was insensitive to
endo-
-acetylglucosaminidase H (Endo H) treatment, suggesting that it
was devoid of N-linked sugar chains (123); (ii)
-elimination and concanavalin A reactivity of the 180 kDa species
indicated that this protein contains O-glycosidically linked sugars
(59, 123); and (iii) treatment of the HMWM-260 species with
Endo H resulted in the detection of the HMWM-180 as the only species
recognized by the MAb 4C12 from ATCC 26555 (59). In strain
3153A, treatment of the material released by
ME and Zymolyase with
Endo H yielded two species of 260 and 220 kDa.
The involvement of the species recognized by MAb 4C12 in the mycelial
cell wall construction and morphogenesis arises from several
complementary observations.
(i) 1,4-Diaminobutanone, an ornithine decarboxylase inhibitor
(327), and the chelating agent EDTA (160) both
block normal germ tube formation in C. albicans without
affecting the overall cell growth and protein synthesis. Although there
may be other effects, these compounds appear to inhibit the synthesis
and export, respectively, of the wall mannoprotein recognized by MAb
4C12.
(ii) A C. albicans yeast monomorphic mutant lacks this
mycelium-specific epitope (128). Treatment of cells with
cystamine, an inhibitor of glutamyltransferases postulated to be
involved in the formation of covalent bonds between cell wall proteins, almost completely blocked the incorporation of the species containing the epitope recognized by MAb 4C12 into the nascent walls of
regenerating protoplasts but did not inhibit their release into the
medium (456).
(iii) Fab fragments prepared from MAb 4C12, an immunoglobulin G1 (IgG1)
subclass antibody, inhibited germ tube formation (62). Binding of Fab fragments may alter the native configuration of the
260-kDa mannoprotein, causing its abnormal and irregular deposition in the cell wall as revealed by indirect immunofluorescence. Intact MAb
4C12 did not inhibit germ tube formation, and indirect
immunofluorescence showed confluent and homogeneous binding of the
antibody to the surface of mycelial cells. In this context, Fab
fragments from a MAb directed against the peptide portion of a cell
surface specific glycoprotein of Dictyostelium discoideum
inhibited the initial stages of the cell differentiation process in
this slime mold (506). Similarly, the yeast-to-mycelium
transition in C. albicans can also be envisaged as a cell
differentiation process. These observations support the contention that
HMWM are not mere passive components of the cell wall but may play an
important and active morphogenetic role in modulating the organization
of the remainder of the cell wall constituents to obtain the final
supramolecular structure specific for each morphology (327,
479-482).
Epitope recognized by MAb 3D9.
Protein from a germ
tube culture purified by affinity chromatography on fibrinogen was used
as immunogen in the production of MAbs. One of these antibodies, MAb
3D9 of the IgM class, reacted only with germ tube surfaces as judged by
indirect immunofluorescence (324). The fluorescence was
homogeneous along the germ tube. However, after 48 h of growth,
the fluorescence was less intense and heterogeneous, with its greatest
reactivity at the tip. This observation suggested that expression was
greater at the point of active growth. Whether the diminution of
reactivity behind the growing tip was a result of shedding of the
determinant or alterations and rearrangements in the mature hyphal wall
is unclear. While the presumed presence of the determinant in the
culture medium points to the first explanation, the possibility that
excess antigen is secreted to the exocellular environment during growth can not be eliminated. Western blot analysis of EDTA-
ME and
Zymolyase extracts from yeast cells and germ tubes confirmed reactivity with germ tube moieties. The reactive moiety was polydisperse. The
determinant was larger than 210 kDa in the chemical extract and ranged
from 110 to 220 kDa in the Zymolyase extract. The larger size in
extract containing reducing agent parallels that observed with the
determinant of MAb 4C12, as discussed above. The sensitivity of the
determinant to proteases and insensitivity to periodate indicated that
the epitope was a peptide. Analysis by SDS-polyacrylamide gel
electrophoresis (PAGE) of the protein purified from Zymolyase extracts
of germ tubes revealed a single disperse band of 110 to 170 kDa that
was reactive with concanavalin A (325). The final product
was enriched 126-fold for the protein and 16-fold for carbohydrate. MAb
3D9 did not react with Rhodotorula or
Saccharomyces or any of 40 isolates distributed among six
other Candida species (324). Reactivity was
observed with all 58 isolates of C. albicans examined. The
determinant appears to be specific to C. albicans and the
hyphal form.
Hwp1p. HWP1 (hyphal wall protein) was cloned by screening a cDNA library with adsorbed antiserum that reacted only with hyphal surfaces (513). Further analysis showed that the ORF encoded a 234-amino-acid sequence with a calculated molecular mass of 22,750 Da containing a typical signal sequence and signal site for yeast KEX2-encoded endoprotease. More interestingly, the sequence revealed a series of tandem repeats containing a 10-amino-acid motif rich in proline and glutamine that covered much of the remaining sequence. No consensus N-glycosylation sites were found. The C terminus was rich in serine and threonine, providing potential O-glycosylation sites. A 2.3-kb mRNA was detected only under growth conditions where hyphae were produced. Antiserum raised to the recombinant protein reacted only with hyphal surfaces. Similar expression of Hwp1p was detected on the surface of 20 other C. albicans strains. The antiserum also reacted with fungi in tissue sections of colonized mice. Again, only hyphal surfaces were reactive. Western blot analysis of Zymolyase extracts of hyphal forms showed a pattern of polydisperse reactivity at approximately 34 kDa. No reactivity was detected with extracts of yeast cells. A recombinant protein produced in Pichia pastoris was about twice the calculated size. The authors suggest that the differences may be attributable to anomalous migration of proline-rich proteins, glycosylation, and protease activity of Zymolyase. As a proline-rich protein, Hwp1p may share properties with similar proteins in which proline residues are proposed function to maintain polypeptide chains in extended conformations and to mediate noncovalent interactions between chains. As noted by the authors, salivary proline-rich proteins are found in this group. These proteins are a substrate for transglutaminase of buccal epithelial cells to which C. albicans can adhere. This protein on candidal surfaces may also be a substrate. The repeats also contain cysteine that may be involved in covalent linkages.
Hyr1p.
A hyphally regulated gene, HYR1, was
isolated and characterized (16). Northern analysis confirmed
that the 3-kb transcript of the gene was expressed under several
conditions favoring formation of germ tubes but not under yeast growth
conditions. The ORF encoded a predicted 937-amino-acid polypeptide of
94.1 kDa. The sequence contained an N-terminal signal sequence and
C-terminal sequence for attachment of a GPI anchor. The sequence also
contained 17 N-glycosylation sites and a domain rich in serine and
threonine. Another domain was rich in serine, glycine, and asparagine
and contained seven copies of a 4-amino-acid motif, NEGS, of unknown function. The presence of an N-terminal signal sequence, a C-terminal GPI signal sequence, and a serine- and threonine-rich region is shared
with several other sequences that are associated with the S. cerevisiae cell wall (Cwp1p, Cwp2p, Tip1p, Aga1p, Ag
1p, and Flo1p) (291, 444, 538, 555) or membrane sequences
(388). Other C. albicans sequences have similar
structural characteristics: the putative cell wall protein Als1p
(discussed in a subsequent section) (212), the protein
encoded by clone 8M (477), membrane protein Phr1p
(467), and possibly the putative Hyr1-like protein associated with HYR99 (473).
Immunomodulatory 65-kDa Mannoprotein (MP65)
Cassone and colleagues (45, 65, 169, 542, 543) have studied the main mannoprotein components of C. albicans implicated in immunomodulation of host defense. Among the mannoproteins present in an acidic extract (MP-F2), a 65-kDa mannoprotein (MP65) is a main target of human T-cell response. The proliferative response stimulated by this component was of an antigenic nature rather than a mitogenic one, and the response was targeted mainly to polypeptide epitopes (65, 542). A similar constituent was present in the material released to the culture medium by C. albicans (45, 543). MP65 was further purified by immunoaffinity chromatography with MAbs generated against putative protein epitopes of the molecule (169). MP65 has a pI of 4.1 and a protein-to-polysaccharide ratio of 1.8:1. The moiety appears to contain only O-linked sugar residues, as deduced from its sensitivity to dilute alkali but not to several endoglycosidases. Nanogram doses of purified MP65 induced extensive T-cell proliferation of human peripheral blood mononuclear cells.
Heat Shock Proteins
One of the most highly evolutionarily conserved features of living organisms is the ability to respond to a sudden change of temperature (heat shock response) and to other adverse environmental conditions. This response involves the increased production of a set of proteins collectively referred to as heat shock proteins (hsps), whose production presumably contributes to the protection and damage repair of cells following stress (312). Initially identified as proteins whose synthesis was enhanced by an increase in temperature, several of the major hsps have been described since then to play important roles in all major growth-related processes, such as cell division, DNA synthesis, transcription, translation, protein folding and transport, and membrane translocation (312). Several hsps are synthesized constitutively, reflecting the important cellular functions performed by these proteins under nonstress conditions. hsps are also immunodominant antigens and major targets of host immune response during different types of infection (240, 241, 323, 332, 581). The response to hsps may also be involved in autoimmunity (241, 332, 582). Several families of hsps exist which are designated according to their average apparent molecular mass (e.g., hsp90, hsp70, and hsp60). Some of these families are divided into different subfamilies, and each subfamily may have different members.
The response of C. albicans to heat shock includes the synthesis of a set of proteins with an ample array of molecular masses (588). Genes coding for proteins belonging to the hsp90 and hsp70 families have been found in C. albicans (131, 278, 303, 316, 335, 532). Interestingly, the cellular location of some of these gene products is not confined to the cytosolic compartment, since they are also present in the cell wall and at the cell surface (303, 340). This extracellular localization could be a common feature of several fungal hsps, since it has been described also for Histoplasma capsulatum (168) and S. cerevisiae (294). As components of fungal cell walls, hsps may play roles similar to those described in the cytoplasm.
hsp90. The structure of hsp90 is highly conserved in organisms ranging from bacteria to humans. Members of the hsp90 family of proteins play important roles in protein biogenesis and have been referred to as molecular chaperones. hsp90s interact with a variety of cellular proteins, such as steroid hormone receptors (410) and tyrosine kinases (95), and have been associated with morphological changes in pathogenic fungi and protozoa (322, 488, 554). S. cerevisiae contains two genes encoding hsp90, HSC82 and HSP82. HSC82 is a constitutively expressed gene only weakly induced upon stress exposure, while HSP82 is expressed at a much lower basal level and is strongly activated after exposure to heat shock (32).
In C. albicans, an immunodominant 47-kDa antigen was identified as a heat-stable breakdown product of hsp90 (335). This 47-kDa component was first identified as one of the major targets of the immune response mounted by patients with systemic candidiasis (334, 335) and is different from enolase (143, 329, 517). C. albicans hsp90 or its fragments circulate in the body fluids of patients with disseminated candidiasis. The 47-kDa antigen was isolated from patient sera by affinity chromatography (338), and detection of antigenemia has potential diagnostic value (334). Circulating fungal hsp90 may also play a role in pathogenesis (332, 336). Antibodies to the 47-kDa antigen correlated with survival to infection both in humans and in animal models (339, 342). Antibody to the 47-kDa antigen was present in the majority of patients with chronic mucocutaneous candidiasis and AIDS (47, 339), and it has been suggested that it mediates the protective effect of humoral immunity in systemic candidiasis (339, 342). Epitope mapping showed that patients recovering from systemic candidiasis produce antibodies against both fungus-specific and conserved epitopes of hsp90 (342). In particular, a highly conserved epitope, LKVIRK, was recognized by all patients with antibody to the 47-kDa antigen (341), and both patient sera and a murine MAb raised to this epitope when given prophylactically reduced mortality in a mouse model of invasive candidiasis (342). Treatment with a human recombinant antibody fragment to the same epitope also reduced the mortality of infected mice and improved renal function in sublethally challenged mice (331). The authors proposed that the fungal hsp90 may bind to host proteins, thereby interfering with host protein structure or function, and that antibody may neutralize the ability of the fungal hsp90 to bind to host proteins. Matthews et al. used an affinity-purified monospecific antibody against the 47-kDa antigen and immunoelectron microscopy techniques to study the subcellular localization of this molecule (340). Results showed that it was present in the cytoplasm and the cell wall of both yeast and mycelial cells of C. albicans. This extracellular location implies that the 47-kDa antigen is naturally exposed and readily available to antibodies produced by the host, without the necessity for cellular breakage. This extracellular location may also be responsible for its high antigenicity and some of the other properties (mainly immunoprotection) associated with the immune response to this molecule. More recently, a full-length C. albicans HSP90 gene was isolated by screening cDNA and genomic libraries with a probe derived from the S. cerevisiae homolog HSP82 (532). The predicted mass of C. albicans hsp90 was 81 kDa, and the C-terminal portion was identical to the previously described 47-kDa fragment (334). Expression of HSP90 was regulated during growth and morphological transition and after heat shock. Southern blotting analysis revealed only one HSP90 locus (532). The inability to isolate an homozygous null mutant is consistent with the notion that a single HSP90 locus exists in C. albicans and that hsp90 is essential for viability.hsp70. hsp70s are highly conserved in organisms ranging from bacteria to humans. The DnaK chaperones are the prokaryotic homologues of hsp70s (437), having about 50% identity to all eukaryotic hsp70s. The eukaryotic proteins are between 50 and 98% identical. Sequence similarity between hsp70 proteins extends over the entire protein, but particularly highly conserved regions are present in the N-terminal domain (30, 89). The hsp70s are not restricted to heat shock protection; they also play a role in protein folding, translocation of proteins across membranes, and gene regulation (90, 91, 155, 156, 431). In S. cerevisiae, at least 10 HSP70-like genes have been described and classified into five families from SSA to SSE (288, 374, 440, 502). Most of the proteins encoded by these genes are present at considerable levels under all growth conditions, although their synthesis is increased after exposure to stress. The SSA family includes four members, SSA1 to SSA4, with 80 to 97% DNA sequence similarity (218). Cell viability requires moderate to high levels of at least one of the proteins encoded by this family (567). Under normal growth conditions, both SSA1 and SSA2 genes were expressed at moderate levels, while heat shock resulted in increased expression of SSA1 and strong induction of both SSA3 and SSA4 expression (218). Inactivation of either SSA1 or SSA2 did not result in an obvious phenotype. However, ssa1 ssa2 double mutants were unable to form colonies at 37°C (88). They were viable and grew more slowly than the parental strain at temperatures lower than 37°C as a result of a high expression of SSA4 (567). Until recently, the gene products of the SSA subfamily of hsp70 have been considered to be located exclusively in the cytosol of S. cerevisiae (91, 312). However, we have described the presence of Ssa1p and Ssa2p in the cell wall of this budding yeast, where they could play a similar role to that in the cytoplasm (294).
In C. albicans, three different genes encoding members of the hsp70 protein family have been described (131, 278, 303, 316). By screening a C. albicans cDNA library with antibodies to whole fungal cells, La Valle et al. (278) isolated a clone encoding a stress protein of C. albicans whose deduced amino acid sequence was 84% similar to the product of S. cerevisiae SSA1. As expected, Southern blots of digested DNA probed with the cloned cDNA under low-stringency conditions indicated the presence of other members of the HSP70 gene family in C. albicans. Confirming this observation, antiserum raised to the recombinant protein recognized two bands in C. albicans whole cell extracts with apparent molecular masses of about 70 kDa. Northern blot experiments with the cloned cDNA as a probe showed the presence of 2.4- and 2.2-kb hybridization bands. Expression of the 2.4-kb constituent was heat inducible. A second member of the hsp70 family of proteins was identified by our group (303). The nucleotide and deduced amino acid sequences of a cDNA clone coding for a constitutively expressed 70-kDa cell wall protein (5) showed a high degree of homology and identity to the SSA1 and SSA2 sequences of S. cerevisiae. The relationship with the SSA family was further supported by the reactivity of the 70-kDa candidal component with antibody recognizing the Ssa proteins of S. cerevisiae. Thus, to reflect the existence of multiple members of this family in C. albicans, and in accordance with the nomenclature of S. cerevisiae, we proposed that the original HSP70 designation of La Valle et al. (278) be replaced with SSA1 and that the gene corresponding to the second member of this family be named SSA2. Several lines of evidence demonstrated that a member(s) of the hsp70 family of proteins is present in the cell wall of C. albicans (303). Affinity-purified antibody to the Ssa2 fusion protein produced by the cloned cDNA fragment identified a 70-kDa moiety in the
ME extracts containing cell wall components from both
morphologies of the organism. Indirect immunofluorescence demonstrated
its presence at the cell surface. Immunoelectron microscopy showed that
it was present in both the cytoplasm and the cell wall. Biotinylation
of intact cells with a derivative that did not permeate the cell
membrane demonstrated that the 70-kDa protein was present outside the
cell membrane before extraction. Furthermore, and confirming the
results obtained with C. albicans, members of the hsp70
family of proteins have been found in the cell wall of S. cerevisiae (294).
Members of the hsp70 family are highly immunogenic proteins and are
major targets of the host immune response to different pathogenic
microorganisms, including pathogenic fungi (240, 241, 323).
La Valle et al. (278) reported that sera from three healthy individuals contained antibodies to C. albicans Ssa1p and
suggested that presence of such antibodies could contribute to
protection against infection. It was also pointed out that the
variability in this generally conserved protein was predominantly in
the C-terminal region, which is also the immunodominant region
(241). Moreover, preliminary experiments suggested that
recombinant Ssa1p induces T-lymphocyte proliferation. In the case of
the product of C. albicans SSA2, serum samples from both
normal individuals and patients with candidiasis contained antibodies
against the C-terminal portion of Ssa2p (303). hsp70 is also
recognized by sera of patients with oral and esophageal infection
(524). It has also been demonstrated that the antibody
response in a murine model of systemic candidiasis includes reactivity
against a 75-kDa hsp (85). Due to the high levels of
homology between the different hsp70s, a combination of antibodies to
the different members of this family in C. albicans as well
as to hsp70s from other microorganisms may be present in the host
serum. These reactivity patterns are also likely to be the result of
combination of antibodies against conserved epitopes and epitopes
unique to individual C. albicans hsps.
In any case, the ubiquitous nature of hsps, along with their high
degree of homology, poses interesting challenges to the immune system
of the host. First, the presence of epitopes shared by a number of
infectious agents may provide the immune system with a universal signal
for infection, and antibodies to these conserved regions could provide
some natural resistance to infection, somewhat in between innate and
acquired immunity. Second, epitopes shared by the parasite and the host
may trigger deleterious autoimmune responses (240). This
could also be true for immune responses against highly conserved
immunodominant glycolytic enzymes (see below).
Heat shock or stress mannoproteins. Heat shock mannoproteins with approximate molecular masses of 180 to 200, 130 to 150, 90 to 110, and 60 to 70 kDa have been identified as being involved in the secretory immune response during mucosal candidiasis (413, 417). These molecules were expressed after a temperature shift from 25 to 37°C and were detected by indirect immunofluorescence. The antigenic determinants recognized by secretory IgAs in saliva and vaginal washings were polysaccharide in nature (413). Subculturing on agar at 25°C switched off expression of the antigens from mucosal isolates, while several transfers were required to reduce expression by isolates from deep infections (417). Since factors other than temperature can influence the in vitro and in vivo expression, these cell wall components should be considered "stress" proteins. The 200-kDa component appeared to be the main component recognized by vaginal secretory IgA. The 180- to 200-kDa component also enhanced tumor necrosis factor secretion by a murine macrophage cell line (411).
Glycolytic Enzymes
Glycolytic enzymes, which are highly conserved through evolution, appear to be important during C. albicans pathogenesis, since they act as major inducers of host immune responses and are major allergens during candidiasis (161, 219, 221, 489, 517, 530). Glycolytic enzymes can constitute up to 30% of total soluble proteins in S. cerevisiae (201). The presence of glycolytic enzymes in the cell wall of C. albicans has been reported recently. Enolase was found to be associated with glucan in the inner layers of the cell wall (8). Another report localized this enzyme on the surface of C. albicans cells, probably due to adventitious binding of enolase released from lysed cells (132). Phosphoglycerate kinase (PGK) was found in the cell wall and at the surface (6). We have also recently reported the presence of a cell wall-bound form of GAPDH (161). The presence of alcohol dehydrogenase (ADH) in the cell wall also has been suggested (406) as the fibronectin receptor. Together, localization of presumably "intracellular" glycolytic enzymes in the cell wall of C. albicans is rather intriguing, as are the possible roles that these molecules could play as part of the cell wall (e.g., energetic role, antigenicity, surface receptors), as well as the mechanisms involved in their secretion. However, the presence of glycolytic enzymes on microbial surfaces is not unprecedented. GAPDH has been reported as a major surface protein on group A streptococci (Streptococcus pyogenes), where it not only is enzymatically active but also serves as a binding protein for fibronectin, lysozyme, myosin, actin, and plasmin (403, 572). In Kluyveromyces marxianus, the same enzyme protein has been identified as a constitutive protein of the cell wall, and its level increases substantially upon induction of flocculation (136). ADH is also a surface protein of Entamoeba histolytica, where it has been reported to display receptor activities for a number of extracellular matrix (ECM) components (579). PGK, GAPDH, and triose-phosphate isomerase have been found on the surface of Schistosoma mansoni (173, 280, 503) and have been suggested as potential candidates for vaccine development.
Enolase. Enolase (2-phospho-D-glycerate hydrolyase) is an enzyme of the glycolytic pathway, where it catalyzes the dehydration of 2-phosphoglycerate to phosphoenolpyruvate. It also catalyzes the reverse reaction during gluconeogenesis. It is among the most abundant proteins in C. albicans and S. cerevisiae (201). In S. cerevisiae, enolase is encoded by two genes whose expression is differentially regulated depending on the carbon source and growth phase (343) and is coordinately regulated with the expression of other glycolytic enzymes (314). Different groups have reported the cloning and characterization of the C. albicans enolase gene (143, 330, 521). Although only one gene was initially detected by Southern analysis (143, 330), further experiments demonstrated the presence of two enolase gene loci (420). However, it is not known whether both loci provide functional genes.
C. albicans enolase was first described as a cytoplasmic antigen, with an approximate molecular mass of 48 kDa, that elicited strong humoral responses in patients with disseminated candidiasis (517). Subsequently, this molecule was identified as enolase (144, 329). It is abundantly produced both in vivo and in vitro, where it is found in the liquid culture supernatant (520, 564). It circulates in the blood of patients with disseminated candidiasis, and detection of antigenemia has been shown to be a marker for invasive infection (564). In addition, it is an immunodominant antigen (517), and anti-enolase antibodies may have diagnostic value (177, 356, 557, 558). It has also been described as an allergen (219, 221). In a murine model of systemic candidiasis, it was demonstrated that C. albicans enolase stimulated both cellular and humoral responses (520). More recently, an immunoprotective effect of anti-enolase antibodies was suggested (556). Recently, Angiolella et al. (8) very elegantly identified enolase as a glucan-associated integral component of the cell wall of C. albicans. These authors provided several lines of evidence suggesting that enolase was a bona fide component of the cell wall, including demonstration of its incorporation into the cell wall (which was inhibited by cilofungin, a lipopeptide inhibitor of glucan synthesis in fungi) and detection by immunoelectron microscopy in inner wall layers of intact cells and isolated cell walls. In accordance with previous reports (521), these authors reported the absence of enolase on the surface of fungal cells.Phosphoglycerate kinase. PGK catalyzes the hydrolysis of 1,3-bisphosphoglycerate to 3-phosphoglycerate with the production of ATP. Alloush et al. (6) reported cloning PGK1 by screening a cDNA expression library with antiserum to cell wall proteins. Antibody affinity purified to product of the clone detected a 40-kDa constitutively expressed cell wall protein and bound to the surface of intact cells. The presence of PGK in the cell wall was confirmed by two methods. Cell wall proteins of whole cells were biotinylated with a derivative which does not permeate the membrane, and PGK was found among the biotinylated proteins. Immunoelectron microscopy revealed that the protein was present at the outer surface of the cell membrane and in the cell wall as well as in the cytoplasm.
Glyceraldehyde-3-phosphate dehydrogenase.
GAPDH
catalyzes the conversion of glyceraldehyde 3-phosphate to
1,3-bisphosphoglycerate and the concomitant reduction of
NAD+. We have recently isolated a cDNA clone by
immunoscreening an expression library with pooled sera from two
patients with systemic candidiasis and five neutropenic patients with a
high level of anti-C. albicans IgM antibodies
(161). The encoded polypeptide was reactive only with sera
from patients with systemic candidiasis. The nucleotide sequence of the
coding region of the genomic clone showed homology (78 to 79%) to
S. cerevisiae TDH1 to TDH3 genes coding for
GAPDH, and their amino acid sequences showed 76% identity; thus, the
gene has been designated TDH1. Western blot analysis with a
polyclonal antiserum against the purified cytosolic C. albicans GAPDH (PAb anti-GAPDH) revealed reactivity of a single 33-kDa band in the
ME cell wall extracts. Indirect
immunofluorescence demonstrated the presence of GAPDH at the candidal
cell surface. Semiquantitative flow cytometry analysis showed
sensitivity of the GAPDH form to trypsin and its resistance to removal
with 2 M NaCl or 2% SDS. The specificity of the reaction was indicated by decreased fluorescence in the presence of soluble GAPDH. A cell
concentration-dependent GAPDH activity was detected in intact blastoconidia and germ tubes. Activity was reduced by pretreatment with
trypsin, formaldehyde, and PAb anti-GAPDH. These observations indicate
that an immunogenic, enzymatically active cell wall-associated form of
the glycolytic enzyme GAPDH is found at the cell surface of C. albicans (161).
Alcohol dehydrogenase. ADH catalyzes the reduction of acetaldehyde to ethanol with the formation of NAD+. A possible relationship between C. albicans ADH and receptors for vitronectin and fibronectin has been suggested (406). However, its putative surface location, deduced from its role as an adhesin, has not been further studied. The nucleotide sequence of the gene ADH1 encodes a 350-amino-acid polypeptide with high homology to other yeast ADHs (27, 489).
Binding Proteins (Receptors) for Host Ligands
Since the cell wall is the outer surface of the organism, it is inescapable that physical interactions between the fungal cell and the host will be mediated by cell wall moieties. The potential interactions involve contact with phagocytic cells, host cells of every organ infectable by the fungus, extracellular matrix, and soluble proteins. In the balance of the relationship between the fungus and the host, these interactions may serve to promote the "interest" of the fungus in maintaining itself as a human commensal or establishing metastatic disease or the "interest" of the host in protecting itself against invasion of sterile sites and overgrowth in areas of normal colonization. It is not clear that all of these interactions have been identified, and it is even less clear that we know the roles played by these interactions in the development of infection. The task of deciphering the interactions and their role in pathogenesis is complicated, since there are multiple virulence factors and their importance may be influenced by the strain of the fungus, by the host tissue that is infected, and by underlying factors associated with host status. The concept of a virulence set hypothesis has been discussed by Cutler (96) in his review of putative virulence factors.
Although other cell wall components such as chitin,
-glucan, and
lipid play roles in the adhesion of C. albicans (158,
398, 476), proteins and mannoproteins are unquestionably the
major mediators of adhesion. Early studies in the mid-1980s that
sparked interest in the host ligands bound by C. albicans
and the proteins that mediated such interactions were reports of the
binding of human fibrinogen (34) and of complement fragments
iC3b and C3d (194). Since then, additional host ligands and
some of the fungal binding proteins or receptors for these ligands have
been identified. The most relevant features of candidal cell wall
adhesins and receptors for host ligands are summarized in Table
3. Most of these proteins appear to be
among the medium-size polypeptide components present in
the cell wall of C. albicans. For some ligands, several
candidal proteins are able to bind the host protein, and it appears
that some fungal proteins may be able to bind more than one ligand. The
relationships between these multiple binding entities that have been
detected in vitro and among isolated components and their functional
role in the intact organism remain to be elucidated.
|
Serum proteins. The fact that C. albicans can interact with and respond to serum proteins has been recognized for many years. The ability of serum to stimulate the in vitro formation of germ tubes is well established and has been used as an element of species identification (535). The ability of the organism to stimulate the alternative complement pathway was also described 20 years ago (432). An effect on coagulation proteins was also noted during infection (409) and in vitro a decade later by Maisch and Calderone (313). To a large extent, interest in the interactions of C. albicans with serum proteins initiated the cascade of the studies of interactions between the fungus and host ligands at the molecular level.
(i) Serum albumin and transferrin. The ability of intact C. albicans cells to bind different serum proteins in vitro (including albumin, transferrin, and fibrinogen) was initially described by several authors on the basis of optical (immunofluorescence) and electron microscopy observations (33, 34, 401, 548). While the binding of fibrinogen has been examined more extensively, as discussed below, the binding of serum albumin and transferrin has not been investigated further.
(ii) Fibrinogen.
Interaction of serum proteins
with C. albicans has been particularly well characterized
for fibrinogen. In vitro binding of human fibrinogen was reported
initially to occur exclusively on short germ tubes and mature hyphae of
the organism and with higher avidity than other serum proteins such as
albumin and transferrin (34, 401, 548). Binding was not
detected to yeast cells grown on Sabouraud medium. Among different cell
surface mannoproteins that appeared to be responsible for adhesion of
C. albicans cells to plastic surfaces, two species with
molecular masses of 68 and 60 to 62 kDa were shown to interact with
fibrinogen. They also interacted with laminin and C3d, the terminal
degradation product of the complement C3 component (35,
550). This multiple interaction lead to the suggestion that
candidal fibrinogen-binding proteins may be related to mammalian
integrins of the
2 or
3 subset (33, 34, 548) (see below). Using iodinated whole fibrinogen, and D and
E fibrinogen fragments, Annaix et al. (9) showed that fibrinogen and the D fragment bound to C. albicans germ
tubes. The D fragment is an 85-kDa moiety containing the
carboxy-terminal portions of fibrinogen. The binding was time
dependent, saturable, and reversible. An average of 6,000 binding sites
were determined per germ tube, with a dissociation constant
(Kd) of 5.2 × 10
8 M. Binding
was not inhibited by several sugars, suggesting that the interaction
was not a lectin type of binding. Ligand affinity blotting of a
DTT-iodoacetamide extract with the D fragment identified a single
68-kDa candidal moiety with binding activity.
ME extracts of both yeast
cells and germ tubes. The mp58 species may represent a specific
candidal receptor for the ligand, since other mammalian proteins, such as laminin, fibronectin, type IV collagen, and C3d, did not bind in
ligand affinity blotting experiments (60, 300). The protein is likely to be present in the cell wall as part of a multisubunit complex, since it migrates on native polyacrylamide gels at a much
larger size (300). A cDNA clone for mp58 was isolated by immunoscreening a C. albicans expression library
(5). The gene, FBP1 (fibrinogen binding protein),
showed condition-dependent transcription, since the mRNA transcript was
found only when both yeast and germ tubes were grown in a minimal
medium and was not detected when the cells were incubated in rich
medium (5). Since the expression of FBP1 appears
to be regulated by nutrition, fibrinogen binding may not be the primary
function of mp58. In addition, since expression is environment
dependent, this may account, at least partly, for the differences in
the pattern of fibrinogen binding to cells observed by the two research
groups as mentioned above (9, 34, 60, 548). It may also
account for differences in the fibrinogen-binding molecular species
identified in these studies. However, since the experimental conditions
were different in the various studies, more specific comparisons are required to determine whether there is a single fibrinogen binding protein.
The mp58 species contained N- and O-glycosidically linked sugar
residues that represent 18 to 20% and 3 to 4%, respectively, of its
molecular mass. These carbohydrate residues appear to be involved
(particularly, the O-linked carbohydrate moiety) in the interaction
with the ligand (60). mp58 has exposed hydrophobic domains,
as determined by its ability to bind to polystyrene-latex microbeads
(295, 299).
The mp58 species was found to possess two other interesting structural
features. It contained epitopes that mimic collagenous domains or
sequences of the type IV collagen molecule (484) as well as
ubiquitin-like epitopes (486). The collageneous domains may
define additional adhesive or binding motifs. Detection of collagenous
domains in cell surface moieties seems not to be a unique feature of
C. albicans. Celerin et al. (68) recently reported that amino acid sequences in surface fimbriae of the fungus
M. violaceum showed strong similarity to sequences that are
characteristic of the collagen gene family. Antiserum recognizing the
fimbrial protein epitopes reacted with surface moieties from other
fungal species including C. albicans (67).
The mp58 species is also ubiquitinated and shares this property with at
least two other cell wall moieties (486). Two-dimensional electrophoretic analysis and immunoblot experiments with antibodies to
ubiquitin and the purified mp58 showed colocalization of reactivity, suggesting that mp58 was ubiquitinated. In an enzyme-linked
immunosorbent assay, antibody to mp58 reacted with ubiquitin. In the
context of receptors, ubiquitination has intriguing implications.
Ubiquitination of cell surface receptors, e.g., a lymphocyte homing
receptor, has been described for higher eukaryotes (282, 504,
580). Reversible multiubiquitination and deubiquitination may
turn the cell surface receptor signaling function on or off (368,
404). Thus, it is tempting to speculate that some C. albicans ubiquitinated receptors, such as mp58, are somehow
involved in signaling the fungal cell about its external environment
and triggering a response to that signal.
The surface distribution of the fibrinogen binding moieties has been
determined by several methods. The initial studies involved indirect
immunofluorescence. These studies suggested that the binding was
generally heterogeneously dispersed on the surface of germ tubes
(34, 60, 328) and on the small proportion of yeast cells (11 to 20%) that bound fibrinogen. This heterogeneous distribution was
confirmed by other methods. Scanning electron microscopy showed that
fibrinogen-coated latex beads would also decorate the surface of germ
tubes with some areas of clustering (548). Transmission
electron microscopy showed areas of increased concentration of bound
gold particle-fibrinogen conjugates. On thin sections, the clusters
extended from the surface into the wall, although the inner wall was
only weakly labeled. Pretreatment with formaldehyde or
ME reduced or
abolished binding. We analyzed fibrinogen binding in serial sections of
yeast cells and germ tubes by confocal fluorescence microscopy
(328). These sections supported the heterogeneous dispersion
of fibrinogen binding on the surface and indicated that the
heterogeneous distribution observed by regular microscopy was not due
to focal-plane artifacts. A similar heterogeneous surface distribution
of mp58 was observed when a polyclonal antibody (PAb anti-mp58) raised
to the purified molecule was used as a probe. All collection strains
and fresh clinical isolates of C. albicans we have examined
so far express mp58-like molecules on their surface (487).
These strains exhibit both the ability to bind fibrinogen and react
with PAb anti-mp58, although differences in expression that depended on
growth conditions and strain were also found.
The mp58 fibrinogen binding protein is expressed in vivo
(302). Immunohistochemical techniques with the PAb anti-mp58
were applied to tissue specimens from patients with confirmed systemic and mucocutaneous candidiasis. Most yeast cells and hyphal filaments were strongly positive. Although the proportion of positive yeast cells
was not determined, there is a sense that this proportion may be higher
than that observed in vitro (60, 328). The in vivo
expression of mp58 provides support for the contention that fibrinogen
binding may be important in host interactions. In this context, the
ability of C. albicans cells to bind fibrinogen may be a
virulence-related property, since coagulation proteins such as fibrin
appear to be the receptor for C. albicans cells that adhere
to blood clots in vivo (34). Disseminated intravascular coagulation was reported to occur in parallel, in some instances, with
severe Candida septicemia (409). Moreover,
binding to fibronectin that is believed to be one of the host ligands
for Candida adhesion (51, 443) and binding of
platelets to C. albicans cells appears to be mediated by
fibrinogen (313, 439, 547).
(iii) Complement fragment C3d. The ability of C. albicans cells to rosette antibody-sensitized erythrocytes coated with C3d as well as iC3b complement fragments was first described by Heidenreich and Dierich (194) and latter reported by other investigators (for a review of this topic, see reference 50).
A C3d-binding protein was purified from extracts of whole hyphal organisms by affinity chromatography. The purified receptor consisted of a doublet of 60 and 66 to 68 kDa. However, the biological activity, i.e., binding of C3d, appeared to be associated with the 60-kDa component that is expressed at the cell surface of hyphal elements (52, 289, 470, 563). Although it was initially thought that C. albicans yeast cells did not express C3d binding proteins, immunoelectron microscopy with a MAb to the purified C3d receptor revealed otherwise (235). An epitope cross-reacting with this MAb was detected on the plasma membrane of blastoconidia. During germination, it became associated with the cell wall, mostly at the cell surface of the organism. This component was a 50-kDa protein that, in addition to the hyphal 60-kDa moiety, has been reported to exhibit major C3d binding activity (563). Both the purified 50- and 60-kDa moieties were able to inhibit rosetting of erythrocytes coated with iC3b (90%) and C3d (50 to 64%) with hyphae. Other authors have identified additional components with different molecular masses that exhibited antigenic cross-reactivity toward antibodies (PAb anti-C3d) to the major cell wall C3d binding protein previously characterized (52, 289). In one study, a major component of 55 to 60 kDa and minor species of 67 to 68 and 20 kDa were detected in extracts from hyphae (235). In another study, moieties of 66, 40, and 21 kDa were detected in
ME extracts from blastoconidia
and hyphae (300). In a study of parental and clotrimazole-tolerant clones, reactive species of 94, 68, 60, 50 and 31 kDa were detected in the DTT extract of the parental strain
(145). The differences observed in these studies could be
due to one or more sources, including extraction procedures, strain and
growth conditions, differences in glycosylation, and lack of
specificity of the probe used for immunodetection. On the other hand
PAb anti-C3d appeared to be a highly specific probe, since it did not
cross-react with other well-characterized candidal cell surface
receptors such as the mp58 fibrinogen binding moiety. This supports the
contention of a separate identity for the mp58 moiety and the C3d
receptor (300). C3d binding protein is presumably present in
the cell wall in association with itself or other proteins, since it is
found in cell wall extracts in a form with an apparent molecular weight
larger than that detected by SDS-PAGE (300, 470).
Both direct and indirect evidence indicate that the 50- and 60-kDa
species are mannoproteins that differ in the glycosylation of a unique
polypeptide (52, 289, 470, 563). Mannoproteins obtained by
concanavalin A affinity chromatography inhibited rosetting. The two
components present in DTT extracts reacted in blotting experiments with
concanavalin A and were sensitive to periodate treatment. Differences
in the carbohydrate moiety were shown by the demonstration of
differences in reactivity with sugar-specific reagents
(563). The 60-kDa, but not the 50-kDa, mannoprotein reacted
with wheat germ agglutinin. Endoglycosidase F and
N-glycanase altered the 60-kDa species, with the generation
of 40- to 45-kDa products (470, 563). Treatment with
neuraminidase resulted in loss of immunoreactivity of the 60-kDa
moiety, presumably due to loss of carbohydrate (563) or possibly
contaminating protease activity (as noted above). Treatments that
targeted protein but not those that targeted carbohydrate reduced
rosetting. Thus, the carbohydrate moiety is unlikely to be involved in
ligand binding. This is in contrast to mp58 fibrinogen binding species,
where O-linked mannose appear to be involved in ligand binding
(60).
One of the moieties that was recognized by the PAb anti-C3d receptor
(300) also reacted with anti-ubiquitin antibody
(486). This 40-kDa moiety, along with the mp58 molecule and
the candidal laminin receptor characterized by our group
(296), is a major ubiquitinated protein in the cell wall
(see the discussion of mp58, above).
The relationship, if any, of the candidal and mammalian receptors for
C3d is unclear. Significant differences in the isoelectric point and
amino acid composition have been reported between the Candida 60-kDa C3d-binding protein and the mammalian C3d
receptor (CR2) (470). Both MAbs and PAbs directed to CR2
failed to react directly with C. albicans cells (115,
117, 162). However, in one report, an anti-human CR2 antibody was
able to inhibit rosetting of C3d-coated erythrocytes with C. albicans (115). In any case, due to the functional
similarities, the term "CR2" or "CR2-like" has also been used
for the candidal C3d receptor (149, 563).
The candidal receptor for C3d is expressed in vivo (235).
Immunoelectron microscopy was used to examine expression by fungal cells in kidney tissue and peritoneal lavage fluid from infected mice.
Fungal cells in peritoneal lavage fluid showed intense staining of
mother cells of germ tubes, germ tubes, and pseudohyphae. Staining of
the parental yeast cells was greatest at the innermost layers of the
cell wall and minimal at the surface, which was consistent with the in
vitro distribution. In contrast, germ tubes and pseudohyphae exhibited
staining throughout the cell wall. In kidney tissue, the C3d receptor
was expressed primarily on the cell wall of hyphae and pseudohyphae.
The CR2 protein is also immunogenic in vivo (149). In a
lymphoblastogeneic assay, lymphocytes from lymph nodes and spleens from
infected mice were stimulated to a greater extent than were lymphocytes
from control mice. In an intravenous murine model of infection, several
avirulent clones had reduced expression of C3d binding ability but not
iC3b binding ability (145). These clones were isolated as
tolerant to clotrimazole, and, while all clones grew under conditions
favoring hyphal formation, some differences in morphology of the
organisms were noted. The clones differed in lipase activity but not
acid proteinase. An analysis of the cell wall proteins of one clone
demonstrated that the components associated with C3d binding were
quantitatively and qualitatively altered. While this correlation with
C3d binding but not iC3b binding and virulence supports a role for C3d
binding in infection, it is not sufficient to determine its
contribution to or role in pathogenesis.
The C3d receptor is one of the best-characterized
glyco(manno)proteins present on the surface of C. albicans, yet its role in the infectious process is mostly unknown
(50, 406). The fact that the C3d-binding protein is also
expressed in vivo (149, 235) and the isolation of avirulent
C. albicans strains with a reduced ability to recognize C3d
(145) support a possible role for this candidal adhesin as
virulence factor. However, the mechanism(s) by which it may contribute
to pathogenesis remains speculative. Clumping between opsonized and
nonopsonized C. albicans cells by using complement receptors
may lead to aggregate formation that would protect the fungus from
phagocytosis. Another possibility is participation in iron acquisition
from complement-opsonized erythrocytes, as has been suggested for iC3b
binding proteins discussed in the subsequent section. In this context,
the deposition of complement fragments on any surface, e.g.,
endothelial cells, would provide a potential bridge for adhesion of
C. albicans to that surface.
(iv) Complement fragment iC3b.
The presence of
iC3b-binding components on the surface of hyphal forms of C. albicans was reported by Heidenreich and Dierich (194)
and subsequently confirmed for both yeast and hyphal forms (115,
162). Very early in the study of the iC3b binding protein, various laboratories hypothesized that the functional similarity between the fungus and host cells in binding iC3b might extend to a
structural similarity of the receptors involved. Antibodies to the
human receptors were used as probes of candidal surfaces. Human
complement receptors 3 and 4 (CR3 and CR4) bind iC3b and are two
members of the human
2 subset of the integrin family of
receptors (86, 460). These heterodimeric proteins differ in
their
subunits. CR3 contains the
M subunit, and CR4
contains the
X subunit.
M and
X are polypeptides of 165 and 150 kDa, respectively,
and, in mammals, they each combine with a common
2 chain
of 95 kDa. At least eight MAbs that recognize
M exhibit high to moderate reactivity with C. albicans, and one MAb
recognizing
X shows high reactivity with the fungus
(25, 115, 117, 146, 162, 210; for a review, see
reference 209).
M antibodies as a measure of
iC3b binding capacity, reactivity was also detected on yeast cells,
although at a low level (162). Yeast cells grown in 50 mM
glucose bound more antibody than did cells grown in 5 mM glucose, and
the extent of the response was strain dependent. Binding of
radiolabeled ligand to yeast cells demonstrated that binding was
saturable and reversible, with an association constant of 2.45 × 106 liters/mol. The authors noted that this constant was
very similar to that for human CR3. Carbon source also affected iC3b
binding capacity as yeast cells grown in glucose had a four to six fold higher expression of the receptor compared to those grown in glutamate (210).
Identification of the candidal receptors for iC3b was initially
attempted by Eigentler et al. (117). Using a monoclonal
antibody to the
M chain (MAb OKM-1), these authors
immunoprecipitated a 130-kDa protein along with minor components of 50 and 100 kDa from extracts of C. albicans cells previously
labeled with 125I. Later, a 165-kDa moiety was detected in
cytosolic and membrane fractions but not in cell wall extracts of the
yeast cells by Western immunoblotting, again with MAb OKM-1
(210). More recently, a number of polypeptides with
molecular masses of 70, 66, 55, and 42 kDa were purified by affinity
chromatography from whole homogenates of hyphal forms of C. albicans (4). The 42-kDa moiety was affinity purified
on C3 and reacted with MAb OKM-1. The three other components were
isolated by affinity chromatography with antiserum prepared to the 42 kDa species. However, the high-molecular-weight components, i.e., the
130- and 165-kDa species, detected in previous studies were not
identified in this work. The 66-, 55-, and 42-kDa proteins
cross-reacted with MAb OKM-1 in Western immunoblotting experiments.
However, differences were observed in the ability of these moieties to
bind C3, C3b, and iC3b. Ligand affinity blots revealed binding of these
three complement components to the 42-kDa species, whereas the 55-kDa
protein reacted with C3 but only weakly with C3b and iC3b, and the
66-kDa component failed to bind any C3 ligand. Neuraminidase treatment
of the 66-kDa component resulted in the appearance of a 42-kDa moiety
and of two other proteins between 55 and 66 kDa, presumably due to loss
of carbohydrate or possibly contaminating protease activity (as noted
above). The initial 55-kDa species almost completely disappeared
following enzyme treatment, with some slight evidence of aggregation
products. The 42-kDa entity was essentially unaffected by the
treatment. None of the components was affected by treatment with
endoglycosidase F. The 55- and 66-kDa moieties were suggested to be
glycosylated forms of the 42-kDa entity. The antiserum against the
42-kDa species inhibited the binding of iC3b-coated erythrocytes to the
fungus and bound to a human cell line expressing CR3. The authors
concluded that although candidal CR3-like and human CR3 receptors have
antigenic similarity and bind identical ligands, they may differ in
structure.
The binding of iC3b, the cross-reactivity of intact Candida
cells and isolated candidal macromolecular components towards a number
of MAbs recognizing epitopes on the
X and chains, and the similarity in molecular mass between the
M and
X chains and the 130- and 165-kDa candidal proteins
reactive toward MAb OKM-1 indicate functional antigenic and structural
relationships between the iC3b receptor of C. albicans and
human CR3 and CR4. Because of these similarities, the C. albicans iC3b receptor is frequently termed the integrin analog
(for reviews, see references 49, 50, 208, 209, and
406). Recently, these similarities have been used to
construct probes for a candidal gene. Gale et al. (153) used
as a probe a fragment of the transmembrane region of
M
to screen a partial C. albicans genomic library. Isolated clones were then probed with a degenerate oligonucleotide for a
conserved cytoplasmic sequence of
X. The isolated
sequence,
INT1, revealed an ORF encoding 1,164 amino
acids (ca. 185 kDa) with no extensive database homology. The sequence
contains a putative membrane-spanning region and cytoplasmic tail.
Within the deduced amino acid sequence there is an I region, found in
five
-integrin subunits, that has 18% identity to the I domain of
M, and the region contains three potential partial
motifs for binding divalent cations. PAbs prepared to the peptide
corresponding to the second cation binding site and to an
RGD-containing peptide were prepared. These antisera reacted with 82 and 64% of yeast cells, respectively. The gene was expressed in
S. cerevisiae under the GAL1-10 promoter, and
19% of transformed cells reacted with MAb OKM-1, compared to 6% of
control cells. However, the binding of iC3b to S. cerevisiae cells expressing the gene was not examined. When the gene was induced,
the S. cerevisiae cells formed structures that resembled germ tubes. This is clearly an intriguing gene, and features of the
deduced protein proposed to be membrane anchored and exposed at the
cell wall surface differ from features of others identified or proposed
as cell wall proteins.
There are a number of questions to be resolved before an unambiguous
identity can be assigned to the iC3b receptor and determination to what
extent it is indeed an integrin analog. It should be noted that no
evidence has been found for the presence of a
2 protein in C. albicans. In any case, the relationship of the
medium-molecular-weight components reacting with MAb OKM-1 detected by
Alaei et al. (4) and the other high-molecular-weight
species, previously detected, that also cross-react with this antibody
(117, 210) is unknown. The predicted unglycosylated size of
Int1p (153) is greater than any species that is detected
by MAb OKM-1 in extracts or that is reported to bind ligand (4,
117, 208). There is also some question associated with the
unambiguous subcellular location of the iC3b-binding species in intact
cells. MAbs to
M and
X are detected by
immunofluorescence as binding at the surface of C. albicans
yeast cells and hyphae (25, 115, 117, 146, 162, 176, 210).
This observation is consistent with the suspected role of epitopes
recognized by these MAbs as cell surface-bound receptors for C3b and
iC3b. However, immunoblotting and ligand affinity-blotting moieties
that cross-react with MAb OKM-1 and bind C3 derivatives were detected
mostly in cytosolic extracts or whole homogenates of C. albicans cells (4, 117, 210). While the functional and
antigenic similarities between the candidal binding protein and the
human CR3 and CR4 seem to rest on firm ground, the structural
relationships between these molecules remain in question and require
further work to be established clearly.
As for the C3d binding proteins, several functions have been suggested
for the iC3b receptors of C. albicans in the pathogenesis of
candidiasis, although in this case a more clear relationship of these
candidal components with virulence and pathogenicity appears to exist.
A spontaneous mutant strain selected as being resistant to cerelenin
was also reduced in its ability to adhere to fibrin clots and to cause
endocarditis or vaginitis in animal models. This strain was examined
for the presence of C3d and iC3b binding proteins (395).
Rosetting of iC3b-coated but not C3d-coated erythrocytes was impaired
in the mutant strain, which showed a 53% reduction. Extracts from the
wild-type strain but not from the mutant strain were able to inhibit
rosetting. This further supported the loss of functional iC3b receptors
in the mutant strain. The iC3b-binding moieties may participate in the
process for acquiring iron from opsonized erythrocytes, as suggested by Moors et al. (367). C. albicans activates the
alternate pathway of complement, and, in vivo, "bystander"
deposition of complement fragments on erythrocytes may supply the
ligands to mediate binding of the fungus. By rosetting such
erythrocytes, C. albicans may gain access to their iron
through the candidal cell surface hemolysin-mediated lysis
(317). Gilmore et al. (162) proposed a protective
mechanism in which iC3b that was noncovalently attached to the receptor on the surface of C. albicans may cause masking of the
recognition site on iC3b for CR3 receptors of neutrophils, thus
decreasing phagocytosis of iC3b-coated candidal cells. They observed
that yeast cells of one strain coated with MAb Mo1 (an anti-human CR3 antibody) that blocked the receptor showed approximately 65%
phagocytosis compared to 55% for uncoated yeast cells when incubated
with serum and neutrophils.
The ability of C. albicans to bind to iC3b via a specific
receptor may play an important role in the adherence of the fungus to
the host epithelial and endothelial surfaces (25, 26, 146, 176). Yeast cells grown in glucose express more iC3b receptor than cells grown in glutamate and have increased binding to human umbilical vein cells (176). Blocking of the receptor with
iC3b resulted in decreased binding. Among other Candida
spp., C. stellatoidea but not C. tropicalis,
C. parapsilosis, C. krusei, or C. lusitaniae rosetted iC3b-coated erythrocytes (115,
194). Bendel et al. (26) examined the correlation
between expression of the iC3b receptor and adhesion to HeLa cells. The
proportion of cells binding MAb OKM-1 was greatest for C. albicans (68%) followed by C. tropicalis (32%), with
C. parapsilosis, C. glabrata, C. lusitaniae, C. krusei, and S. cerevisiae
ranging from 18 to 1%. A similar hierarchy was obtained for adhesion,
since C. albicans and C. tropicalis adhered similarly with 45 to 50% of yeast cells bound and C. krusei
and S. cerevisiae adhered with 10 to 12% of yeast cells
bound. In another study, it was noted that C. albicans
showed greater surface fluorescence with MAb OKM-1 than did C. tropicalis but that adhesion of the two species to HeLa cells was
similar (25). Incubation of C. albicans with
anti-
M MAbs OKM-1 and Mo1, iC3b, or several RGD-containing peptides from iC3b significantly inhibited the adhesion
of C. albicans to HeLa cells while C. tropicalis
binding was not inhibited by iC3b or its peptides. On the other hand, purified fibronectin and fibronectin-RGD peptides inhibited the adhesion of C. tropicalis but not C. albicans.
After growth in serum-free medium, the presence of iC3b and fibronectin
was observed on the surface of HeLa cells. Treatment of HeLa cells with
anti-C3 antibody but not anti-fibronectin antibody inhibited the
adhesion of C. albicans, and the reverse was true for
C. tropicalis. These observations support different
mechanisms for adherence of C. albicans and C. tropicalis to epithelial cells. Overall, these studies, while
implicating iC3b receptors in candidal adhesion, also show that other
adhesins are involved, since inhibition of the iC3b receptor does not
completely abolish the interaction with host cells.
Extracellular matrix proteins. The initiation of studies on the ability of C. albicans to bind and adhere to components of ECM is attributable largely to Klotz (248, 249, 251). Klotz showed that C. albicans yeast cells bound at the junctions of endothelial cells in confluent layers and that binding was enhanced when endothelial cells were removed from the substrate or contracted, resulting in ECM exposure. ECM proteins, collagen type IV, laminin, and fibronectin immobilized on plastic plates mediated the binding of yeast cells to the coated wells. ECM components form a network by interactions with each other. For example, entactin (nidogen) has the ability to interact with other ECM components such as fibronectin, fibrinogen, laminin, and type IV collagen (142, 575, 576). Thus, multiple binding targets are simultaneously present and adjacent in the ECM. Another potential contributor to the interaction are the collageneous domains present in candidal proteins, e.g., p37 laminin binding protein of yeast cells and mp58 fibrinogen binding protein (484). Some ECM proteins have collagen binding sites, and these may bind to candidal proteins containing collagenous domains. Therefore, in vivo binding to ECM is likely to involve multiple receptors binding to different ligands. These may be candidal receptors that bind to similar binding sites on ECM components as do integrins (see below), as well as ECM components that have collagen binding sites that bind to candidal proteins via collagenous domains. In general, the receptors are expressed extensively on hyphae, and this has been postulated as one of the ways by which germ tubes contribute to the development of infection. Although yeast cells are the most likely form to be hematogenously disseminated and extravasate, only a few yeast cells express the various binding capacities in vitro. An obvious question, then, is whether interactions between extravasating yeast cells and ECM contribute to establishing and maintaining infection. Three possibilities may be considered. First, not all extravasating yeast cells may need to bind for an infection to be initiated. Second, more cells may express the various receptors in vivo. Third, with the multiplicity of binding interactions that are available to the fungus, most yeast cells may express at least one of these, and that may be sufficient for binding.
In mammalian systems, the majority of molecules involved in cell adhesion to ECM components are members of the supergene family of integrins. These binding proteins are highly conserved receptors that mediate cell-matrix and cell-cell interactions in a wide variety of biological processes including infectious diseases (216, 457). The parallel between candidal complement fragment receptors and host integrins and candidal ECM receptors and host integrins was not unappreciated. The presence of candidal moieties exhibiting cross-reactivity with antibodies raised against the
and
chains
of integrins has been reported (25, 102, 115, 162, 176, 210, 318,
464, 465). In this case the
1 subunit found in
some mammalian integrins mediating binding to ECM was also detected in
C. albicans membranes or cell surface (318, 464,
465). It was suggested that binding of C. albicans to
fluid-phase and immobilized human basement membrane glycoproteins and
endothelium, e.g., laminin, fibronectin, entactin, and vitronectin, is
mediated, at least partly, by integrin analogs (or perhaps homologs)
present at the surface of fungal cells (49, 50, 102, 116, 176, 209, 250, 259, 406, 464, 465). The possible existence of integrin
analogs for complement fragment receptors in C. albicans cells has been discussed above.
(i) Laminin.
Laminin, a major component of the
basement membrane (539), is a large multidomain glycoprotein
that seems to play a critical role not only in normal cell adhesion but
also during tissue invasion and metastasis by tumor cells and
pathogenic microorganisms. Contemporaneous with the study by Klotz
(249) on the binding of the fungus to immobilized ECM
components, Bouchara et al. (35) reported the binding of
laminin to germ tubes grown in medium 199. As determined by indirect
immunofluorescence, no binding to yeast cells grown in Lee medium was
detected. Immunoelectron microscopy showed that this binding was in the
outermost fibrillar layer. Radiolabeled laminin was used to show that
binding was saturable and specific. Further analysis indicated about
8,000 binding sites per organism with a Kd of
1.3 × 10
9 M. Binding was reduced by fibrinogen but
not fibronectin, serum albumin, or several sugars, suggesting that
binding was not lectin-like.
(ii) Fibronectin. C. albicans and other Candida species adhere to fibronectin. Fibronectin is a large (440-kDa) dimeric glycoprotein that circulates in plasma and is found as part of ECM. Various functional domains of the molecule have been identified; they include binding domains denoted as fibrin, collagen, DNA, cell (containing an RGD sequence), and heparin. Initial studies of the adhesion of Candida cells to endothelium suggest a role for fibronectin as the most prominent host ligand for candidal adhesion (248, 257, 472, 507), and binding of C. albicans to immobilized fibronectin was demonstrated by Skerl et al. (507). The binding was inhibited by mannan and was reduced by proteolytic treatment of fungal cell surfaces. The fibronectin receptor appeared to be distinct from C3d and iC3b binding activities when fibronectin binding in strains deficient in the other activities was examined (380). Several studies in different laboratories have examined the candidal receptor and its ligand binding characteristics. However, there are differences between these studies that may reflect the presence of multiple adhesins. A contribution by strains, experimental conditions, or assay methods is also a possible explanation for the differences in results reported. Comparisons between studies are also difficult, since the same parameters were not determined in each study. While a number of observations are consistent with homology between the candidal fibronectin receptor(s) and a mammalian integrin, some are not.
The first receptor study by Klotz and Smith (253) showed that binding of soluble fibronectin to C. albicans yeast cells was saturable, with approximately 8,000 binding sites per cells and a Kd of 1.1 × 10
8 M. Binding occurred rapidly and was not reversible in a 2-h period. In a
later study, Nègre et al. (380) found two classes of
binding sites: a small number (approximately 5,000 per cell) of
high-affinity binding sites (Kd, 1.3 × 10
9 M) and a large number (approximately 30,000 per cell)
of low-affinity sites (Kd, 1.2 × 10
7 M). The binding in this study occurred more slowly
and was reversible. This study used a broader concentration range that
facilitated the detection of two binding classes. Differences were also
reported for the effect of cations, in particular calcium, on binding. Initially, binding was found to be enhanced by two- to more than threefold by the presence of Ca2+ (222, 259).
The Ca2+ effect was more pronounced at pH 7, near the
optimal binding pH 6, than at pH 4 (222). In a subsequent
study, fibronectin binding decreased with increasing concentrations of
Ca2+ and was enhanced by the presence of EDTA, since in the
presence of the chelator the number of high-affinity binding sites
doubled (380). Nègre et al. (380) pointed
out that the lack of calcium dependence differed from that expected for
an integrin-like receptor and suggested that previous investigations
may have been looking at a calcium-dependent effect of binding to
plastic, the substratum to which fibronectin is bound in assays with
insoluble ligand. However, the Ca2+ effect observed by
Jakab et al. (222) was with soluble fibronectin.
Some disagreements have been reported both in the identity of
fibronectin fragments that interact with C. albicans and in the inhibitors of binding. Some results support the collagen binding domain as the site of soluble fibronectin binding, while others support
the cell binding domain as the major recognition site. The cell binding
domain is also suggested to be the major site of binding to immobilized
fibronectin on the basis of some observations, while other results
support multiple binding sites. Penn and Klotz (407)
reported that among proteolytic fibronectin fragments, the 120-kDa
soluble cell binding domain but not the gelatin or heparin binding
domain bound to fungal cells. Santoni et al. (465) reported
that the fungus bound to the immobilized 120-kDa fragment. On the other
hand, Nègre et al. (380) found that the 120-kDa moiety
was less active in inhibiting soluble fibronectin binding than the
gelatin/collagen domain but more active than the fibrin and least
active heparin binding domains. Adhesion was less specific with
fragments from each of the four binding domains promoting adhesion of
the fungus to acrylic disks coated with any of the fragments. Jakab et
al. (222) reported that the collagen binding fragment of
fibronectin was a less effective inhibitor (25%) of soluble
fibronectin binding than was a fragment containing the cell binding
domain (85%).
There is also disagreement concerning inhibitors of interactions of the
fungus with soluble and immobilized fibronectin. Klotz and Smith
(253) and Jakab et al. (222) reported that RGD
and related peptides inhibited binding. RGD was the most effective peptide inhibitor (15 to 28%) of soluble fibronectin binding
(222, 253). The GRGESP and GRGDTP peptides were less
effective inhibitors, and GRGDSP was ineffective (253).
However, GRGESP was an effective inhibitor (88%) of binding to
immobilized ligand. In contrast, Santoni et al. (465) found
that GRGDSP but not GRGESP could inhibit binding to insoluble
fibronectin. The difference with respect to GRGESP and GRGDSP
inhibition is of particular interest, since it affects the possibility
that the fungal receptor is an integrin homolog (465).
GRGDSP but not GRGESP is an effective inhibitor with mammalian
integrins. In opposition to these observations, Nègre et al.
(380) reported that a recombinant 120-kDa fibronectin fragment with the RGDS sequence deleted was as good a promoter of
C. albicans binding as was the native sequence. They also
found that RGD peptides did not block soluble fibronectin binding. The inhibitory effect of heparin has also differed among studies. Heparin
has been reported to inhibit soluble fibronectin binding (222) but not the binding of the 120-kDa fragment containing the cell binding domain (407). Heparin and heparan sulfate
were found to inhibit binding to immobilized fibronectin, apparently by
binding to fibronectin and interfering with recognition or access to
the binding site(s) by C. albicans (254).
Klotz et al. (259) used affinity chromatography to isolate a
fibronectin binding component(s) from a detergent extract of yeast
cells. Two bound proteins with unreduced molecular masses of 60 and 105 kDa were detected by SDS-PAGE, and two species of 62 and 72 kDa were
detected under reducing conditions. The proteins were present in the
cell membrane as well as in the cell wall of yeast cells and were also
found in germ tubes. The proteins present in the yeast cell extract
were eluted from columns of fibronectin or gelatin coupled to agarose
with EDTA,
-methylmannopyranoside, or peptides containing the RGD
sequence. Both moieties appeared to be mannoproteins on the basis of
their ability to bind concanavalin A. The 60-kDa component in extracts
was found to exhibit cross-reactivity with antibodies raised to the
human integrin receptor for fibronectin, vitronectin, and complement
(MAbs OKM-1 and Mo1 for the
M subunit). The
anti-fibronectin receptor antiserum also identified two other major
reactive moieties of 50 and 90 kDa and several less reactive species in
the same size range. This reactivity further indicated that candidal
cell wall glycoproteins that are probably related to integrins may be
receptors responsible for yeast cell adherence to ECM (259).
On the basis of this assumption, a method similar to that used to
purify animal integrins was used to isolate the fungal binding protein
(256). In SDS-PAGE, this procedure yielded a highly
glycosylated protein of approximately 60 kDa, whose N terminus was
blocked to Edman degradation. It eluted from a molecular mass sizing
chromatography column with an apparent molecular mass of 42 kDa. A
similar phenomenon was observed when the C3d binding protein was
subjected to gel permeation chromatography, and these authors suggested
that the apparently anomalous migration might be due to some
interactions with the column matrix retarding elution (470).
These experiences suggest that size determinations for cell wall
proteins obtained by gel permeation chromatography must be considered
carefully if they are not supported by other procedures.
On the other hand, the presence of a fibronectin receptor antigenically
related to the
5
1 mammalian integrin has
been reported for cells of C. albicans and other
Candida spp. (465). The binding to C. albicans of antibodies to human integrin subunits and the human
fibronectin receptor was examined by fluorescence flow cytometry. Reactivity was detected with yeast cells with anti-
5
antibodies (MAb SAM1 and marginally with MAb P1D6) and with two
anti-fibronectin receptor antiserum. The percentage of positive
organisms, approximately 97%, was greater when germ tubes were
analyzed with one anti-fibronectin receptor antiserum. In addition, two
MAbs (A1A5 and 4B4) for the
1 subunit that were negative
with yeast cells stained 41 to 59% of the germ tubes. Anti-fibronectin
antibody completely inhibited yeast cell and germ tube adhesion to
immobilized fibronectin, while an RGD-containing peptide partially
inhibited binding. MAb SAM1 (anti-
5) also inhibited
binding, while MAb 4B4 (anti-
1) partially inhibited
binding. These results suggest that the C. albicans receptor
is antigenically and functionally related to
5
1 integrin. With the same commercial
anti-human fibronectin receptor antiserum, Western blot analysis of
undialyzed extract revealed three major reactive species between
approximately 40 and 50 kDa and a polydisperse reactivity above 143 kDa
(164). However, these species did not represent all the
moieties in the extract that were able to bind ligand, since additional
species larger than 50 kDa and smaller than 35 kDa were detected in a ligand affinity blot.
MAb SAM1 and the two anti-fibronectin receptor antisera were used to
examine for a similar receptor on other species (464). Reactivity was observed with C. tropicalis, C. stellatoidea and C. glabrata, with C. tropicalis exhibiting the greatest activity with MAb SAM1.
C. krusei showed marginal reactivity with the antibodies. C. tropicalis and C. stellatoidea bound to
immobilized fibronectin to a greater extent than did C. glabrata, while C. krusei bound only marginally. Thus,
a correlation appears to exist between the expression and function of
the
5
1 integrin-like fibronectin receptor
and the hierarchy of relative virulence among the pathogenic Candida spp. Quite recently, DeMuri and Hostetter
(102) have examined a
1 fibronectin receptor
in C. tropicalis. Binding of fibronectin was saturable and
reversible, with 854 receptors per cell and a Kd
of 2.3 × 10
9 M. The receptor density is about 6- to
10-fold lower than estimated for C. albicans (253,
380). An extract of a cell membrane preparation inhibited
fibronectin binding (102). A ligand affinity blot of the
extract identified a band of approximately 125 kDa. Immunoblotting with
an antiserum to a human fibronectin receptor
(
5
1) also identified a similar-sized
band, although reactivity with smaller bands was detected with both
receptor and control antisera. MAb P1D6 (anti-
5) did not
react with the extract, while an antiserum to
1 reacted
with the 125-kDa moiety. A fibronectin binding protein of 105 kDa was
immunoprecipitated from a cell extract. These observations suggested
that C. tropicalis contained the
1 subunit
but not a corresponding
subunit, and the authors suggested that one subunit might be sufficient.
Although the regulation of fibronectin receptor expression is still
poorly understood, expression of the fibronectin receptor(s) appears to
be regulated in part by environmental conditions. The nutrient
composition of the growth medium is one of the most commonly observed
parameters affecting binding capacity. The binding of fibronectin is
influenced by the batch of medium used for fungal growth
(380). Differences in binding between organisms grown on
Sabouraud dextrose medium in suspension and on agar were noted (222). Organisms grown in suspension at 37°C bound 60%
more fibronectin than when grown at 21°C. When grown under conditions
that resulted in differences in cell surface hydrophobicity (CSH), the
more hydrophobic cells showed increased binding to fibronectin. Silva et al. (505) also demonstrated that hydrophobic cells bound
in greater numbers than hydrophilic cells to immobilized fibronectin. Yeast cells grown on Sabouraud medium bound some 2.5 times more fibronectin than did organisms grown on Lee medium and more than 5 times as much as those grown on yeast nitrogen base (578). Metabolically active yeast cells (26 and 37°C) bound more ligand than
did cells maintained at 4°C (253). Recently, hemoglobin has been identified as an inducer of fibronectin receptors in C. albicans cells (578). In the presence of hemoglobin,
the binding of soluble fibronectin was enhanced 20- to 80-fold. The
induction was specific for hemoglobin, since hemin, Fe, and
protoporphyrin IX could not substitute. Thus, the effect was not just
an increase in the Fe concentration. A small enhancement of expression
was observed with globulin, globin, and myoglobin. Cells were required to grow in the presence of hemoglobin to manifest the increased expression, and the induction was reversible when hemoglobin was removed. Induced cells also showed increased binding to immobilized fibronectin and confluent endothelial cell layers. However, removal of
endothelial cells from the wells did not result in an increased binding
to the exposed matrix material. The effect of hemoglobin on adhesive
potential is interesting, since, as discussed above, the organism has
hemolytic activity (317). Exposure of C. albicans to the vascular compartment may induce receptors that enhance further
interactions of the fungus with the host.
Considering all the experimental evidence reported, it seems likely
that there is more than one mechanism mediating the binding of
fibronectin to candidal surfaces. There may be multiple fibronectin receptors. As noted in the discussion of laminin binding (see above),
the preparation of the extract used to identify reactive species may
profoundly affect the outcome (164). In fresh, undialyzed extracts, multiple fibronectin binding species were identified. In
dialyzed extracts, the number and relative contribution of the species
were altered. In addition, only some of the reactive species identified
by ligand affinity blots were detected with antiserum to the human
receptor. Antigenic differences between human receptors and candidal
receptors may also contribute to differences, as may the conditions
used for analysis. Santoni et al. (465) found a difference
in reactivity with C. albicans and other species among
anti-
-subunit MAbs. In a later study that failed to identify a
reactive moiety, the less reactive MAb was used (102).
Alternatively, a single receptor could recognize multiple domains with
different affinities. There is precedence for the latter among proteins
such as the staphylococcal fibronectin binding protein (36).
A third possibility is that there is a single receptor protein that in
different forms or states of modification has affinity for different
domains of fibronectin.
The expression of fibronectin binding proteins has not been examined
specifically in vivo. However, both in vitro and in vivo observations
support the hypothesis that binding to fibronectin is a contributor to
host interactions. Since the preferential adhesion to ECM as opposed to
endothelial cells was reported (248), adhesion studies have
focused on soluble and immobilized fibronectin as discussed above.
These provide models of exposure to serum fibronectin and ECM. However,
several studies have suggested that fibronectin can mediate cellular
adhesion (230, 248, 472, 507). Binding to both buccal and
vaginal epithelial cells in suspension was reduced by the addition of
fibronectin (230, 507). These epithelial cells were
demonstrated by immunofluorescence techniques to have fibronectin on
their surfaces. Vaginal epithelial cells could be demonstrated to be
composed of two populations that differed in surface fibronectin
(230). More C. albicans yeast cells bound to the
high-fibronectin epithelial cells than to the low-fibronectin epithelial cells, and adhesion to the high-fibronectin cells was inhibited by the addition of exogenous fibronectin. The
high-fibronectin epithelial cells were more abundant in epithelial-cell
populations recovered during the first or fourth week of the menstrual
cycle, during pregnancy, and from diabetic women (475). In a
model of nonbacterial thrombotic endocarditis, it was noted that
fibronectin was present on treated but not normal rabbit cardiac
valvular endothelium and that there was a correlation between organisms that bound fibronectin and those that caused infection
(472). In vivo evidence of a role of adhesion to fibronectin
or any other ECM ligand in pathogenesis is at best scant. Binding of
C. albicans to substrates with RGD recognition motifs
contributed to studies to examine the effect of peptides containing the
motif in model systems. Klotz et al. (260) reported that an
RGD-containing peptide reduced the census of yeast cells in several
tissues in a rabbit model of infection 4 h after intravenous
inoculation and proposed that the effect could be attributable to
blocking the adherence to host substrates. In a perfused murine liver
model, treatment of yeast cells with RGD-containing peptides increased
the trapping and killing of yeast cells when they were infused into the
liver (469). The authors suggested that binding of the
peptide to the yeast surface might serve as an opsonin, promoting
killing by Kupffer cells. Another possibility would be that inhibition
of adherence to other liver cells increased the proportion of yeast cells that were available for phagocytosis and killing. Whether the
multiple fibronectin receptors indicated by several studies result from
processing of the product or a single gene or from the expression of
multiple genes, a genetic approach to examine the contribution
interactions with soluble and insoluble fibronectin and role of the
various binding moieties will be very challenging.
(iii) Entactin. López-Ribot and Chaffin (293) examined the interaction between C. albicans and entactin (nidogen), a novel adhesion glycoprotein molecule present in the ECM, especially in the basement membrane (239). Entactin is a sulfated glycoprotein that contains an RGD sequence and that forms a tight complex with laminin and interacts with collagen IV, fibronectin, fibrinogen, and itself. The interaction of entactin with intact cells and the binding moieties present in cell wall extracts was examined. Cells of both the yeast and the hyphal morphologies of the fungus were found to bind entactin, as detected by an indirect immunofluorescence assay. Most germ tubes bound entactin, and binding was heterogenously distributed on the hyphal surface with no reactivity on the parent yeast cell. A small percentage of nongerminated yeast cells in a germ tube culture bound entactin, and about 10% of cells in a yeast culture expressed the entactin binding capacity.
Cell wall material in a
ME extract from both morphologies bound to
immobilized entactin. The specificity of the binding was demonstrated
by the ability of either an anti-entactin antibody or an antiserum to
cell wall components to block the binding. No morphological differences
were associated with the binding components, since extracts from yeast
cells were able to completely inhibit the binding of germ tube
components to entactin and vice versa. Binding utilized both
RGD-dependent and -independent binding sites, since an RGDS peptide
inhibited binding by approximately 50%. Thus, there are at least two
sites on the entactin molecule that are recognized by candidal binding
proteins. A single RGD sequence is present in the central domain of
entactin. Preincubation of the extracts with laminin or fibronectin
depleted the extracts of some entactin binding capacity. This may be
due to a promiscuous receptor that binds multiple ligands, e.g., RGD
motif, or to a multisubunit receptor that contains binding proteins for
several ECM components.
The entactin binding components of the extract were detected by ligand
affinity blotting with entactin. Moieties with molecular masses of
approximately 25, 44, and 65 kDa present in
ME cell wall extracts
from both growth forms reacted with entactin. These bands, which appear
to be identical in the two growth forms, may represent different stages
of modification of the same entactin binding protein or different
binding proteins that may recognize the same or different adhesive
domains on entactin. Since entactin has the ability to bind to
collagen, as noted above, one or more of these proteins may contain
collagenous domains that are interacting with the collagen binding site
of entactin. The possible relationship (if any) of these molecules to
some other receptor-like molecules described for C. albicans
within the same molecular weight range remains undetermined.
(iv) Vitronectin.
C. albicans cells can bind
vitronectin (serum-spreading factor) (222). Vitronectin is a
constituent of vascular walls and dermis. It is present in serum and is
involved in the regulation of blood coagulation (97). It
contains a number of domains capable of interacting with microorganisms
and mammalian cells, including an RGD sequence that binds eukaryotic
integrin receptors and a glycosaminoglycan-binding domain that
interacts with complex carbohydrates and glycoconjugates (182,
528). The characteristics of vitronectin binding to
Candida were found to be the same as and to differ significantly from those of other ECM components such as fibronectin. The binding of vitronectin increased during late exponential growth of
the organism (222). Two studies that have examined the
effect of growth temperature and cell surface hydrophobicity (CSH) on the interaction have reached somewhat different conclusions. Jakab et
al. (222) found that cells grown at 37°C bound 35% more
soluble vitronectin than did cells grown 21°C and that cells with
increased CSH bound somewhat more vitronectin than did cells with more
hydrophilic surfaces. On the other hand, Silva et al. (505)
found that hydrophobic cells grown at 23°C did not differ
significantly in their adhesion to immobilized vitronectin from cells
grown at 37°C. The interaction with soluble vitronectin was optimal
at pH 4 and was enhanced substantially by calcium at pH 7 (222). A reduction in the binding capacity of cells
following heating or treatment with several proteases suggested the
presence of a protein receptor. Among potential binding inhibitors, a
64% reduction was observed with fibronectin and a minimal reduction of
10% with fibrinogen and collagen type I, while no effect was noted
with type IV collagen and gelatin. Unlike other ECM ligands, no clear
role for the RGD motifs present in the vitronectin molecule was
established, since RGD and RGDS were ineffective inhibitors while GRGDS
was somewhat effective (20% inhibition). Heparin was the most
effective inhibitor (50 to 85% inhibition) (222, 286). This
suggests that binding may be through the glycosaminoglycan binding
region of vitronectin. Analysis of binding of plasma vitronectin
revealed the presence of both high- and low-affinity receptors
(286). For the high-affinity receptor, analysis yielded a
determination of 98,000 binding sites per cell with a
Kd of 3.5 × 10
7 M. This
dissociation constant is similar to the low-affinity binding constant
reported in one study for fibronectin (380), although the
number of binding sites is larger than reported for any other ligand.
ME (286). In the blotting analysis, heparin completely inhibited vitronectin binding, although it inhibited
the binding to intact cells by only 50%. More recently, Olson et al.
(398) have reported that fungi interact with vitronectin through cell wall
-glucan, similarly to the mechanism described for
Pneumocystis carinii (287). The authors
hypothesized that the glycosaminoglycan binding region of vitronectin
bound cell wall
-glucan. Using
-glucan from S. cerevisiae, they demonstrated by suspension binding analysis that
there was a concentration-dependent specific binding between
vitronectin and
-glucan. Assuming that the candidal vitronectin
receptor would be antigenically related to the human integrin
vitronectin receptor, Klotz et al. (259) analyzed an
octylglucoside extract of isolated cell walls with antiserum to the
human receptor. Moieties of 50, 60, and 90 kDa were most reactive,
although several other components in the same molecular weight range
were also detected.
Since it has been reported that vitronectin is adsorbed to polymeric
biomaterials to a much higher degree than other ECM and serum proteins,
attachment of C. albicans to indwelling plastic catheters
and prostheses (contaminated medical material is a major cause of
nosocomial Candida infections [see below]) could take place through interactions with vitronectin. In conclusion, vitronectin binding may represent a novel adherence mechanism of C. albicans cells to host tissues and biomaterials (222).
Binding to vitronectin may also be a protective mechanism for the host.
Interaction with vitronectin appears to increase the binding of
C. albicans to a macrophage cell line and phagocytosis
(286). Vitronectin-coated
-glucan particles stimulate
tumor necrosis factor alpha release from macrophages, although at high
concentrations the
-glucan suppressed cytokine release
(398). Since
-glucan is common to fungi, this may be a
general fungal recognition system. Binding of C. albicans to
macrophage may involve multiple mechanisms or may be specific to
macrophages from different tissues. As noted below, moieties of both
acid-labile and acid-stable mannan appear to mediate the binding to
splenic macrophages (234, 285).
(v) Collagens. Klotz (249) showed that C. albicans bound to immobilized type IV collagen, a component of basement membrane, and also to type I collagen. Binding to gelatin (denatured type I collagen) was about one-third lower than to the native form in this study, although in a more recent study the binding to native and denatured collagen was similar (255). Binding to type I collagen was reduced by about half to five fold by the removal of calcium and magnesium ions (249, 259). Calcium mediated most of the ion enhancement, since removal of calcium effected nearly a threefold reduction (259).
Adhesion of C. albicans to type I and type IV collagen is inhibited almost completely by fibronectin and substantially by a GRGRSP peptide (253). Adhesion to type I but not type IV collagen is inhibited about 40% by a GRGDTP peptide. On the other hand, adhesion to type IV but not type I collagen is inhibited by an RGD peptide. Heparin inhibited the binding to type I and type IV collagen (254). When tested with type I collagen, heparan sulfate and dextran sulfate were also inhibitors. These compounds appeared to mediate the inhibition by binding to the ECM ligand rather than to the fungus. An unfractionated tryptic digest of gelatin almost completely abolished the binding of C. albicans to immobilized type IV and type I collagen, gelatin, fibronectin, and laminin (255). Fragments of gelatin produced by CnBr digestion were also examined. Several peptides isolated by high-pressure liquid chromatography were very effective in inhibiting binding to immobilized gelatin. The only identifiable peptide was a 47-amino-acid fragment with residues 40 to 86 of the
-1 chain of
type I collagen that contains three RGX sequences but not RGE or RGD
sequences. Several peptides from the
-1 chain were synthesized and
examined. Only a 10-amino-acid peptide (residues 778 to 787),
GQRGVVGLPG-NH2, was active, causing 68% inhibition. The
authors suggest that inhibitory fragments from gelatin are
biocompatible and are potential candidates for reducing adherence to
host proteins in vivo.
Klotz et al. (259) used affinity chromatography to isolate
receptors for gelatin present in an detergent extract of yeast cells.
Two proteins of 60 and 105 kDa were obtained. The same two proteins
were obtained from extracts of germ tubes and by affinity isolation
with a fibronectin matrix. These proteins were discussed in the section
on fibronectin binding proteins, above.
Mannan adhesins and other binding proteins. In addition to the cell wall receptors that interact with host proteins found in serum and ECM, C. albicans has mannoproteins and proteins that bind other host ligands or that contribute to hydrophobic interactions. Among these additional interactions are recognition between carbohydrates and proteins. The carbohydrate partner may be either the candidal adhesin, as in the mannan moiety of mannoproteins, or the host ligand recognized by candidal lectin-like proteins. Furthermore, C. albicans can bind to plastic materials. Adhesion to plastic is not an esoteric interaction, since binding of the fungus to plastic materials found in catheters and protheses may contribute to the development of infection and deterioration of these devices and since adherent organisms may be more resistant to antifungal drugs.
(i) Mannan adhesins.
In addition to the ability of
protein moieties to interact with the host, the mannan portion of
mannoprotein may be involved in the fungus-host interaction. Two
different oligosaccharides of mannan have been implicated in the
adhesion of hydrophilic yeast cells to the marginal zone of murine
spleen. A mutant strain deficient in the acid-labile portion of mannan
was reduced in its ability to bind to marginal zone areas and displayed
less specificity in binding, since cells also adhered to white pulp (73). Cutler and colleagues demonstrated that yeast cells
bound to macrophages of the marginal zone and that mannan inhibited the
binding to spleen and lymph node tissue (236). They
identified a
-1,2-linked mannotetraose as the entity possessing
adhesive activity in the acid-labile mannan (285). An
additional adhesin that contributes significantly to the binding of
yeast cells to the marginal zone has been found in the acid-stable
portion of mannan (234). Factor 6, a mannooligosaccharide
that confers serotype A specificity, also contributes to epithelial
adhesion (357). A factor 6-deficient strain or serotype B
strains showed reduced adhesion to exfoliated human buccal epithelial
cells compared to serotype A cells. Mannan from serotype A parental
cells but not from the deficient strain, as well as antiserum to factor 6, inhibited the binding of C. albicans A cells. O-linked
mannosyl moieties of cell wall proteins may also play a role. The
O-linked oligosaccharides of the 58-kDa fibrinogen binding protein have been implicated in the binding of ligand (60).
(ii) Hydrophobic proteins. CSH in C. albicans appears to be related to a plethora of host interactions and fungal functions. These interactions and functions include the ability of the microorganism to adhere to epithelial and endothelial cell surfaces, ECM proteins, and plastic indwelling devices; to evade the action of phagocytic cells; and to enhance the uptake of substances from the medium (10, 39, 130, 185-187, 252, 258, 298, 309, 500, 549, 562).
Preliminary attempts to characterize cell wall components that may confer a hydrophobic character to the surface of C. albicans suggested that several surface proteins were potentially involved in CSH of the organism. Tronchin et al. (549) reported the existence of germ tube-specific proteins with molecular masses of >200,000, 200,000, 68, and 60 kDa involved in the adherence of C. albicans to plastic as discussed below. Adherence to a plastic substrate suggests that these moieties have hydrophobic character. Later, Hazen et al. (193) reported that treatment of C. albicans cells with lyticase, a
-1,3-glucanase
preparation, released at least four medium- to low-molecular-mass
(<65-kDa) surface proteins that were unique or more abundant in
hydrophobic yeast cells. Another experimental approach to detecting
this class of proteins was developed based on the preferential binding
of hydrophobic proteins to latex spheres (295). Material
released from the surface of intact yeast cells and germ tubes by mild
treatment with
ME or Zymolyase was adsorbed onto latex-polystyrene
microspheres. SDS-PAGE analysis of the adsorbed proteins showed that
different sets of low- to medium-molecular-weight (from 20 to 67 kDa)
proteins and mannoproteins were associated with each of the four
fractions. Thus, different proteins, including species released both by
the reducing agent and by hydrolysis of glucan linkages, appeared to
contribute to hydrophobic properties of yeast cells and germ tubes.
Hydrophobic components appeared to be more abundant in the extracts
from germ tubes than from yeast cells. This is in agreement with
observations indicating that mycelial filaments of C. albicans are invariably hydrophobic regardless of the CSH displayed by the mother blastoconidia from which the germ tubes emanate
(183, 184, 186, 189, 295, 297). Hydrophobic interaction chromatography-high-pressure liquid chromatography analysis of C. albicans surface proteins indicated that hydrophobic
proteins are usually smaller than 50 kDa while hydrophilic proteins are predominantly larger than 90 kDa (190, 191). This difference is most probably due to the distinct glycosylation levels between hydrophobic and hydrophilic cell wall proteins (188). On the other hand, freeze-fracture examination of the most external cell surface layers revealed structural differences between hydrophobic and
hydrophilic cells. Thus, hydrophilic cells exhibit a dense layer of
fibrils, composed mostly of high-molecular-weight mannoproteins, that
is absent or scant in hydrophobic cells (190). Hazen and Hazen (191) suggested that the amount of cell wall-bound
hydrophobic proteins remains constant but the amount of hydrophilic
masking proteins varies during growth. Hence, conversion from surface hydrophilicity to hydrophobicity by C. albicans cells could
be due to changes in the length and concentration of fibrils present in
the external wall layer (190, 191) or to changes in the
glycosylation levels of cell wall mannoproteins (188, 501).
Such changes, in turn, may account for the shifts in CSH within a
population observed as a consequence of the morphologic transition or
of different physiologic and environmental conditions.
Overall, the observations in the studies mentioned above indicate that
CSH of C. albicans cells could be ascribed to protein and
mannoprotein species that appear to be quantitatively minor wall
components. However, detection of a relatively large assortment of
hydrophobic molecules suggests that they may simultaneously play other
essential physiological roles rather than exclusively confer the
hydrophobic character to the cell surface. In this context, the germ
tube proteins with molecular masses of 68 and 60 kDa (sometimes a
doublet of 60 and 62 kDa) described by Tronchin et al.
(549), which appear to be involved in the adherence of C. albicans cells to plastic, may also act as receptors for
laminin, fibrinogen, and C3d (35, 549). Evidence suggesting
that the mp58 fibrinogen binding mannoprotein (60) and
possibly the p37 laminin receptor (294) contain exposed
hydrophobic domains has been reported (295, 299, 483).
Whether these receptors are hydrophobic or whether hydrophobic forces
facilitate the initial contact and enhanced stability for receptor
interactions between fungal and host ligands is not known (185,
187). In the case of the mp58 moiety, its postulated hydrophobic
character would facilitate self-association of individual molecules
within the highly glycosylated hydrophilic environment of the
whole-cell-wall structure, leading to areas of increased density.
Self-association may thus explain the clustering or asymmetric
distribution of the mp58 within the cell wall structure
(328). Clustering of receptors is a phenomenon that, as
stated above, could increase the security of interaction between the
fungal cell and the host.
Using a polyclonal antiserum against yeast hydrophobic proteins, Glee
et al. (163) demonstrated that hydrophobic species are also
exposed on fungal cells present in host tissues. In vivo expression
supports the contention that CSH may play a role in candidal virulence
and pathogenesis, since hydrophobic cells are more virulent in an
animal model (10). In agreement with previous reports, this
antiserum recognized hydrophobic proteins predominantly in the
low-molecular-mass range (163). Several C. albicans secreted enzymes and receptor-like molecules have been
characterized in this size range. However, distinct antibodies to the
candidal secreted aspartyl proteinase and exo-
-(1,3)-glucanase were
negative for moieties recognized by the polyclonal antiserum
anti-hydrophobic proteins (163). These two enzyme proteins
appear not to be among the hydrophobic moieties or to share
determinants with them. Hydrophobic cells showed increased binding to
several ECM components, i.e., fibronectin, laminin, fibrinogen, and
type IV collagen, compared to hydrophilic cells (505). Among
the proteins recognized by antiserum to hydrophobic proteins are some
proteins that also react with anti-human fibronectin receptor antiserum
(164). Enhanced binding to the ECM by hydrophobic proteins
may be a contributor to the enhanced virulence of hydrophobic cells. On
the other hand, the rate of accumulation and the amount of bound
complement factor C3 were similar for hydrophilic and hydrophobic yeast
cells (270). Thus, there may be a difference in
glycosylation patterns between proteins that bind complement and those
that bind ECM.
(iii) Fimbriae.
The presence of long, thin filamentous
protein cell surface appendages termed fimbriae in C. albicans strains was initially reported by Gardiner et al.
(154). Fimbriae may mediate adhesive interactions between
the fungus and the host. As discussed above, further characterization
of purified fimbrial preparations revealed that the major structural
subunit of the fimbriae is a glycoprotein with a molecular mass of
approximately 66 kDa (583). The glycoprotein consists of 80 to 85% carbohydrate (primarily D-mannose) and 10 to 15%
protein composed of 50% hydrophobic amino acid residues. It is unclear
whether there are additional minor components that contribute to the
fimbrial structure and function. The fimbriae bind directly to buccal
epithelial cells (BECs), and purified fimbrial preparations inhibit
C. albicans binding to BECs (583). The ability of
C. albicans yeast cells to bind specifically to the
glycosphingolipid lactosylceramide has been reported (226). In this regard, C. albicans fimbriae also bind to
asialo-GM1 (gangliotetraosylceramide) in a saturable and
concentration-dependent manner (584). Therefore, the
fimbrial protein appears to be the moiety mediating binding to
glycosphingolipids displayed on the surface of human BECs and could
represent an adhesion motif for fungal cells (226).
Bacterial pili may also bind to the glycosphingolipid
asialo-GM1, and antibodies to Pseudomonas
aeruginosa pili cross-reacted with fimbriae (585). Recent studies showed that the epitope that confers receptor-binding properties (adhesintope) to C. albicans fimbriae appears to
be identical to that present in P. aeruginosa pili
(279, 586). Antibodies prepared to the bacterial adhesintope
inhibited binding (43 to 50%) of the fungus to BECs. Two synthetic
peptides from the P. aeruginosa adhesintope were competitive
inhibitors of binding to asialo-GM1 (58 to 69%) and BECs
(48 to 59%). The smaller peptide, DEQGIPK, that was the central region
of the larger peptide was somewhat less effective than the larger
peptide. These conserved adhesive motifs present in adhesins from
evolutionarily distant microorganisms may account for the recognition
of host ligands bearing
GalNAc(1-4)
Gal groups. It has been
demonstrated that a number of pulmonary pathogens are able to utilize
the
GalNAc(1-4)
Gal sequence as the ligand or receptor to attach
to host tissues (271). Hence, this carbohydrate motif may
also play a role in the genesis of Candida infections.
(iv) Plastic binding proteins. The ability of C. albicans cells to adhere to plastic medical devices was established some time ago. After adherence the organism may propagate and establish biofilms. The release of microorganisms from biofilms formed on different types of medical implants, prostheses, or catheters may contribute to or initiate acute disseminated nosocomial infections, whose frequency has increased dramatically in the last years due precisely to this reason (119, 166). In this context, a large number of nosocomial infections caused by Candida species derive from the use of different types of medical catheters and prostheses (390). Organisms may also colonize denture materials and adhere to saliva-coated plastic, as noted below. Organisms adhering to plastic may also be less susceptible to antifungal drugs (180, 231), and colonization may contribute to deterioration of the devices (48, 172, 321, 559).
It was suggested in early studies on plastic adherence that CSH plays a major role in this process (258, 354, 358). However, the nature of candidal cell surface moieties potentially involved in the attachment of C. albicans to plastic remained undetermined in these studies. McCourtie and Douglas (344) demonstrated that yeast cells grown in galactose were most strongly adherent to acrylic. Galactose-grown cells have an additional surface layer that may mediate the adherence to plastic. In later studies from their laboratory (discussed in the following section), similar conditions were shown to promote binding to epithelial cells, and material accumulating in the medium inhibited epithelial adhesion (92, 93, 345, 544). The relationship between material promoting epithelial adhesion and adherence to plastic is not known. Subsequently, Tronchin et al. (549) reported that germ tubes of C. albicans had a fibrillar surface layer that was responsible for enhanced adherence of the microorganism to polystyrene plastic. Analysis by SDS-PAGE of the material retained on plastic surfaces after removal of attached fungal cells allowed further characterization of the adhesins present in the fibrillar layer that could mediate binding to plastic. Two components of 68 and 60 kDa and two high-molecular-mass components (a 200-kDa moiety and another species with a molecular mass higher than 200 kDa) were solubilized from the plastic surface. The 68-kDa component appeared to be one of the major constituents of the germ tube surface layers. Further evidence for the role of cell wall surface moieties in binding to plastic has recently been reported (459). The authors described differential effects of several MAbs on germination and adhesion. MAb 3D9, discussed previously as identifying a germ tube protein, had no effect on either germination or adhesion. Incubation of yeast cells in the presence of MAb B9E decreased both germination and binding to polystyrene, whereas MAb 21E6 decreased germination but enhanced adhesion. Among Candida spp., C. albicans is less adherent than C. krusei and more adherent than C. glabrata (179). Adhesion to plastic is likely to involve additional proteins. First, adhesion of C. albicans to plastic is regulated by environmental conditions and the phenotypic state of the organism (243, 344, 458). Second, as discussed in previous sections, the expression of cell wall proteins appears to be a very dynamic process. One may expect that the pattern of surface components with the ability to interact with plastic will vary depending on the strain, the morphologic transition process, or the nutritional and environmental shifts (e.g., temperature, composition of the culture medium, or phenotypic switching), factors that are known to affect the protein and mannoprotein composition of the cell wall of C. albicans (6, 59, 63, 72, 159, 195, 297, 301, 326, 422, 525). Hence, adhesion of C. albicans to plastic could be mediated by cell wall moieties that play other physiological roles (as suggested for protein and mannoprotein species conferring CSH) (295) rather than by specific surface components. Because of their molecular mass and their topological location at the most external layers of the cell wall structure, the two high-molecular-weight species with affinity for plastic, detected by Tronchin et al. (549), could be equivalent to the HMWM that form the dense layer of fibrils present on the surface of hydrophilic cells (190). However, one may expect that these fibrillar proteins will display a hydrophilic character, while hydrophobic interactions appear to be essential for the attachment of C. albicans cells to plastic materials (258, 354, 358). These large plastic-adhering proteins were minor components and were not found in the culture medium (549). However, we have detected the presence of highly glycosylated HMWM in cell wall extracts from C. albicans (295) and in the material secreted to the culture medium by cells of both growth phases that were specifically retained on the surface on polystyrene-latex microspheres (299). These observations suggest that these species have exposed hydrophobic domains, most probably present in the peptide moiety. It is the peptide portion of the mannoprotein molecules that predominantly exhibited the ability to bind to plastic through hydrophobic bonds (540). C. albicans is able to form biofilms (181). Biofilms consist of a monolayer or multilayer of cells embedded within a matrix of extracellular polymeric material (351). Three observations may account for the ability of this fungus to form such biofilms. (i) C. albicans cells can release into the medium protein and mannoprotein species chemically and antigenically related to the components bound to the cell wall that have exposed hydrophobic domains (2, 299, 543). (ii) Some wall components are not tightly bound to the wall structure since they are easily retained on the substratum where the cells attach (549). (iii) As noted in the following section, there may be complementary molecules in the released and surface-bound material that mediate adhesion. Hawser and Douglas (181) showed that the extent of biofilm formation depended on the type of catheter material. Biofilm formation was greatest on latex, which is frequently used in urinary catheters, followed by silicone elastomer and polyvinyl chloride, which is frequently found in central venous catheters. It was substantially lower on polyurethane and 100% silicone. In addition, strains differed in the extent of biofilm formation. Scanning electron microscopy showed that biofilm consists of a dense network of the various candidal morphological forms as well as extracellular material. The fungus can bind to silicone found in denture lining and voice prostheses (48, 565). Adhesion to denture soft lining materials was strain variable, greater to an acrylic base than to the liner, and reduced after coating with saliva (565). Changes in the material may offer potentiation of adhesion, since adherence to experimental silicone materials was lower than to a commercial lining material. Binding to silicone voice prostheses differed between two strains, with the strain having the more negative zeta potential binding more slowly to the negatively charged silicone rubber (48). Coating the silicone with saliva reduced binding, and bound organisms detached when an air bubble was passed through the flow chamber. Microorganisms may exist in mixed biofilms containing both bacteria and yeasts, as observed on silicone voice prostheses, where C. albicans strains were reported to have hydrophilic surfaces while the bacterial hydrophobicities were variable (382).(v) Epithelial binding lectin-like protein. The adhesion of C. albicans to BECs or vaginal epithelial cells facilitates colonization and can be regarded as the first step in the pathogenesis of Candida infections. Several categories of candidal adhesins appear to be involved in this process: (i) integrin analogs, (ii) fimbrial adhesins, (iii) lectin-like adhesins, and (iv) factor 6 (49, 50, 96, 110, 111, 209, 406). Of these, lectin-like interactions between the protein moiety of a candidal lectin-like mannoprotein adhesin and a carbohydrate receptor on the surface of the host cell seem to be a major mechanism of adhesion to epithelial cells. The presence of candidal lectin-like adhesins with specificity for L-fucose or GlcNAc has been reported (37, 53, 92, 93, 544). Fucose was the major inhibitor of binding of one strain of C. albicans to human BECs, while glucosamine and GlcNAc were major inhibitors of the binding of another strain (93). Synthesis of the lectin-like proteins was increased when yeasts were grown in galactose (345). While two different lectin-like proteins were produced, each strain appeared to produce only a single such protein with affinity for either L-fucose or GlcNAc (53, 93). None of these adhesins have been fully characterized, and there is no information on the molecular mass of the native moiety bearing the adhesion motif. However, a fucoside-binding protein fragment of an adhesin was purified from culture supernatants of C. albicans yeast cells by affinity adsorption chromatography on the trisaccharide determinant of the H blood group antigen that terminates in an L-fucose residue (53, 544). Before chromatography, the protein was treated with papain, N-glycanase, and dilute alkali. The purified adhesin fragment was devoid of carbohydrate, although no further biochemical characteristics of this molecule were reported. Analysis of the purified biotinylated adhesin by SDS-PAGE and Western blotting with 125I-streptavidin and subsequent autoradiography revealed a band corresponding to a protein with a molecular mass of 15.7 kDa (53). However, the intact mannoprotein moiety containing the fucoside-binding fragment is likely to be considerably larger.
These lectin-like proteins can mediate epithelial adhesion. Binding to human BECs and vaginal epithelial cells was examined with strains with different sugar specificities (93). The extracellular material recognizing L-fucose led to a more than 50% inhibition of binding of the homologous strain(s) producing the L-fucose lectin-binding material. Strains producing proteins recognizing GlcNAc were inhibited less than 30%. The material recognizing GlcNAc had no effect on the strains producing the L-fucose binding material. The purified fragment of the L-fucose binding protein inhibited the binding of yeast cells to BECs by up to 80% (53, 544). The failure to obtain complete inhibition suggests that other adhesins contributed to binding. A chromatography overlay assay was used to examine the binding of yeast cells, culture supernatant material, and purified fragment to glycosphingolipids extracted from human BECs and sheep erythrocytes (53). All bound to the same components that contained fucose. However, yeast cells but not the adhesin preparation bound to a component containing GlcNAc, possibly in the form of an A blood group antigen, suggesting that all adhesins may not be recovered in the culture supernatant. Binding to other extract components was not detected. This study also indicated that blood group antigens can act as epithelial cell receptors for C. albicans. More recently, Enache et al. (129) have examined the binding of C. albicans to an esophageal cell line (HET1-A) that is mediated in part by a lectin-like interaction. Yeast cells grown in galactose bound more extensively than did cells grown in glucose. With this strain of C. albicans, GlcNAc and glucosamine inhibited binding by about 40%. A 190-kDa species was detected in the
ME
extracts of galactose-grown but not glucose-grown yeast cells by
Aurodyne-stained blots of SDS-PAGE-separated proteins. This species was
postulated to be associated with the increased adherence of
galactose-grown cells. Whether this species is a cell wall-bound form
of the material found by McCourtie and Douglas (345) is not
known.
Such lectin-like interactions may contribute to other host or self
interactions. Although binding to intact erythrocytes mediated by the
lectin-like moiety was not examined by Cameron and Douglas (53), the recognition of sugar ligands on erythrocyte
surfaces may contribute to a fungal system to obtain iron, as discussed above. The presence on the cell surface of ligands that are recognized by this lectin-like protein offers the possibility that fungal cell
association is mediated, at least in part, by these complementary sugar-lectin moieties. In any case, further work is required to fully
characterize these lectin-like candidal adhesins and to establish their
relationship, if any, to other cell surface-bound components (e.g., the
fimbrial adhesin) of the fungus, which are known to recognize other
carbohydrate-containing molecules displayed on the surface of human
epithelial cells such as glycosphingolipids (see above).
(vi) Agglutinin-like proteins.
Several genes have been
identified that have homology to fungal agglutinin genes, in particular
S. cerevisiae AG
1 encoding
-agglutinin
(291). The proteins encoded by these genes are candidates for surface binding interactions. In C. albicans, the
ALS (agglutinin-like sequence) family consists of at least
four genes that may encode cell wall proteins (212, 473). In
S. cerevisiae,
-agglutinin mediates cell-cell interaction
during the mating of haploid yeast. It is possible that the
ALS genes are remnants of such a cycle in C. albicans or encode proteins that have been subverted to another
function. Like Ag
1p, the Als proteins had hydrophobic N and C
termini, suggestive of processing through the secretory pathway and
addition of a GPI anchor. Recently, the GPI anchor of Ag
1p was shown
to be lost during covalent attachment of the protein to cell wall
glucan (306). One unusual property of the Als proteins was a
central domain of a tandemly repeated 36-amino-acid motif. These tandem
repeats were not found in Ag
1p. The number of copies of this
repeated motif was highly variable, depending on which C. albicans strain was examined. In addition, ALS alleles in the same strain may exhibit different numbers of copies of the
repeat motif. The repeat sequences were rich in serine, threonine, and
proline and contained a consensus N-glycosylation site, suggesting that
the repeat region would be highly N and O glycosylated. If indeed Als1p
is in the cell wall, along with Hwp1p (513) (discussed above), it will be the second cell wall protein to contain a repeat motif. The repeat motifs of the Als proteins and Hwp1p are not the
same. While ALS genes were originally isolated due to their expression in RPMI 1640-grown hyphae but not in YEPD-grown yeast forms,
the genes do not appear to be regulated by the yeast-hyphal transition.
Instead, regulation is dependent on components of the culture media.
1, especially at
the N terminus, where it shows characteristics reminiscent of Ig
domains that may be implicated in binding. Its relationship to other
ECM binding moieties described above remains to be established.
(vii) Adherence to Streptococcus spp. and other bacteria. As a commensal of the oral cavity, C. albicans must adhere to surfaces and cells of the oral cavity to prevent clearance by the flushing action of saliva. In addition to adhesins that mediate the binding to BECs discussed in other sections, the organism can bind salivary proteins and oral and nonoral bacteria. These interactions appear to be effected through multiple mechanisms. Macroscopic and microscopic aggregation or agglutination of isolates with C. albicans has been observed with strains of Streptococcus sanguis, S. salivarius, S. mutans, S. mitis, Fusobacterium nucleatum, Actinomyces viscosus, Lactobacillus amylovorus, and Bacteroides gingivalis (13, 213). In general, agglutination with bacteria other than streptococcal species was sensitive to heat treatment of the bacteria and to inhibition by a sugar. For these species, the interaction suggested a lectin-like interaction with candidal surface carbohydrate. The streptococcal coagglutination appeared to involve a different mechanism, which has been examined more extensively in subsequent studies by Jenkinson and colleagues.
C. albicans and C. tropicalis but not C. kefyr and C. krusei were able to bind or coaggregate with S. gordonii (202). This interaction appeared to be a general property of the fungus, since numerous strains exhibited the ability to bind to the bacterium. In addition to S. gordonii, C. albicans yeast cells bound to S. oralis and S. sanguis but not to S. mutans and S. salivarius when the bacteria were immobilized in microtiter plate wells or cosedimented (203, 224). These results differ to some extent from the previous study in that binding to S. mutans and S. salivarius was not observed. Binding was greater for yeast cells grown at 37°C than at 28°C (224). The greatest coaggregation was observed when the cells were starved for glucose. The increase appeared to be due to synthesis of a new protein, since the response was inhibited by the presence of trichodermin or amphotericin B. The change was not related to hydrophobicity, since no change in this property was noted. The binding was inhibited by the addition of EDTA and heat or proteolytic treatment of yeast cells. Addition of calcium ions or treatment of yeast cells with
ME did not alter coaggregation. Thus, candidate
adhesins are among the proteins that can be released by
-glucanase
treatment, although many proteins are present in both chemical and
enzymatic extracts. Cell wall polysaccharide from S. gordonii inhibited the reaction (203). Antibody to the polysaccharide also reduced binding. This polysaccharide contained rhamnose, glucose, N-acetylgalactosamine, glucose, and
GlcNAc. The binding was not inhibited by sugars found in the
polysaccharide or fucose or mannose (203, 224), suggesting
that the candidal recognition motif is a more complex oligosaccharide
structure. The failure of sugars to inhibit the reaction suggests that
the fungal adhesin is not the epithelial binding lectin-like adhesin discussed elsewhere in this review; on the other hand, the bacterial polysaccharide contains some of the same sugars recognized by this
lectin-like adhesin.
However, the interactions are not restricted to recognition of
bacterial carbohydrates (204). Treatment of the bacteria
with alkali only partially reduced the interaction with the fungus and
suggested the participation of alkali-insensitive moieties. Candidates
for this interaction were found among surface proteins that were
already known to contribute to bacterial interactions. Inactivation in
S. gordonii of cshA that specified a
high-molecular-mass protein resulted in about a 50% reduction in the
binding of C. albicans cells. Antibody to the amino-terminal
nonrepetitive domain of the protein but not the C-terminal portion
containing repetitive amino acid blocks partially inhibited the binding
of C. albicans. When the nonrepetitive and repetitive
domains were immobilized in plate wells, they both supported candidal
adhesion. Inactivation of the bacterial sspA or
sspA and sspB genes, encoding antigen I/II
adhesins, resulted in a greater decrease in binding (about 80%). When
a recombinant Enterococcus faecalis strain expressed the
sspB gene, binding of C. albicans was increased
threefold compared to that for the nontransformed strain. The mutant
strains of S. gordonii retained expression of the
polysaccharide, supporting the contribution of the proteins to binding.
Similar proteins are also expressed by S. oralis and
S. sanguis but not by S. mutans and E. faecalis, providing a basis for differences in coadherence among
bacterial species. These various studies support multiple interactions
between streptococci and C. albicans.
(viii) Adherence to salivary proteins. C. albicans can bind several salivary proteins, although very little is known about the cell wall components mediating the binding. C. albicans adheres to human salivary proteins when these proteins are use to coat dental acrylic or lining material or hydroxyapatite beads, a model for pellicle formation on tooth surfaces (54, 113, 385, 560). Several bacterial species, e.g., S. sanguis and A. viscosus, can bind to pellicle. Several C. albicans strains adhered to the beads, although differences in the extent of binding were noted (54). Glucose starvation of yeast cells grown at 28°C enhanced adhesion. Treatment of the bound salivary proteins but not the fungus with neuraminidase increased binding. Deglycosylation of salivary proteins bound to glass slides reduced the binding of the fungus (384). These observations suggest that carbohydrates may be involved in binding. Neuraminidase secreted by oral bacteria could increase the availability or identity of ligands participating in binding by exposing sugar residues that are recognized by candidal adhesins, e.g., the fucose-binding protein discussed above.
More than one salivary component may be involved. Fractionation of saliva showed that proline-rich proteins (PRPs) and statherin promoted binding to beads (54). In addition, an unknown component of another fraction of parotid saliva supported binding. Parotid saliva that is rich in PRPs significantly increases the binding to denture acrylic compared to that for submandibular/sublingual saliva (560). A number of PRPs have been described and implicated in the binding of some bacteria to pellicle (108). Binding of radiolabeled yeast cells to membranes containing electrophoretically separated saliva proteins identified four major reactive species (17, 20, 24, and 27 kDa) (399). Purification and partial-sequence analysis indicated that these were basic PRPs. PRPs may also become bound to oral epithelial cells and may contribute to the binding to those cells. Mucins in human submandibular and sublingual saliva bind to both yeast cells and germ tubes, as detected by their presence in an extract of candidal and bound saliva proteins (113). Little binding was detected with components of parotid saliva. Similarly, the submandibular and sublingual saliva promoted yeast binding when bound to polymethylmethacrylate beads. On the other hand, in the same study, purified mucin failed to bind yeast cells to coated beads or to replace mucin-depleted saliva, suggesting that purification may alter the recognition structure. Mucins do not bind to the hydroxyapatite beads, and mucin fractions were not active in the study by Cannon et al. (54). In a solid-phase overlay assay with electrophoretically separated salivary components from either human or rat saliva transferred to nitrocellulose, a single reactive component was detected (199). The reactive component of human saliva was identified as a low-molecular-weight mucin, MG2 in human saliva and rat submandibular gland (RSMG) mucin in rat saliva. The purified RSMG component had characteristics of both mucin and proteoglycan (200). The binding moiety contained glycosaminoglycans and human blood group A oligosaccharide, which are generally associated with proteoglycans and mucins, respectively. Enzyme sensitivity assays suggested the presence of both chondroitin sulfate and heparan sulfate. The binding capacity was associated primarily with the heparan sulfate side chains. This finding contrasts with a previous report that while heparan sulfate inhibited fungal binding to ECM, it did so by binding to ECM and not directly to the fungus (254). In contrast to the observation that mucin was the only reactive species in an overlay assay of separated salivary components (199), as noted above, multiple PRPs were identified as reactive species in a recent study (399). These differences have yet to be resolved. Binding of salivary components to silicone surfaces of denture soft lining material or voice prostheses may reduce binding compared to the uncoated material, as discussed previously (48, 565).(ix) Miscellaneous. A DNA sequence of C. albicans, AAFI, that confers enhanced adhesion to both polystyrene and epithelial cells as well as autoaggregation properties to S. cerevisiae transformants has been isolated (20, 114). A 30-kDa protein that may be responsible for these phenomena in S. cerevisiae transformants was identified on the surface of both yeast and hyphal C. albicans cells (21). The authors suggested that this moiety may be related to the cysteine-rich 30-kDa hydrophobins that have been isolated from the cell surface of Schizophyllum and Aspergillus species (568, 569). The ability of the 30-kDa protein to promote autoaggregation in S. cerevisiae transformants indicates that the cell surface molecule may also be involved in the interaction among the fungal cells, acting as an aggregation factor. In fact, the formation of macroscopic aggregates is commonly observed in C. albicans mycelial cultures. Further work is obviously required to determine the role of this protein in candidal biology and host interactions.
A 49-kDa component that was able to inhibit the binding of C. albicans to human BECs by about 40% was obtained from two strains of C. albicans yeast cells grown on galactose (225). The component that was present in culture supernatants or extracted from cells by salt and heat was about 96% proteinaceous with 4% carbohydrate and minor amounts of phosphate and sulfate. Although the similarity in size to enolase and the 47-kDa hsp90 fragment found in the cell wall was noted, the study did not examine the effect of sugars or other ligands or antibodies on the binding to epithelial cells. The relationship of this species to the lectin-like binding protein, iC3b receptor, or other epithelial cell adhesin is unknown.WHERE ARE WE GOING? THE MYSTERIES AND CHALLENGES
|
|
|---|
A term that has been used in studies about cell wall proteins and in this review is "dynamic." This term has been used to remind us that the cell wall is not a static, invariant structure but, rather, a structure that can change during the life of a single cell in response to the growth state and a variety of environmental stimuli. This plasticity of an organelle that is required to maintain the integrity of the cell in its normal milieu is perhaps surprising. However, the budding cycle, cell growth, and hyphal formation require that this protective envelope be modulated in even its structural role. As demonstrated by the studies considered in this review, the regulation of expression of components in the cell wall occurs at several levels. Even in the glucan and chitin component, the fraction that one may be tempted to consider most invariant, there is temporal regulation of synthesis during the cell cycle involving multiple enzymes (for recent reviews, see references 80 and 246).
In the previous sections of this review, we have focused primarily on individual components of the cell wall. These observations suggest the direction of studies in the near future. Thus, we can anticipate additional studies to identify cell wall proteins and their functions in vitro, particularly if they are postulated as being contributors to pathogenesis, and we can expect the extension of studies of identified proteins to demonstrate the role of specific components in host interactions. These latter studies are likely to take advantage of the increasing experience with molecular genetics with this organism and emerging views of host immune response. In these concluding remarks, we would like to summarize many of the observations from the standpoint of the questions they have raised about the mechanisms required to produce and regulate the structure and function of the proteins and mannoproteins in the cell wall. Some of the recent observations are quite surprising and raise questions that we would not have considered a few years ago.
The mannoprotein and protein fraction contains some 40 or more species that, in itself, introduces a measure of complexity to the cell wall. Redundancy appears to be common among binding proteins or receptors, with several moieties binding each ligand or plastic. Identification of proteins in cell wall or cell extracts is not synonymous with surface localization, which is a requirement to be the mediator of the binding observed in intact cells. Thus, with the exception of the plastic binding proteins that were isolated by a method that implies exposure of the fungal surface to the substratum, it is not clear that each of these components is present at the cell surface. For most of these proteins that bind the same ligand, we do not know whether they represent products of different genes, are related by processing, or both. Another complicating factor is the possibility that processing alters the ligand specificity or binding site used by the binding protein.
Another related issue is the suggestion made several years ago that candidal binding proteins are multifunctional. Supporting this contention is the similarity of apparent molecular size for some components, the competition among ligands for isolated components, and the analogy to mammalian integrins that may bind more than one ligand. On the other hand, some ligands bind to more than one integrin. In contrast to these observations, there are some proteins that seem to bind a single ligand, e.g., the mp58 fibrinogen binding protein and the p37 laminin receptor moieties. Two studies that directly addressed this point determined that the C3d binding and mp58 fibrinogen binding proteins were different and that laminin and fibrinogen binding were not colocalized in yeast cells (300, 302). The fungus also appears to use multiple interactions to bind to host cells and substrates. Two mannan adhesins have been identified in mediating the binding to splenic macrophage. C. albicans can bind to multiple ligands present in ECM and do so via more than one binding site, i.e., RGD-peptide dependent and independent. Multiple binding interactions have also been suggested to mediate the binding to epithelial cells, e.g., mannan factor 6, lectin-like protein, and iC3b binding protein. Unraveling the individual contribution of the various binding proteins, those that are singular and those that are promiscuous in their ligand specificity, to the complex substrates presented by the host tissue compared to the use of purified ligands in vitro will be challenging.
Multiple mechanisms affect the expression of various cell wall mannoproteins and proteins. First, expression may regulated at the level of gene transcription as judged from Northern blot analysis. Among the genes whose expression is regulated by nutrient conditions are the genes for mp58 (FBP1) and ALS1 (5, 212). At least two genes, HWP1 and HYR1, appear to be expressed only in hyphae (16, 513). There are also proteins whose level of expression responds to in vitro growth conditions. Thus, more iC3b binding protein is detected at elevated glucose levels and more lectin-like protein is detected when cells are grown on galactose rather than glucose (162, 210, 345). There are also proteins and protein modifications that are expressed on some cells but not others in the population (60, 72, 296). Some determinants are also expressed by a variable number of cells in the population, apparently depending on the stage of culture growth (41, 42, 72).
Expression of the SAP gene family clearly is subject to a variety of controls of environment, strain, and morphology. Determination of the conditions affecting locus-specific expression is under way, and elucidation of the regulatory circuits will surely follow (214, 359). Miyasaki et al. (359) have suggested that there may be different trans-acting elements present in different strains or whose expression is controlled by morphology that contribute to differences in locus expression. For other proteins, variable expression within a population exposed to the same environmental conditions poses some interesting questions. The phenomenon is similar to penetrance, in which not all organisms with an appropriate genotype express the phenotype. Nonexpressing yeast cells can give rise to expressing germ tubes, and subsequent yeast cultures have a population of variable expression. For the mp58 and p37 fibrinogen and laminin binding proteins, the expressing yeast cells were among the largest cells in the population. Since older cells are generally larger than young ones (70), an intriguing possibility is that yeast cell expression is associated either with age or with some alteration in control of cell size.
Multiple posttranslational mechanisms determine cell wall protein expression. Proteins whose cellular location is morphology dependent are examples of one type of regulation (5, 394, 563). Since at least two of these proteins differ in size in the different locations, a posttranslational processing-dependent mechanism of targeting may be hypothesized. Thus, when processed in one way, the protein bears a signal that targets one destination, and when processed in another way, it bears a different destination signal. Such a change could also be effected by a regulation of mRNA splicing that removed signals for processing and targeting under one condition but not the other. In the case of the one protein where gene expression has been examined (5), no obvious difference was noted in the size of the transcript in a Northern blot.
Another type of regulation is represented by proteins that are
differentially distributed within the cell wall. First, there are
proteins that are secreted through the cell wall to the exocellular environment, and then there are proteins that are retained within the
cell wall. However, retained proteins can differ in their location.
Some proteins are homogeneously distributed at the surface, and others
are heterogeneously distributed (59, 62, 293, 296, 328). At
least one protein, enolase, is located internally and is not expressed
at the surface (8). Some proteins are thought to be
covalently linked to glucan (237, 238, 247, 268, 462, 463).
However, proteins that are postulated to be covalently linked, i.e.,
releasable by
-glucanases, may also be released by treatment with
reducing agents (57). Among the proteins that have signal
sequences are proteins such as Sap, whose presumed major destination is
the exocellular environment, as well as proteins that remain
predominantly wall associated. Therefore a signal sequence is not
sufficient to determine the extracellular location. The retention or
release mechanisms have yet to be explored fully.
These examples suggest the likely existence of multiple methods for
targeting cell wall proteins to specific locations and retention of
proteins in the cell wall. Gene sequences clearly indicate that some
proteins are secreted by the classical endoplasmic reticulum-Golgi
pathway. Proteins such as Hwp1, Hyr1p, Sap proteins,
-N-acetylglucosaminidase, and putative Als1p contain a
signal peptide sequence associated with routing through this pathway (55, 215, 292, 359, 571). On the other hand, other cell wall
proteins do not appear to contain such a signal peptide. These proteins
include hsp70, enolase, PGK, and GAPDH, which that have been
demonstrated to be bona fide cell wall components. A few exceptions of
secreted proteins without such a signal sequence have been noted in
plants, animals, and microbes (272). These proteins in
prokaryotic organisms and the model yeast S. cerevisiae appear to be secreted by substrate-specific transport systems (ATP
binding cassette [ABC] transporters), while the mechanisms for such
proteins in mammalian cells are unknown. The secretion of
a-factor in S. cerevisiae involves the ABC
transporter Ste6p. Other cell wall proteins appear to be secreted by as
yet unknown pathways (81). If this is a valid analogy, the
existence of several such systems for this group of C. albicans proteins would be predicted. The presence of an hsp70
among this group raises another possibility. Among functions associated
with cytoplasmic hsp70 is translocation across intracellular membranes.
hsp70 may assist in its own translocation across the plasma membrane or may contribute to the translocation of other proteins. If members of
this group of proteins provide important or essential functions for
C. albicans, substrate-specific transporters may constitute a new target for antifungal agents.
One area in which we have minimal information, even from the model
system of S. cerevisiae, is how proteins are targeted to specific cell wall locations. As noted above, there are several aspects
to localization of a protein within the cell or cell wall. In S. cerevisiae,
-agglutinin is modified by addition of a GPI anchor
that is lost during covalent attachment to cell wall glucan (306) and a truncated protein missing the GPI anchor is
secreted to the medium (573). To date, no C. albicans cell wall proteins have been demonstrated to have a GPI
anchor, although Hyr1p and the putative cell wall protein Als1p contain
a likely sequence. Two proteins, determinants of which are recognized
by MAb 4C12 or 3D9, are both released by
-glucanases, but both may
also be found in
ME extracts. If the enzymatically released moieties are covalently attached to glucan, there are several possibilities to
explain this partitioning. First, the moieties could be secreted in
both a GPI-tailed form (enzymatically released) and an unmodified form
(chemically released). A second possibility would be that some of the
bound form is subsequently released endogenously within the wall. A
third possibility is that excess moiety is secreted and only a portion
is attached.
Another subcellular partitioning problem is found with the hsp70, PGK, GAPDH, and enolase proteins that are found both in the cytoplasm and the cell wall. There must be some mechanism to apportion the protein between the two sites. For enolase, two genes have been identified, and the function of the two loci is unknown (420). One possibility is that the loci specify intra- and extracellular enolase. The cell wall enolase protein is blocked at its N terminus, and this type of modification could be used as a partitioning mechanism. Unlike enolase, only one locus is proposed for PGK (309). Subcellular partitioning may influence the regulatory circuit(s) affecting the regulation of the gene. The promoter region of C. albicans PGK1 did not contain some of the regulatory sequences found in S. cerevisiae (6), and the noncoding regions of other glycolytic enzymes are less highly conserved than the coding regions (530). These differences support the potential for different regulation between the two species that could be related in part to the subcellular partitioning in C. albicans.
A homogeneous and heterogeneous distribution of moieties on the cell surface has been demonstrated. However, mechanisms to effect such differences in distribution have not been addressed. Since there is thought to be minimal mobility within the cell wall, such an asymmetric distribution is likely to occur during cell wall synthesis. Indeed, surfaces of formaldehyde-fixed cells show the same distribution pattern of fibrinogen binding as do viable cells (60). Thus, this asymmetry is not induced by ligand binding. Furthermore, the mp58 and p37 binding proteins, which are both asymmetrically distributed, are not codistributed in cells that express both activities (302). Such a subcellular localization could be introduced by an asymmetric delivery of the proteins to the growing cell wall or by self-aggregation following delivery. However, the last possibility would suggest that different proteins are separately delivered or have different aggregation mechanisms.
Although none of the glycolytic enzyme proteins present in the cell wall have been demonstrated to also bind host ligands, there is a precedent among other microbial systems for this activity. With several proteins of the glycolytic pathway present, at least two of which appear to be enzymatically active, the possibility that the function of these proteins is indeed enzymatic will have to be considered. This is particularly interesting, since the reactions are able to generate ATP and NADH, which could be used for extracellular reactions, such as covalent linkages between cell wall components. However, this would also require that the substrates for the reaction be available.
Lastly, there is tantalizing evidence that cell wall adhesins/binding proteins are environmental sensors capable of initiating an alteration in fungal gene expression. Bailey et al. (14) showed that the profile of abundant proteins was altered by adherence to HeLa cells and that after adhesion, at least one protein appeared to become phosphorylated. Alterations of gene expression are mediated by some integrins (216). If the functional analogy of some surface proteins with integrins extends beyond the identity of the ligand, binding of ligands such as ECM may also initiate a cascade of signals that alter gene expression. If this suggestion is substantiated, a whole new avenue of investigation will open to determine the genes and functions altered by adhesion and the adhesive interactions that are able to initiate such events. In this context, it is provocative that the major ubiquitinated proteins of the cell wall also are binding proteins. There are suggestions that ubiquitination may be involved in the regulation of receptor signaling for some mammalian receptors (368, 404).
FINAL COMMENT AND OUTLOOK
|
|
|---|
Our investigation into the proteins and mannoproteins of the cell wall of C. albicans is little more than a decade old. From these studies, along with those of the glucan and chitin component, has emerged a picture of a complex organelle. The number of proteins and mannoproteins found in wall in itself provides some measure of complexity. To this is added the evidence that proteins and mannoproteins collectively and individually do not have the same patterns of distribution within the wall, at the cell surface, or secreted to the extracellular environment. Furthermore, proteins are not retained in the wall by the same mechanisms, i.e., covalent or noncovalent attachment, and this again applies to some individual proteins that appear to have both mechanisms. A schematic model showing some of these aspects of distribution of cell wall components and the distribution of various protein and glycoprotein species in the wall structure is presented in Fig. 4. The identification and function of some these extracellular proteins as hydrolyases, adhesins, and putative structural proteins were not unexpected. However, the identity of some proteins to intracellular enzymes, the antigenic, functional, or structural relationships that some proteins appear to have with mammalian integrins, and the redundancy of proteins with apparently similar functions were not anticipated. The cell wall proteins are subject to regulation at the transcriptional and posttranslational levels by mechanisms that are responsive to environmental conditions and growth state. In turn, some cell wall proteins may be sensors of environmental contacts that initiate a signal for alterations in fungal gene expression. The localization of proteins within the cell wall is apparently subject to regulatory mechanisms that we are only now recognizing and have not yet begun to explore. This organelle is integral to fungal biology and pathogenesis of candidal infection, and unraveling its mysteries will provide challenges for the next decade.
|
ACKNOWLEDGMENTS
|
|
|---|
Work in the laboratory of W.L.C. was supported by Public Health Service grant AI23416 from the National Institutes of Health. Work in the laboratory of J.P.M. was supported by grants from DIGICyT (PM92-0246) and CICyT (SAF95-0595), Ministerio de Educación y Ciencia, and FISSS (93/0801), Ministerio de Sanidad y Consumo, Spain. The support of grant CRG 931457 (NATO Collaborative Research Grants Programme) to W.L.C. and J.P.M. is also acknowledged. J.L.L.R. acknowledges support from Public Health Service grant 1 R29 AI42401-01 and a Pfizer Medical Education Grant.
We thank Frans Klis for providing manuscripts prior to publication.
FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, Lubbock, TX 79430. Phone: (806) 743-2513. Fax: (806) 743-2334. E-mail: micwlc{at}ttuhsc.edu.
REFERENCES
|
|
|---|
| 1. | Abad-Zapatero, C., R. Goldman, S. W. Muchmore, C. Hutchins, K. Steart, J. Navaza, C. D. Payne, and T. L. Ray. 1996. Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents. Protein Sci. 5:640-652[Medline]. |
| 2. |
Aguiar, J. M.,
F. Baquero, and J. M. Jones.
1993.
Candida albicans exocellular antigens released into a synthetic culture medium: characterization and serological response in rabbits.
J. Gen. Microbiol.
139:3005-3010 |
| 3. |
Akashi, T.,
M. Homma,
T. Kanbe, and K. Tanaka.
1993.
Ultrastructure of proteinase-secreting cells of Candida albicans studied by alkaline bismuth staining and immunocytochemistry.
J. Gen. Microbiol.
139:2185-2195 |
| 4. |
Alaei, S.,
C. Larcher,
C. Ebenbichler,
W. M. Prodinger,
J. Janatova, and M. P. Dierich.
1993.
Isolation and biochemical characterization of the iC3b receptor of Candida albicans.
Infect. Immun.
61:1395-1399 |
| 5. | Alloush, H. M., J. L. López-Ribot, and W. L. Chaffin. 1996. Dynamic expression of cell wall proteins of Candida albicans revealed by probes from cDNA clones. J. Med. Vet. Mycol. 34:91-97[Medline]. |
| 6. |
Alloush, H. M.,
J. L. López-Ribot,
B. J. Masten, and W. L. Chaffin.
1997.
3-Phosphoglycerate kinase: a glycolytic enzyme present in the cell wall of Candida albicans.
Microbiology
143:321-330 |
| 7. |
Anderson, J.,
R. Mihalik, and D. R. Soll.
1990.
Ultrastructure and antigenicity of the unique cell wall pimple of the Candida opaque phenotype.
J. Bacteriol.
172:224-235 |
| 8. | Angiolella, L., M. Facchin, A. Stringaro, B. Maras, N. Simonetti, and A. Cassone. 1996. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J. Infect. Dis. 173:684-690[Medline]. |
| 9. | Annaix, Y., J. R. Bouchara, G. Tronchin, J. M. Senet, and R. Robert. 1990. Structures involved in binding human fibrinogen to Candida albicans germ tubes. FEMS Microbiol. Immunol. 64:147-154. |
| 10. |
Antley, P. P., and K. C. Hazen.
1988.
Role of yeast cell growth temperature on Candida albicans virulence in mice.
Infect. Immun.
56:2884-2890 |
| 11. |
Ashman, R. B., and J. M. Papadimitriou.
1995.
Production and function of cytokines in natural and acquired immunity to Candida albicans infection.
Microbiol. Rev.
59:646-672 |
| 12. |
Ataoglu, H.,
J. Zueco, and R. Sentandreu.
1993.
Characterization of epitopes recognized by Candida factor 1 and 9 antisera by use of Saccharomyces cerevisiae mnn mutants.
Infect. Immun.
61:3313-3317 |
| 13. |
Bagg, J., and R. W. Silverwood.
1986.
Coagglutination reactions between Candida albicans and oral bacteria.
J. Med. Microbiol.
22:165-169 |
| 14. |
Bailey, A.,
E. Wadsworth, and R. A. Calderone.
1995.
Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signalling events.
Infect. Immun.
63:569-572 |
| 15. | Bailey, D. A., N. A. R. Gow, and A. J. P. Brown. 1995. GenBank accession no. Z544197. |
| 16. |
Bailey, D. A.,
P. J. F. Feldman,
M. Bovey,
N. A. R. Gow, and A. J. P. Brown.
1996.
The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins.
J. Bacteriol.
178:5353-5360 |
| 17. | Ballou, C. E. 1976. Structure and biosynthesis of the mannan component of the yeast cell envelope. Adv. Microb. Physiol. 14:93-158[Medline]. |
| 18. |
Banerjee, A.,
K. Ganesan, and A. Datta.
1991.
Induction of secretory acid proteinase in Candida albicans.
J. Gen. Microbiol.
137:2455-2461 |
| 19. | Banno, Y., T. Yamada, and Y. Nozawa. 1985. Secreted phospholipases of the dimorphic fungus Candida albicans: separation of three enzymes and some biological properties. Sabouraudia 23:47-54[Medline]. |
| 20. |
Barki, M.,
Y. Koltin,
M. Yanko,
A. Tamarkin, and M. Rosenberg.
1993.
Isolation of a Candida albicans DNA sequence conferring adhesion and aggregation on Saccharomyces cerevisiae.
J. Bacteriol.
175:5683-5689 |
| 21. |
Barki, M.,
Y. Koltin,
M. van Wetter, and M. Rosenberg.
1994.
A Candida albicans surface antigen mediating adhesion and autoaggregation in Saccharomyces cerevisiae.
Infect. Immun.
62:4107-4111 |
| 22. |
Barrett-Bee, K., and M. Hamilton.
1984.
The detection and analysis of chitinase activity from the yeast form of Candida albicans.
J. Gen. Microbiol.
130:1857-1861 |
| 23. |
Barret-Bee, K.,
Y. Hayes,
R. G. Wilson, and J. F. Riley.
1985.
A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts.
J. Gen. Microbiol.
131:1217-1221 |
| 24. |
Barturen, B.,
J. Bikandi,
R. San Millán,
M. D. Moragues,
P. Regúlez,
G. Quindós, and J. Pontón.
1995.
Variability in expression of antigens responsible for serotype specificity in Candida albicans.
Microbiology
141:1535-1543 |
| 25. | Bendel, C. M., and M. K. Hostetter. 1993. Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis. J. Clin. Invest. 92:1840-1849. |
| 26. | Bendel, C. M., J. St. Sauver, S. Carlson, and M. K. Hostetter. 1995. Epithelial adhesion in yeast species: correlation with surface expression of the integrin analog. J. Infect. Dis. 171:1660-1663[Medline]. |
| 27. | Bertram, G., R. K. Swoboda, G. W. Gooday, N. A. R. Gow, and A. J. P. Brown. 1996. Structure and regulation of the Candida albicans ADH1 gene encoding an immunogenic alcohol dehydrogenase. Yeast 12:115-127[Medline]. |
| 28. | Bobichon, H., D. Gache, and P. Bouchet. 1994. Ultrarapid cryofixation of Candida albicans: evidence for a fibrillar reticulated external layer and mannan channels within the cell wall. Cryo-Lett. 15:161-172. |
| 29. | Bodey, G. P. 1993. In Candidiasis: pathogenesis, diagnosis, and treatment, 2nd ed. Raven Press, New York, N.Y. |
| 30. | Boorstein, W., T. Ziegelhoffer, and E. A. Craig. 1994. Molecular evolution of the HSP70 multigene family. J. Mol. Evol. 38:1-17[Medline]. |
| 31. |
Borg, M., and R. Rüchel.
1988.
Expression of extracellular acid protease by proteolytic Candida spp. during experimental infection of oral mucosa.
Infect. Immun.
56:626-631 |
| 32. |
Borkovich, K.,
F. Farrelly,
D. Finkelstein,
J. Taulien, and S. Lindquist.
1989.
Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperature.
Mol. Cell. Biol.
9:3919-3930 |
| 33. | Bouali, A., R. Robert, G. Tronchin, and J.-M. Senet. 1986. Binding of human fibrinogen to Candida albicans in vitro: a preliminary study. J. Med. Vet. Mycol. 24:345-348[Medline]. |
| 34. |
Bouali, A.,
R. Robert,
G. Tronchin, and J. M. Senet.
1987.
Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of Candida albicans.
J. Gen. Microbiol.
133:545-551 |
| 35. |
Bouchara, J. P.,
G. Tronchin,
V. Annaix,
R. Robert, and J. M. Senet.
1990.
Laminin receptors on Candida albicans germ tubes.
Infect. Immun.
58:48-54 |
| 36. | Bozzini, M., L. Visai, P. Pignatti, T. E. Petersen, and P. Spezial. 1992. Multiple binding sites in fibronectin and the staphylococcal fibronectin receptor. Eur. J. Biochem. 207:327-333[Medline]. |
| 37. |
Brassart, D.,
A. Woltz,
M. Golliard, and J. R. Neeser.
1991.
In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc 1 2Gal -bearing complex carbohydrates.
Infect. Immun.
59:1605-1613 |
| 38. |
Braun, B. R., and A. D. Johnson.
1997.
Control of filament formation in Candida albicans by the transcriptional repressor TUP1.
Science
277:105-109 |
| 39. |
Braun, P. C.
1994.
Surface hydrophobicity enhances cortiscosterone incorporation in Candida albicans.
Infect. Immun.
62:4087-4090 |
| 40. |
Brawner, D. L., and J. E. Cutler.
1984.
Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody.
Infect. Immun.
43:966-972 |
| 41. |
Brawner, D. L., and J. E. Cutler.
1986.
Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans.
Infect. Immun.
51:327-336 |
| 42. |
Brawner, D. L., and J. E. Cutler.
1986.
Variability in expression of cell surface antigens of Candida albicans during morphogenesis.
Infect. Immun.
51:337-343 |
| 43. | Brawner, D. L., and J. E. Cutler. 1987. Cell surface and intracellular expression of two Candida albicans antigens during in vitro and in vivo growth. Microb. Pathog. 2:249-257[Medline]. |
| 44. |
Brawner, D. L.,
J. E. Cutler, and W. L. Beaty.
1990.
Caveats in the investigation of form-specific molecules of Candida albicans.
Infect. Immun.
58:378-383 |
| 45. | Bromuro, C., A. Torosantucci, M. J. Gómez, F. Urbani, and A. Cassone. 1994. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans. J. Med. Vet. Mycol. 32:447-459[Medline]. |
| 46. | Bullen, J. J. 1981. The significance of iron in infection. Rev. Infect. Dis. 3:1127-1138[Medline]. |
| 47. | Burford-Mason, A. P., R. C. Matthews, and J. R. B. Williams. 1987. Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans. J. Infect. 14:147-157[Medline]. |
| 48. | Busscher, H. J., G. I. Geertsema-Doornbusch, and H. C. van der Mei. 1997. Adhesion to silicone rubber of yeast and bacteria isolated from voice prostheses: influence of salivary conditioning films. J. Biomed. Mater. Res. 34:201-209[Medline]. |
| 49. | Calderone, R. A. 1993. Molecular interactions at the interface of Candida albicans and host cells. Arch. Med. Res. 24:275-279[Medline]. |
| 50. |
Calderone, R. A., and P. C. Braun.
1991.
Adherence and receptor relationships of Candida albicans.
Microbiol. Rev.
55:1-20 |
| 51. | Calderone, R. A., and W. M. Scheld. 1987. Role of fibronectin in the pathogenesis of candidal infections. Rev. Infect. Dis. 9(Suppl. 4):400-403. |
| 52. |
Calderone, R. A.,
L. Linehan,
E. Wadsworth, and A. L. Sandberg.
1988.
Identification of C3d receptors on Candida albicans.
Infect. Immun.
56:252-258 |
| 53. |
Cameron, B. J., and L. J. Douglas.
1996.
Blood group glycolipids as epithelial cell receptors for Candida albicans.
Infect. Immun.
64:891-896 |
| 54. |
Cannon, R. D.,
A. K. Nand, and H. F. Jenkinson.
1995.
Adherence of Candida albicans to human salivary components adsorbed to hyroxyapatite.
Microbiology
141:213-219 |
| 55. |
Cannon, R. D.,
K. Niimi,
H. F. Jenkinson, and M. G. Shepherd.
1994.
Molecular cloning and expression of the Candida albicans -N-acetylglucosaminidase (HEX1) gene.
J. Bacteriol.
176:2640-2647 |
| 56. | Casal, M., and M. J. Linares. 1983. Contribution to the study of the enzymatic profiles of yeast organisms with medical interest. Mycopathologia 81:155-159[Medline]. |
| 57. |
Casanova, M., and W. L. Chaffin.
1991.
Cell wall glycoproteins of Candida albicans as released by different methods.
J. Gen. Microbiol.
137:1045-1051 |
| 58. |
Casanova, M., and W. L. Chaffin.
1991.
Phosphate-containing proteins and glycoproteins of the cell wall of Candida albicans.
Infect. Immun.
59:808-813 |
| 59. |
Casanova, M.,
M. L. Gil,
L. Cardeñoso,
J. P. Martínez, and R. Sentandreu.
1989.
Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans.
Infect. Immun.
57:262-271 |
| 60. |
Casanova, M.,
J. L. López-Ribot,
C. Monteagudo,
A. Llombart-Bosch,
R. Sentandreu, and J. P. Martínez.
1992.
Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans.
Infect. Immun.
60:4221-4229 |
| 61. |
Casanova, M.,
J. L. López-Ribot,
J. P. Martínez, and R. Sentandreu.
1992.
Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques.
Infect. Immun.
60:4898-4906 |
| 62. |
Casanova, M.,
J. P. Martínez, and W. L. Chaffin.
1990.
Fab fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans.
Infect. Immun.
58:3810-3812 |
| 63. | Casanova, M., J. P. Martínez, and W. L. Chaffin. 1991. Identification of germ tube cell wall antigens of Candida albicans. J. Med. Vet. Mycol. 29:269-272[Medline]. |
| 64. | Cassone, A. 1989. Cell wall of Candida albicans: its functions and its impact on the host. Curr. Top. Med. Mycol. 3:248-314[Medline]. |
| 65. | Cassone, A., A. Torosantucci, C. Palma, M. J. Gómez, C. M. Ausiello, and J. Y. Djeu. 1992. Cell wall constituents of Candida albicans as biological response modifiers, p. 159-166. In A. L. Goldstein, and E. Garaci (ed.), Combination therapies. Plenum Press, New York, N.Y. |
| 66. | Cawley, T. N., M. G. Harrington, and R. Letters. 1972. A study of the phosphate linkages in phosphomannan in cell walls of Saccharomyces cerevisiae. Biochem. J. 129:711-720[Medline]. |
| 67. | Celerin, M., A. W. Day, A. J. Castle, and D. E. Laudenbach. 1995. A glycosylation pattern that is unique to fimbriae from the taxon Microbotryales. Can. J. Microbiol. 41:452-460. |
| 68. | Celerin, M., J. M. Ray, N. J. Schisler, A. W. Day, W. G. Stetler-Stevenson, and D. E. Laudenbach. 1996. Fungal fimbriae are composed of collagen. EMBO J. 15:4445-4453[Medline]. |
| 69. |
Cenciarelli, C.,
D. Hou,
K. C. Hsu,
B. L. Rellahan,
D. L. Wiest,
H. T. Smith,
V. A. Fried, and A. M. Weissman.
1992.
Activation-induced ubiquitination of the T cell antigen receptor.
Science
257:795-797 |
| 70. | Chaffin, W. L. 1984. The relationship between yeast cell size and cell division in Candida albicans. Can. J. Microbiol. 30:192-203[Medline]. |
| 71. | Chaffin, W. L., and D. M. Stocco. 1983. Cell wall proteins of Candida albicans. Can. J. Microbiol. 29:1438-1444[Medline]. |
| 72. |
Chaffin, W. L.,
J. Skudlarek, and K. J. Morrow.
1988.
Variable expression of a surface determinant during proliferation of Candida albicans.
Infect. Immun.
56:302-309 |
| 73. |
Chaffin, W. L.,
B. Collins,
J. N. Marx,
G. T. Cole, and K. J. Morrow, Jr.
1993.
Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant.
Infect. Immun.
61:3449-3458 |
| 74. | Chambers, R. S., and P. A. Sullivan. 1993. Expression of the exoglucanase gene in yeast and hyphal forms of Candida albicans. FEMS Microbiol. Lett. 111:63-67[Medline]. |
| 75. |
Chambers, R. S.,
M. J. Broughton,
R. D. Cannon,
A. Carne,
G. W. Emerson, and P. A. Sullivan.
1993.
An exo- -(1,3)-glucanase of Candida albicans: purification of the enzyme and molecular cloning of the gene.
J. Gen. Microbiol.
139:325-334 |
| 76. |
Chambers, R. S.,
A. R. Walden,
G. S. Brooke,
J. F. Cutfield, and P. A. Sullivan.
1993.
Identification of a putative active site residue in the exo- -(1,3)-glucanase of Candida albicans.
FEBS Lett.
327:366-369[Medline].
|
| 77. |
Chattaway, F. W.,
M. R. Holmes, and A. J. E. Barlow.
1968.
Cell wall composition of the mycelial and blastospore forms of Candida albicans.
J. Gen. Microbiol.
51:367-376 |
| 78. |
Chattaway, F. W.,
S. Shenolikar, and A. J. E. Barlow.
1974.
Release of acid phosphatase and polysaccharide- and protein-containing components from surface of dimorphic forms of Candida albicans by treatment with dithiothreitol.
J. Gen. Microbiol.
83:423-426 |
| 79. | Chaturvedi, V. P., R. Vanegas, and W. L. Chaffin. 1994. Coordination of germ tube formation and surface antigen expression in Candida albicans. FEMS Microbiol. Lett. 134:99-106. |
| 80. |
Cid, V. J.,
A. Durán,
F. del Rey,
M. P. Snyder,
C. Nombela, and M. Sánchez.
1995.
Molecular basis of cell integrity and morphogenesis in Saccharomyces cerevisiae.
Microbiol. Rev.
59:345-386 |
| 81. |
Cleves, A. E.,
D. N. W. Cooper,
S. H. Barondes, and R. B. Kelly.
1996.
A new pathway for protein export in Saccharomyces cerevisiae.
J. Cell Biol.
133:1017-1026 |
| 82. | Cohen, J., F. Groyne, and M. Merchez. 1986. Nucleotide sequence and transcriptional analysis in Candida albicans and Saccharomyces cerevisiae of the C. albicans gene coding for a secreted glucoamylase. Abstracts of the 13th International Conference on Yeast Genetics and Molecular Biology. Yeast 2:S67. |
| 83. | Cohen, J., M. Francotte, C. Thiriart, F. van Wijnendaele, C. Bruck, and M. de Wilde. 1988. Expression of the HIV-1 ENV (gp160) in the yeast Saccharomyces cerevisiae via expression/secretion vectors and partial characterization of gene product, p. 64. In Cold Spring Harbor Symposium on Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 84. |
Colina, A.,
F. Aumont,
N. Deslaureirs,
P. Belhemeru, and L de Repentigny.
1996.
Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.
Infect. Immun.
64:4514-4519 |
| 85. |
Constantino, P. J.,
K. M. Franklyn,
N. F. Gare, and J. R. Warmington.
1994.
Production of antibodies to antigens of Candida albicans in CBA/H mice.
Infect. Immun.
62:1400-1405 |
| 86. |
Corbi, A. L.,
T. K. Kishimoto,
L. J. Miller, and T. A. Springer.
1988.
The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B.
J. Biol. Chem.
263:12403-12411 |
| 87. | Cortlandt, D. A., J. L. López-Ribot, K. J. Morrow, D. C. Straus, and W. L. Chaffin. 1995. Dynamic expression of a cell surface determinant of Candida albicans. Mycopathologia. 132:1-8. |
| 88. | Craig, E. A., and K. Jacobsen. 1984. Mutations of the heat-inducible 70 kilodalton genes of yeast confer temperature-sensitive growth. Cell 38:841-849[Medline]. |
| 89. |
Craig, E. A., and K. Jacobsen.
1985.
Mutations in cognate gene of Saccharomyces cerevisiae HSP70 result in reduced growth at low temperatures.
Mol. Cell. Biol.
5:3517-3524 |
| 90. | Craig, E., P. J. Kang, and W. Boorstein. 1990. A review of the role of 70 kDa heat shock proteins in protein translocation across membranes. Antonie Leeuwenhoek 58:137-146. |
| 91. |
Craig, E. A.,
B. D. Gambill, and R. J. Nelson.
1993.
Heat shock proteins: molecular chaperones of protein biogenesis.
Microbiol. Rev.
57:402-414 |
| 92. |
Critchley, I. A., and L. J. Douglas.
1987.
Isolation and partial characterization of an adhesin from Candida albicans.
J. Gen. Microbiol.
133:629-636 |
| 93. |
Critchley, I. A., and L. J. Douglas.
1987.
Role of glycosides as epithelial cell receptors for Candida albicans.
J. Gen. Microbiol.
133:637-643 |
| 94. | Cutfield, S. M., E. J. Dodson, B. F. Anderson, P. C. Moody, C. J. Marshall, P. A. Sullivan, and J. F. Cutfield. 1995. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3:1261-1271[Medline]. |
| 95. | Cutforth, T., and G. M. Rubin. 1994. Mutations in hsp83 and cdc37 impair signaling by the sevenless receptor tyrosine kinase in Drosophila. Cell 77:1027-1036[Medline]. |
| 96. | Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218[Medline]. |
| 97. | Dahlbäck, K., H. Löfberg, and B. Dahlbäck. 1987. Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney. Histochemistry 87:511-515[Medline]. |
| 98. | Damagnez, V., M. Rolfe, and G. Cottarel. 1995. Schizosaccharomyces pombe and Candida albicans cDNA homologues of the Saccharomyces cerevisiae UBC4 gene. Gene 155:137-138[Medline]. |
| 99. | De Bernardis, F., L. Agatensi, I. K. Ross, G. W. Emerson, R. Lorenzini, P. A. Sullivan, and A. Cassone. 1990. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161:1276-1283[Medline]. |
| 100. |
De Bernardis, F.,
A. Cassone,
J. Sturtevant, and R. A. Calderone.
1995.
Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.
Infect. Immun.
63:1887-1892 |
| 101. |
De Bernardis, F.,
P. Chiani,
M. Ciccozzi,
G. Pellegrini,
T. Ceddia,
G. DíOffizzi,
I. Quinti,
P. A. Sullivan, and A. Cassone.
1996.
Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.
Infect. Immun.
64:466-471 |
| 102. |
DeMuri, G. P., and M. K. Hostetter.
1996.
Evidence for a 1 integrin fibronectin receptor in Candida tropicalis.
J. Infect. Dis.
174:127-132[Medline].
|
| 103. | de Nobel, J. G., C. Dijkers, E. Hooijberg, and F. M. Klis. 1989. Increased cell wall porosity in Saccharomyces cerevisiae after treatment with dithiothreitol or EDTA. J. Gen. Microbiol. 135:2077-2084. |
| 104. | de Nobel, H., and P. N. Lipke. 1994. Is there a role for GPIs in yeast cell wall assembly? Trends Cell Biol. 4:41-45. |
| 105. | De Nollin, S., F. Thoné, and M. Borgers. 1975. Enzyme cytochemistry of Candida albicans. J. Histochem. Cytochem. 23:758-765[Abstract]. |
| 106. |
Deslauriers, N.,
J. Michaud,
B. Carré, and C. Léveillée.
1996.
Dynamic expression of cell-surface antigens probed with Candida albicans-specific monoclonal antibodies.
Microbiology
142:1239-1248 |
| 107. | Domer, J. E. 1989. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit. Rev. Microbiol. 17:33-51[Medline]. |
| 108. |
Douglas, C. W.
1994.
Bacterial-protein interactions in the oral cavity.
Adv. Dent. Res.
8:254-262 |
| 109. | Douglas, L. J. 1988. Candida proteinases and candidosis. Crit. Rev. Biotechnol. 8:121-129[Medline]. |
| 110. | Douglas, L. J. 1992. Mannoprotein adhesins of Candida albicans, p. 34-50. In J. E. Bennet, R. J. Hay, and P. K. Peterson (ed.), New strategies in fungal disease. Churchill Livingstone, Inc., New York, N.Y. |
| 111. | Douglas, L. J. 1995. Adhesin-receptor interactions in the attachment of Candida albicans to host epithelial cells. Can. J. Bot. 73(Suppl. 1):S1147-S1153. |
| 112. |
Duksin, D., and W. C. Mahoney.
1982.
Relationship of the structure and biological activity of the natural homologues of tunicamycin.
J. Biol. Chem.
257:3105-3109 |
| 113. |
Edgerton, M.,
F. A. Scannapieco,
M. S. Reddy, and M. J. Levine.
1993.
Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate.
Infect. Immun.
61:2644-2452 |
| 114. | Edwards, J. E. 1994. GenBank accession no. U18983. |
| 115. | Edwards, J. E., T. A. Gaither, J. J. O'Shea, D. Rotrosen, T. J. Lawley, S. A. Wright, and M. M. Frank. 1986. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J. Immunol. 137:3577-3583[Abstract]. |
| 116. |
Edwards, J. E.,
C. L. Mayer,
S. G. Filler,
E. Wadsworth, and R. A. Calderone.
1992.
Cell extracts of Candida albicans block adherence of the organisms to endothelial cells.
Infect. Immun.
60:3087-3091 |
| 117. | Eigentler, A., T. F. Schulz, C. Larcher, E. M. Breitwieser, B. L. Myones, A. L. Petzer, and M. P. Dierich. 1989. C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. Infect. Immun. 60:3087-3091. |
| 118. | Ellin, R. J., and S. M. Wolff. 1973. Effect of pH and iron concentration on growth of Candida albicans in human serum. J. Infect. Dis. 127:705-708[Medline]. |
| 119. |
Elliot, T. S. J.
1988.
Intravascular-device infections.
J. Med. Microbiol.
27:161-167 |
| 120. | El Moudni, B., M. H. Rodier, P. Babin, and J. L. Jacquemin. 1997. Metallopeptidase in Candida albicans: immunolocalization in yeast. J. Mycol. Med. 7:5-9. |
| 121. |
El Moudni, B.,
M. H. Rodier,
C. Barrault,
M. Ghazali, and J. L. Jacquemin.
1995.
Purification and characterisation of a metallopeptidase of Candida albicans.
J. Med. Microbiol.
43:282-288 |
| 122. |
Elorza, M. V.,
A. Marcilla, and R. Sentandreu.
1988.
Wall mannoproteins of the yeast and mycelial cells of Candida albicans: nature of the glycosidic bonds and polydispersity of their mannan moieties.
J. Gen. Microbiol.
134:2393-2404 |
| 123. | Elorza, M. V., S. Mormeneo, F. García de la Cruz, C. Gimeno, and R. Sentandreu. 1989. Evidence for the formation of covalent bonds between macromolecules in the domain of the wall of Candida albicans mycelial cells. Biochem. Biophys. Res. Commun. 162:1118-1125[Medline]. |
| 124. |
Elorza, M. V.,
A. Murgui,
H. Rico, and R. Sentandreu.
1987.
Formation of a new cell wall by protoplasts of Candida albicans: effect of papulacandin B, tunicamycin and nikkomycin.
J. Gen. Microbiol.
133:2315-2325 |
| 125. | Elorza, M. V., A. Murgui, and R. Sentandreu. 1985. Dimorphism in Candida albicans: contribution of mannoproteins to the architecture of yeast and mycelial cells. J. Gen. Microbiol. 131:2209-2216[Medline]. |
| 126. |
Elorza, M. V.,
H. Rico, and R. Sentandreu.
1983.
Calcofluor white alters the assembly of chitin fibrils in Saccharomyces cerevisiae and Candida albicans cells.
J. Gen. Microbiol.
129:1577-1582 |
| 127. | Elorza, M. V., H. Rico, D. Gozalbo, and R. Sentandreu. 1983. Cell wall composition and protoplast regeneration in Candida albicans. Antonie Leeuwenhoek J. Microbiol. Serol. 49:457-469. |
| 128. |
Elorza, M. V.,
R. Sentandreu, and J. Ruiz-Herrera.
1994.
Isolation and characterization of yeast monomorphic mutants of Candida albicans.
J. Bacteriol.
176:2318-2325 |
| 129. |
Enache, E.,
T. Eskandari,
L. Borja,
E. Wadsworth,
B. Hoxter, and R. Calderone.
1996.
Candida albicans adherence to a human oesophageal cell line.
Microbiology
142:2741-2746 |
| 130. | Ener, B., and L. J. Douglas. 1992. Correlation between cell-surface hydrophobicity of Candida albicans and adhesion to buccal epithelial cells. FEMS Microbiol. Lett. 78:37-42[Medline]. |
| 131. | Eroles, P., M. Sentandreu, M. V. Elorza, and R. Sentandreu. 1995. Cloning of a DNA fragment encoding part of a 70 kDa heat shock protein of Candida albicans. FEMS Microbiol. Lett. 128:95-100[Medline]. |
| 132. |
Eroles, P.,
M. Sentandreu,
M. V. Elorza, and R. Sentandreu.
1997.
The highly immunogenic enolase and Hsp70p are adventitious Candida albicans cell wall proteins.
Microbiology
143:313-320 |
| 133. | Faille, C., D. W. R. Mackenzie, J. C. Michalski, and D. Poulain. 1992. The evaluation of an enzyme immunoassay using neoglycolipids constructed from Candida albicans oligomannosides to define the specificity of anti-mannan antibodies. Eur. J. Clin. Microbiol. Infect. Dis. 11:438-446[Medline]. |
| 134. |
Faille, C.,
J. C. Michalski,
G. Strecker,
D. W. R. Mackenzie,
D. Camus, and D. Poulain.
1990.
Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of Candida albicans cell wall.
Infect. Immun.
58:3537-3544 |
| 135. |
Faille, C.,
J. M. Wieruszeski,
G. Lepage,
J. C. Michalski,
D. Poulain, and G. Strecker.
1991.
1H-NMR spectroscopy of manno-oligosaccharides of the -1,2-linked series released from the phosphopeptidomannan of Candida albicans VW32 (serotype A).
Biochem. Biophys. Res. Commun.
181:1251-1258[Medline].
|
| 136. | Fernandes, P. A., J. N. Keen, J. B. C. Findlay, and P. Moradas-Ferreira. 1992. A protein homologous to glyceraldehyde-3-phosphate dehydrogenase is induced in the cell wall of a flocculent Kluyveromyces marxianus. Biochim. Biophys. Acta 1159:67-73[Medline]. |
| 137. |
Field, C., and R. Schekman.
1980.
Localized secretion of acid phosphatase reflects the pattern of cell surface growth in Saccharomyces cerevisiae.
J. Cell Biol.
86:123-128 |
| 138. | Finley, D., and V. Chau. 1991. Ubiquitination. Annu. Rev. Cell Biol. 7:25-69. |
| 139. | Finley, D., E. Ozkaynak, and A. Varshavsky. 1987. The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation and other stresses. Cell 48:1035-1046[Medline]. |
| 140. | Fleet, G. H. 1985. Composition and structure of yeast cell walls. Curr. Top. Med. Mycol. 1:24-56[Medline]. |
| 141. | Fleet, G. H. 1991. Cell walls, p. 199-277. In A. H. Rose, and J. S. Harrison (ed.), The yeast, 2nd ed., vol. 4. Academic Press, Ltd., London, United Kingdom. |
| 142. | Fox, J. F., U. Mayer, R. Nischt, M. Aumailley, R. Reinhardt, H. Wiedemann, K. Maun, R. Timpl, T. Krieg, J. Engel, and M. L. Chu. 1991. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 10:3137-3146[Medline]. |
| 143. | Franklyn, K. M., and J. R. Warmington. 1993. Cloning and nucleotide sequence analysis of the Candida albicans enolase gene. FEMS Microbiol. Lett. 111:101-108[Medline]. |
| 144. | Franklyn, K. M., J. R. Warmington, A. K. Ott, and R. B. Ashman. 1990. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunol. Cell Biol. 68:173-178. |
| 145. |
Franzke, S.,
R. A. Calderone, and K. Schaller.
1993.
Isolation of avirulent clones of Candida albicans with reduced ability to recognize the CR2 ligand C3d.
Infect. Immun.
61:2662-2669 |
| 146. | Frey, C. L., J. M. Barone, and D. J. Drutz. 1990. The role of the Candida albicans iC3b receptor in fungal adherence to endothelial cells, abstr. F-101, p. 425. In Abstracts of the 90th General Meeting of the American Society for Microbiology 1990. American Society for Microbiology, Washington, D.C. |
| 147. | Frey, C. L., J. M. Barone, G. Dreyer, Y. Koltin, S. R. Petteway, Jr., and D. J. Drutz. 1990. Synthetic protease inhibitors inhibit Candida albicans extracellular acid protease activity and adherence to endothelial cells, abstr. F-102, p. 425. In Abstracts of the 90th General Meeting of the American Society for Microbiology 1990. American Society for Microbiology, Washington, D.C. |
| 148. |
Fu, Y.,
A. S. Ibrahim,
W. Fonzi,
X. Zhoud,
C. F. Ramos, and M. A. Ghannoum.
1997.
Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans.
Microbiology
143:331-340 |
| 149. |
Fukayama, M.,
E. Wadsworth, and R. A. Calderone.
1992.
Expression of the C3d-binding protein (CR2) from Candida albicans during experimental candidiasis as measured by lymphoblastogenesis.
Infect. Immun.
60:8-12 |
| 150. | Fukazawa, Y. 1989. Antigenic structure of Candida albicans, p. 37-62. In E. Kurstak, G. Marquis, P. Auger, L. de Repentigny, and S. Montplaisir (ed.), Immunology of fungal diseases. Marcel Dekker, Inc., New York. |
| 151. | Fukazawa, Y., and K. Kagaya. 1997. Molecular basis of adhesion of Candida albicans. J. Med. Vet. Mycol. 35:87-99[Medline]. |
| 152. | Fukazawa, Y., A. Nishikawa, M. Suzuki, and T. Shinoda. 1980. Immunochemical basis of the specificity of the yeast: immunochemical determinants of several antigenic factors of yeast, p. 126-136. In H. J. Preusser (ed.), Medical mycology. Gustav Fischer Verlag, Stuttgart, Germany. |
| 153. |
Gale, G.,
D. Finkel,
M. Meinke,
M. McClellan,
J. Olson,
K. Kendrick, and M. Hostetter.
1996.
Cloning and expression of a gene encoding an integrin-like protein in Candida albicans.
Proc. Natl. Acad. Sci. USA
93:357-361 |
| 154. | Gardiner, R. B., M. Canton, and A. W. Day. 1982. Serological studies on the fimbriae of yeast and yeast-like species. Bot. Gaz. 143:534-541. |
| 154a. |
Gaur, N. K., and S. A. Klotz.
1997.
Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins.
Infect. Immun.
65:5289-5294 |
| 155. | Georgopoulus, C., and W. Welch. 1993. Roles of the major heat shock proteins as molecular chaperones. Annu. Rev. Cell. Biol. 9:601-634. |
| 156. | Gething, M. J., and J. Sambrook. 1992. Protein folding in the cell. Nature 355:33-45[Medline]. |
| 157. | Ghannoum, M., and K. Abu-Elteen. 1986. Correlative relationship between proteinase production, adherence, and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol. 24:407-413[Medline]. |
| 158. |
Ghannoum, M. A.,
G. R. Burns,
K. A. Elteen, and S. S. Radwan.
1986.
Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells.
Infect. Immun.
54:189-193 |
| 159. |
Gil, M. L.,
M. Casanova,
J. P. Martínez, and R. Sentandreu.
1991.
Antigenic cell wall mannoproteins in Candida albicans isolates and in other Candida species.
J. Gen. Microbiol.
137:1053-1061 |
| 160. | Gil, M. L., M. Casanova, and J. P. Martínez. 1994. Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch. Microbiol. 161:489-494[Medline]. |
| 161. |
Gil-Navarro, I.,
M. L. Gil,
M. Casanova,
J. P. Martínez, and D. Gozalbo.
1997.
The glycolytic enzyme glyceraldehyde-3-phosphate-dehydrogenase of Candida albicans is a surface antigen.
J. Bacteriol.
179:4992-4999 |
| 162. | Gilmore, B. J., E. M. Retsinas, J. S. Lorenz, and M. K. Hostetter. 1988. An iC3b receptor on Candida albicans. J. Infect. Dis. 157:38-46[Medline]. |
| 163. |
Glee, P. M.,
P. Sundstrom, and K. C. Hazen.
1995.
Expression of surface hydrophobic proteins by Candida albicans in vivo.
Infect. Immun.
63:1373-1379 |
| 164. | Glee, P. M., J. Masouka, W. T. Ozier, and K. C. Hazen. 1996. Presence of multiple laminin- and fibronectin-binding protein in cell wall extract of Candida albicans: influence of dialysis. J. Med. Vet. Mycol. 34:57-61[Medline]. |
| 165. |
Goldman, R. C.,
P. A. Sullivan,
D. Zakula, and J. O. Capobianco.
1995.
Kinetics of -1,3 glucan interaction at the donor and acceptor sites of the fungal glucosyltransferase encoded by the BGL2 gene.
Eur. J. Biochem.
227:372-378[Medline].
|
| 166. |
Goldmann, D. A., and G. B. Pier.
1993.
Pathogenesis of infections related to intravascular catheterization.
Clin. Microbiol. Rev.
6:176-192 |
| 167. |
Goldstein, G.,
M. Scheid,
U. Hammerling,
D. H. Schlesinger,
H. D. Niall, and W. A. Boyse.
1975.
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells.
Proc. Natl. Acad. Sci. USA
72:11-15 |
| 168. |
Gómez, F. J.,
A. M. Gómez, and G. S. Deepe, Jr.
1992.
An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell mediated immune responses and protection in mice.
Infect. Immun.
60:2565-2571 |
| 169. |
Gómez, M. J.,
A. Torosantucci,
S. Arancia,
B. Maras,
L. Parisi, and A. Cassone.
1996.
Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.
Infect. Immun.
64:2577-2584 |
| 170. | Gooday, G. W., W.-Y. Zhu, and R. W. O'Donnell. 1992. What are the roles of chitinases in the growing fungus? FEMS Microbiol. Lett. 100:387-392. |
| 171. |
Gopal, P.,
P. A. Sullivan, and M. G. Shepherd.
1982.
Enzymes of N-acetylglucosamine metabolism during germ-tube formation in Candida albicans.
J. Gen. Microbiol.
128:2319-2326 |
| 172. | Gottlieb, K., and S. Mobarhan. 1994. Review: microbiology of the gastrostomy tube. J. Am. Coll. Nutr. 13:311-313[Abstract]. |
| 173. |
Goudot-Crozel, V.,
D. Caillol,
M. Djabali, and A. J. Dessein.
1989.
The major parasite surface antigen associated with human resistance to schistosomiasis is a 37 kDa glyceraldehyde-3P-dehydrogenase.
J. Exp. Med.
170:2065-2080 |
| 174. | Goyal, S., and G. K. Khuller. 1992. Phospholipid composition and subcellular distribution in yeast and mycelial forms of Candida albicans. J. Med. Vet. Mycol. 30:355-362[Medline]. |
| 175. | Gozalbo, D., M. V. Elorza, R. Sanjuán, A. Marcilla, E. Valentín, and R. Sentandreu. 1993. Critical steps in fungal cell wall synthesis: strategies for their inhibition. Pharmacol. Ther. 60:337-345[Medline]. |
| 176. | Gustafson, K. S., G. M. Vercellotti, C. M. Bendel, and M. K. Hostetter. 1991. Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J. Clin. Invest. 87:1896-1902. |
| 177. |
Gutiérrez, J.,
C. Maroto,
E. Piédrola,
E. Martín, and J. A. Pérez.
1993.
Circulating Candida antigens and antibodies: useful markers of candidemia.
J. Clin. Microbiol.
31:2550-2552 |
| 178. |
Hartland, R. P.,
G. W. Emeson, and P. A. Sullivan.
1991.
A secreted -glucan-branching enzyme from Candida albicans.
Proc. R. Soc. London Ser. B
246:155-160[Medline].
|
| 179. | Hawser, S. 1996. Adhesion of different Candida spp. to plastic: XTT formazan determinations. J. Med. Vet. Mycol. 34:407-410[Medline]. |
| 180. | Hawser, S. 1996. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronized C. albicans cells. J. Med. Vet. Mycol. 34:149-152[Medline]. |
| 181. |
Hawser, S. P., and L. J. Douglas.
1994.
Biofilm formation by Candida species on the surface of catheter materials in vitro.
Infect. Immun.
62:915-921 |
| 182. | Hayman, E. G., M. D. Pierschbacher, S. Suzuki, and E. Ruoslahti. 1985. Vitronectin: a major cell attachment-promoting protein in fetal bovine serum. Exp. Cell Res. 160:245-258[Medline]. |
| 183. |
Hazen, B. W., and K. C. Hazen.
1988.
Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans.
Infect. Immun.
56:2521-2525 |
| 184. | Hazen, B. W., R. E. Liebert, and K. C. Hazen. 1988. Relationship of cell surface hydrophobicity to morphology of monomorphic and dimorphic fungi. Mycologia 80:348-355. |
| 185. |
Hazen, K. C.
1989.
Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells.
Infect. Immun.
57:1894-1900 |
| 186. | Hazen, K. C. 1990. Cell surface hydrophobicity of medically important fungi, specially Candida species, p. 249-295. In R. J. Doyle, and M. Rosenberg (ed.), Microbial cell surface hydrophobicity. American Society for Microbiology, Washington, D.C. |
| 187. |
Hazen, K. C.,
D. L. Brawner,
M. H. Riesselman,
J. E. Cutler, and M. A. Jutila.
1991.
Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues.
Infect. Immun.
59:907-912 |
| 188. | Hazen, K. C., and P. M. Glee. 1994. Hydrophobic cell wall glycosylation by the pathogenic fungus Candida albicans. Can. J. Microbiol. 40:266-272[Medline]. |
| 189. | Hazen, K. C., and B. W. Hazen. 1987. A polystyrene microsphere assay for detecting surface hydrophobicity variations within Candida albicans populations. J. Microbiol. Methods 6:289-299. |
| 190. |
Hazen, K. C., and B. W. Hazen.
1992.
Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans.
Infect. Immun.
60:1499-1508 |
| 191. | Hazen, K. C., and B. W. Hazen. 1993. Surface hydrophobic and hydrophilic protein alterations in Candida albicans. FEMS Microbiol. Lett. 107:83-88[Medline]. |
| 192. | Hazen, K. C., B. W. Hazen, and M. M. Allietta. 1995. Cell wall anchoring to cytoplasmic membrane of Candida albicans. FEMS Microbiol. Lett. 125:143-148[Medline]. |
| 193. |
Hazen, K. C.,
J. G. Lay,
B. W. Hazen,
R. C. G. Fu, and S. Murthy.
1990.
Partial biochemical characterization of cell surface hydrophobicity and hydrophilicity of Candida albicans.
Infect. Immun.
58:3469-3476 |
| 194. |
Heidenreich, F., and M. P. Dierich.
1985.
Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b.
Infect. Immun.
50:598-600 |
| 195. | Hernando, F. L., J. J. Estévez, M. Cebrián, D. Poulain, and J. Pontón. 1993. Identification of Candida albicans cell wall antigens lost during subculture in synthetic media. J. Med. Vet. Mycol. 31:227-237[Medline]. |
| 196. | Herrero, E., P. Sanz, and R. Sentandreu. 1987. Cell wall proteins liberated by Zymolyase from several ascomycetous and imperfect yeasts. J. Gen. Microbiol. 133:2895-2903. |
| 197. | Hershko, A., and A. Ciechanover. 1992. The ubiquitin system for protein degradation. Annu. Rev. Microbiol. 61:761-807. |
| 198. | Hicke, L., and H. Riezman. 1996. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell 84:277-287[Medline]. |
| 199. |
Hoffman, M. P., and C. G. Haidaris.
1993.
Analysis of Candida albicans adhesion to salivary mucin.
Infect. Immun.
61:1940-1949 |
| 200. |
Hoffman, M. P., and C. G. Haidaris.
1994.
Identification and characterization of a Candida albicans-binding proteoglycan secreted from rat submandibular salivary glands.
Infect. Immun.
62:828-836 |
| 201. | Holland, M. J., and J. P. Holland. 1978. Isolation and identification of yeast messenger ribonucleic acids coding for enolase, glyceraldehyde-3-phosphate dehydrogenase, and phosphoglycerate kinase. Biochemistry 17:4900-4907[Medline]. |
| 202. | Holmes, A. R., R. D. Cannon, and H. R. Jenkinson. 1995. Interactions of Candida albicans with bacterial and salivary molecules in oral biofilms. J. Ind. Microbiol. 15:208-213[Medline]. |
| 203. |
Holmes, A. R.,
P. K. Gopal, and H. F. Jenkinson.
1995.
Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii.
Infect. Immun.
63:1827-1834 |
| 204. |
Holmes, A. R.,
R. McNab, and H. F. Jenkinson.
1996.
Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions.
Infect. Immun.
64:4680-4685 |
| 205. | Homma, M., H. Chibana, and K. Tanaka. 1993. Induction of extracellular proteinase in Candida albicans. J. Gen. Microbiol. 139:1187-1193. |
| 206. |
Homma, M.,
T. Kanbe,
H. Chibana, and K. Tanaka.
1992.
Detection of intracellular forms of secretory aspartic proteinase in Candida albicans.
J. Gen. Microbiol.
138:627-633 |
| 207. |
Hopwood, V. D.,
D. Poulain,
B. Fortier,
G. Evans, and A. Vernes.
1986.
A monoclonal antibody to a cell wall component of Candida albicans.
Infect. Immun.
54:222-227 |
| 208. | Hostetter, M. K. 1991. Complement receptors in Candida albicans. Clin. Immunol. Newsl. 11:1-3. |
| 209. |
Hostetter, M. K.
1994.
Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial cells.
Clin. Microbiol. Rev.
7:29-42 |
| 210. | Hostetter, M. K., J. S. Lorenz, L. Preus, and K. E. Kendrick. 1990. The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J. Infect. Dis. 161:761-768[Medline]. |
| 211. |
Howlett, J. A., and C. Squier.
1980.
Candida albicans ultrastructure: colonization and invasion of oral epithelium.
Infect. Immun.
29:252-260 |
| 212. | Hoyer, L. L., S. Scherer, A. R. Shatzman, and G. P. Livi. 1995. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol. Microbiol. 15:39-54[Medline]. |
| 213. |
Hsu, L. Y.,
G. E. Minah,
D. E. Peterson,
J. R. Wingard,
W. G. Merz,
V. Altomonte, and C. A. Tylenda.
1990.
Coaggregation of oral Candida isolates with bacterial from bone marrow transplant recipients.
J. Clin. Microbiol.
28:2621-2626 |
| 214. | Hube, B., M. Monod, D. A. Schofield, A. J. P. Brown, and N. A. R. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14:87-99[Medline]. |
| 214a. |
Hube, B.,
D. Sanglard,
F. C. Odds,
D. Hess,
M. Monod,
W. Schafer,
A. J. P. Brown, and N. A. R. Gow.
1997.
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence.
Infect. Immun.
65:3529-3538 |
| 215. | Hube, B., C. J. Turver, F. C. Odds, H. Eiffert, G. J. Boulnois, H. Kochel, and R. Rüchel. 1991. Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J. Med. Vet. Mycol. 29:129-132[Medline]. |
| 216. | Hynes, R. O. 1992. Integrins: versatility, modulation and signalling in cell adhesion. Cell 69:11-25[Medline]. |
| 217. |
Ibrahim, A. S.,
F. Mirbod,
S. G. Filler,
Y. Banno,
G. T. Cole,
Y. Kitajima,
J. E. Edwards, Jr.,
Y. Nozawa, and M. A. Ghannoum.
1995.
Evidence implicating phospholipase as a virulence factor of Candida albicans.
Infect. Immun.
63:1993-1998 |
| 218. |
Ingolia, T. D.,
M. R. Slater, and E. A. Craig.
1982.
Saccharomyces cerevisiae contains a complex multigene family related to the major heat-shock-inducible gene of Drosophila.
Mol. Cell. Biol.
2:1388-1398 |
| 219. |
Ishiguro, A.,
M. Homma,
S. Torii, and K. Tanaka.
1992.
Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.
Infect. Immun.
60:1550-1557 |
| 220. |
Ishii, N.,
M. Yamamoto,
F. Yoshihara,
M. Arisawa, and Y. Aoki.
1997.
Biochemical and genetic characterization of Rbf1p, a putative transcription factor of Candida albicans.
Microbiology
143:429-435 |
| 221. | Ito, K., A. Ishiguro, T. Kanbe, K. Tanaka, and S. Torii. 1995. Detection of IgE antibody against Candida albicans enolase and its crossreactivity to Saccharomyces cerevisiae enolase. Clin. Exp. Allergy 25:522-528[Medline]. |
| 222. | Jakab, E., M. Paulsson, F. Ascencio, and A. Ljungh. 1993. Expression of vitronectin and fibronectin binding by Candida albicans yeast cells. APMIS 101:187-193[Medline]. |
| 223. |
Jenkinson, H. F., and M. G. Shepherd.
1987.
A mutant of Candida albicans deficient in -N-acetylglucosaminidase (Chitobiase).
J. Gen. Microbiol.
133:2097-2106 |
| 224. |
Jenkinson, H. F.,
H. C. Lala, and M. G. Shepherd.
1990.
Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans.
Infect. Immun.
58:1429-1436 |
| 225. | Jenq, W., C. L. Chen, C. C. Chang, and R. F. E. Crang. 1994. Characterization of a major cell wall antigen and potential adhesin in three strains of Candida albicans. Arch. Microbiol. 162:33-40[Medline]. |
| 226. |
Jiménez-Lucho, V.,
V. Ginsburg, and H. C. Krivan.
1990.
Cryptococcus neoformans, Candida albicans, and other fungi bind specifically to the glycosphingolipid lactosylceramide (Gal 1-4Glc 1-1Cer), a possible adhesion receptor for yeast.
Infect. Immun.
58:2085-2090 |
| 227. | Jones, L., C. Hobden, and P. O'Shea. 1995. Use of a real time fluorescent probe to study the electrostatic properties of the cell surface of Candida albicans. Mycol. Res. 99:969-976. |
| 228. |
Jouault, T.,
A. Bernigaud,
G. Lepage,
P. A. Trinel, and D. Poulain.
1994.
The Candida albicans phospholipomannan induces in vitro production of tumor necrosis factor- from human and murine macrophages.
Immunology
83:268-273[Medline].
|
| 229. |
Jouault, T.,
G. Lepage,
A. Bernigaud,
P. A. Trinel,
C. Fradin,
M. Wieruszeski,
G. Strecker, and D. Poulain.
1995.
-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production.
Infect. Immun.
63:2378-2381 |
| 230. | Kalo, A., E. Segal, E. Sahar, and D. Dayan. 1988. Interaction of Candida albicans with genital mucosal surfaces: involvement of fibronectin in adherence. J. Infect. Dis. 157:1253-1256[Medline]. |
| 231. | Kalya, A. V., and D. G. Ahearn. 1995. Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone. J. Ind. Microbiol. 14:451-455[Medline]. |
| 232. |
Kaminishi, H.,
H. Miyaguchi,
T. Tamaki,
N. Suenaga,
M. Hisamatsu,
I. Mihashi,
H. Matsumoto,
H. Maeda, and Y. Hagihara.
1995.
Degradation of humoral host defense by Candida albicans proteinase.
Infect. Immun.
63:984-988 |
| 233. |
Kaminishi, H.,
M. Tanaka,
T. Cho,
H. Maeda, and Y. Hagihara.
1990.
Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.
Infect. Immun.
58:2139-2143 |
| 234. |
Kanbe, T., and J. E. Cutler.
1994.
Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans.
Infect. Immun.
62:1662-1668 |
| 235. |
Kanbe, T.,
R. K. Li,
E. Wadsworth,
R. A. Calderone, and J. E. Cutler.
1991.
Evidence for the expression of the C3d receptor of Candida albicans in vitro and in vivo by immunofluorescence and immunoelectron microscopy.
Infect. Immun.
59:1832-1838 |
| 236. |
Kanbe, T.,
Y. Han,
B. Redgrave,
M. H. Riesselman, and J. E. Cutler.
1993.
Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph nodes tissue.
Infect. Immun.
61:2578-2584 |
| 237. |
Kapteyn, J. C.,
R. C. Montijn,
G. J. Dijkgraaf, and F. M. Klis.
1994.
Identification of -1,6-glucosylated cell wall proteins in yeast and hyphal forms of Candida albicans.
Eur. J. Cell Biol.
65:402-407[Medline].
|
| 238. |
Kapteyn, J. C.,
R. C. Montijn,
G. J. Dijkgraaf,
H. van den Ende, and F. M. Klis.
1995.
Covalent association of -1,3-glucan with -1,6-glucosylated mannoproteins in cell walls of Candida albicans.
J. Bacteriol.
177:3788-3792 |
| 239. | Katz, A., A. J. Fish, M. M. Kleppel, S. G. Hagen, A. F. Michael, and R. J. Butkwoski. 1991. Renal entactin (nidogen): isolation, characterization and tissue distribution. Kidney Int. 40:643-652[Medline]. |
| 240. | Kauffmann, S. H. E. 1990. Heat shock proteins and the immune response. Immunol. Today 11:129-136[Medline]. |
| 241. | Kauffmann, S. H. E., and B. Schoel. 1994. Heat shock proteins as antigen in immunity against infection and self, p. 495-531. In R. I. Morimoto, A. Tissieres, and G. Georgopoulos (ed.), The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 242. | Kennedy, M. J., and R. E. Sandin. 1988. Influence of growth conditions on Candida albicans adhesion, hydrophobicity and cell wall ultrastructure. J. Med. Vet. Mycol. 26:79-92[Medline]. |
| 243. |
Kennedy, M. J.,
A. L. Rogers, and R. J. Yancey, Jr.
1989.
Environmental alterations and phenotypic regulation of Candida albicans adhesion to plastic.
Infect. Immun.
57:3876-3881 |
| 244. | Kerridge, D. 1993. Fungal dimorphism: a sideways look, p. 3-10. In H. Vanden Bossche, F. C. Odds, and D. Kerridge (ed.), Dimorphic fungi in biology and medicine. Plenum Press, New York, N.Y. |
| 245. |
Klebl, F., and W. Tanner.
1989.
Molecular cloning of a cell wall exo- -1,3-glucanase from Saccharomyces cerevisiae.
J. Bacteriol.
171:6259-6264 |
| 246. | Klis, F. M. 1994. Review: cell wall assembly in yeast. Yeast 10:851-869[Medline]. |
| 247. | Klis, F. M., L. H. P. Caro, J. H. Vossen, J. C. Kapteyn, A. RF. J. Ram, R. C. Montijn, M. A. A. Van Berkel, and H. Van Den Ende. 1997. Identification and characterization of a major building block in the cell wall of Saccharomyces cerevisiae. Biochem. Soc. Trans. 25:856-860[Medline]. |
| 248. | Klotz, S. A. 1987. The adherence of Candida yeast to human and bovine vascular endothelium and subendothelial extracellular matrix. FEMS Microbiol. Lett. 48:201-205. |
| 249. | Klotz, S. A. 1990. Adherence of Candida albicans to components of the subendothelial extracellular matrix. FEMS Microbiol. Lett. 68:249-254. |
| 250. | Klotz, S. A. 1994. Plasma and extracellular matrix proteins mediate in the fate of Candida albicans in the human host. Med. Hypotheses 42:328-334[Medline]. |
| 251. |
Klotz, S. A., and R. D. Maca.
1988.
Endothelial cell contraction increases Candida adherence to exposed extracellular matrix.
Infect. Immun.
56:2495-2498 |
| 252. | Klotz, S. A., and R. L. Penn. 1987. Multiple mechanisms may contribute to the adherence of Candida yeasts to living cells. Curr. Microbiol. 16:119-122. |
| 253. | Klotz, S. A., and R. L. Smith. 1991. A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J. Infect. Dis. 163:604-610[Medline]. |
| 254. | Klotz, S. A., and R. L. Smith. 1992. Glycosaminoglycans inhibit Candida albicans adherence to extracellular matrix proteins. FEMS Microbiol. Lett. 99:205-208. |
| 255. |
Klotz, S. A., and R. L. Smith.
1995.
Gelatin fragments block adherence of Candida albicans to extracellular matrix proteins.
Microbiology
141:2681-2684 |
| 256. |
Klotz, S. A.,
R. C. Chen,
R. L. Smith, and J. B. Rouse.
1994.
The fibronectin adhesin of Candida albicans.
Infect. Immun.
62:4679-4681 |
| 257. |
Klotz, S. A.,
D. J. Drutz,
J. L. Harrison, and M. Huppert.
1983.
Adherence and penetration of vascular endothelium by Candida yeasts.
Infect. Immun.
42:374-384 |
| 258. |
Klotz, S. A.,
D. J. Drutz, and J. E. Zajic.
1985.
Factors governing adherence of Candida species to plastic surfaces.
Infect. Immun.
50:97-101 |
| 259. | Klotz, S. A., M. J. Rutten, R. L. Smith, S. R. Babcock, and M. D. Cunningham. 1993. Adherence of Candida albicans to immobilized extracellular matrix proteins is mediated by calcium-dependent surface glycoproteins. Microb. Pathog. 14:133-147[Medline]. |
| 260. |
Klotz, S. A.,
R. L. Smith, and B. W. Stewart.
1992.
Effect of an arginine-glycine-aspartic acid-containing peptide on hematogenous candidal infections.
Antimicrob. Agents Chemother.
36:132-136 |
| 261. |
Kobayashi, H.,
P. Giummelly,
S. Takahashi,
M. Ishida,
J. Sato,
M. Takaku,
Y. Nishidate,
N. Shibata,
Y. Okawa, and S. Suzuki.
1991.
Candida albicans serotype A strains grow in yeast extract added Sabouraud liquid medium at pH 2.0, elaborating mannans without -1,2 linkage and phosphate group.
Biochem. Biophys. Res. Commun.
175:1003-1009[Medline].
|
| 262. | Kobayashi, H., N. Shibata, H. Mitobe, Y. Ohkubo, and S. Suzuki. 1989. Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch. Biochem. Biophys. 272:364-375[Medline]. |
| 263. | Kobayashi, H., N. Shibata, M. Nakada, S. Chaki, K. Mizugami, Y. Ohkubo, and S. Suzuki. 1990. Structural analysis of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues. Arch. Biochem. Biophys. 278:195-204[Medline]. |
| 264. | Kobayashi, H., M. Takaku, Y. Nishidate, S. Takahashi, M. Takikawa, N. Shibata, Y. Okawa, and S. Suzuki. 1992. Structure of the D-mannan of the pathogenic yeasts, Candida stellatoidea ATCC 20408 (type II) strain, in comparison with that of C. stellatoidea ATCC 36232 (type I) strain. Carbohydr. Res. 231:105-116[Medline]. |
| 265. |
Kobayashi, H.,
N. Shibata, and S. Suzuki.
1992.
Evidences for oligomannosyl residues containing both -1,2 and -1,2 linkages as a serotype A-specific epitope(s) in mannans of Candida albicans.
Infect. Immun.
60:2106-2109 |
| 266. | Kobayashi, H., S. Tanaka, J. Susuki, Y. Kiuchi, N. Shibata, S. Suzuki, and Y. Okawa. 1997. Amended structure of side chains in a cell wall mannan from Candida albicans serotype A strain grown in yeast extract-Sabouraud liquid medium under acidic conditions: detection of the branched side chains corresponding to antigenic factor 4. FEMS Microbiol. Lett. 152:235-242[Medline]. |